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Abstract 
 
 
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized 
by progressive cognitive impairments (Selkoe, 2001). Hippocampal place cells are a well 
understood candidate for the neural basis of one type of memory in rodents; these cells 
identify the animal's location in an environment and are crucial for spatial memory and 
navigation. This PhD project aims to clarify the mechanisms responsible for the cognitive 
deficits in AD at the hippocampal network level, by examining place cell physiology in a 
transgenic mouse model of AD. I have recorded place cells in tg2576 mice, and found that 
aged (16 months) but not young (3 months) transgenic mice show degraded neuronal 
representations of the environment. The level of place cell degradation correlates with the 
animals' (poorer) spatial memory as tested in a forced-choice spatial alternation T-maze 
task and with hippocampal, but not neocortical, amyloid plaque burden. Additionally, pilot 
data show that physiological changes of the hippocampus in tg2576 mice seem to start as 
early as 3 months, when no pathological and behavioural deficits are present. However, 
these changes are not obvious at the neuronal level, but only at the hippocampal network 
level, which represent hippocampal responses to environmental changes. Place cell 
recording provides a sensitive assay for measuring the amount and rate of functional 
deterioration in animal models of dementia as well as providing a quantifiable 
physiological indication of the beneficial effects of potential therapies. 
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Introduction 
 
 
Chapter 1   Alzheimer’s Disease: Clinical Features 
 
 
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized 
by progressive cognitive, language and behavioural impairments, eventually leading to 
dramatic loss of most cortical and subcortical functions and ultimate death (Selkoe, 2001).  
This chapter discusses the clinical characters of AD, including its epidemiology, risk 
factors, clinical syndrome, diagnosis and treatment.  
 
1 Epidemiology 
AD is named after Alois Alzheimer, who in 1907 first reported the case of a middle-
aged woman who developed memory deficits and progressive loss of cognitive abilities 
accompanied by morbid jealousy (Alzheimer, 1907). Nowadays, AD is the most common 
type of dementia, constituting approximately 60-70% of all cases. It occurs in mid- to late-
life, affecting 7–10% of individuals >65 years of age and 40% of persons >80 years 
(McKhann et al, 1984; Evans et al, 1989). The prevalence of this disease is increasing 
because of significant shifts in life expectancy and demographic parameters.  
The vast majority cases of AD occur in sporadic form after 65 years of age, lacking 
alterations in the known set of genetic markers, which suggests either environmental causes 
or a combination of environmental and predisposing genetic determinants. However, 
around 5% of AD cases are early-onset (<65 years of age) and have a definite genetic 
element, whereby they are inherited in an autosomal dominant fashion. Genetic linkage 
analyses have led to the identification of three genes associated with such familial AD 
(FAD) – amyloid β-protein precursor (APP) on chromosome 21 (Goate et al, 1991), 
presenilin-1 (PS-1) on chromosome 14 (Sherrington et al, 1995), and presenilin-2 (PS-2) 
on chromosome 1 (Levy-Lahad et al 1995; Rogaev et al, 1995). Nevertheless, to some 
extent, the sporadic late-onset cases of AD also have a genetic component. The most 
prominent genetic risk factor is the apolipoprotein E (apoE) gene in chromosome 19 
(Strittmatter et al, 1993; next section). Because all these genes potentially influence the 
processing of APP protein and the production of β-amyloid, which is the core component 
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Table 1.1    Key risk factors and protective factors for AD 
Primary risk factors: age; family history; genetic markers such as apoE ε4; trisomy 
21; mutations in presenilin-1 and -2; female gender after 80 years of age; 
cardiovascular risk factors such as hypertension, diabetes, obesity, and 
hypercholesterolemia 
Possible risk factors: head injury; depression; progression of Parkinson-like signs in 
older adults; lower thyroid-stimulating hormone within the normal range; 
hyperhomocysteinemia; folate deficiency; hyperinsulinemia; low educational 
attainments 
Possible protective factors: apoE ε2; regular fish consumption; regular consumption 
of omega-3 fatty acids; high educational level; regular exercise; non-steroidal 
anti-inflammatory drug therapy; moderate alcohol intake; vitamins C, E, B6, and 
B12 and folate intake 
 
Adapted from Desai and Grossberg, 2005 
of amyloid plaques, their functions and mutations will be discussed in the next chapter.  
Both clinically and pathologically, FAD and sporadic AD are highly similar or often 
indistinguishable. This general phenotypic similarity suggests that FAD and sporadic AD 
may share the same pathogenic pathway leading to the stereotypic neuropathology, that the 
role of the mutated genes is simply to accelerate the progression of the disease, and that 
information about FAD is likely to be directly relevant to the pathogenesis of the common, 
sporadic AD (Hardy and Higgins, 1992).  
 
2 Risk factors 
There are behavioural, dietary, environmental and genetical factors that may affect the 
risk of AD (Table 1.1). Age is the single most potent risk factor, with the prevalence rate 
increasing dramatically with age (Breitner and Welsh, 1995). Representative prevalence 
rates are: 5-7% at age 75-85 years; 15-17% at 80-85 years; 35% at 85-90 years; and 50% at 
90-95 years (McKhann et al, 1984; Evans et al, 1989). Other risk factors may include low 
education levels, head injury, consumption of high-calorie diets, and so forth (Mattson, 
2004; Blennow et al, 2007; Table 1.1). In contrast, regular consumption of homocysteine-
related vitamins, antioxidants, could reduce the risk of AD (Blennow et al, 2007; Table 4.1).  
Most AD cases are idiopathic, but to some extent, these cases also have a genetic 
component. The most prominent genetic risk factor is the apoE4 allele of apoE gene 
(Strittmatter et al, 1993). Of its three forms (ε2, ε3 and ε4), the presence of ε4 has been 
shown to increase the likelihood of developing sporadic AD and to accelerate the onset of 
familial AD, whereas ε2 has a protective effect (Corder et al, 1993; Saunders et al, 1993). 
However, the apoE alleles are neither necessary nor sufficient for the development of AD. 
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Some humans homozygous for the ε4 isoform still show no Alzheimer symptoms in their 
ninth decade of life and beyond. Conversely, a great many humans develop AD without 
harboring ε4 alleles. Thus, it is neither specific nor sensitive enough to be used as a 
diagnostic test.  
 
3 Clinical features of Alzheimer’s disease 
The primary manifestations of AD include cognitive impairment, neurological 
abnormalities and neuropsychiatric disturbances (Emilien et al, 2004). Cognition refers to 
higher brain functions such as learning and memory. Early stage of AD is characterized by 
cognitive dysfunction including amnesia (loss of memory), aphasia (impairment of 
language), apraxia (impairment of motor tasks despite normal motor functions) and agnosia 
(impairment of recognition despite intact sensory functions). Neurological abnormalities 
include loss of more fundamental neural functions such as impairment of walking and 
incontinence and occur in the late phases of the illness. Neuropsychiatric alterations are 
common, though are not necessarily present in all patients and may vary over the course of 
the illness. Common symptoms include depression, personality change, delusions and 
hallucinations. Secondary effects of AD include progressive difficulties with instrumental 
activities of daily living such as driving and cooking, with eventual loss of the ability to do 
basic daily tasks such as feeding and toileting.  
3.1 Pattern of cognitive deficits in AD 
Amnesia, aphasia, apraxia and agnosia form the core cognitive dysfunction in AD and 
are involved in the diagnosis criterion of AD. Determining the progression of AD is 
important not only for its diagnosis and staging, but also for identifying the corresponding 
pathogenesis. The majority of patients with sporadic AD exhibit clinical signs during the 
Table 1.2    Four-level classification of memory function in aged humans 
Levels Characterization 
Normal Peak performance preserved during senescence 
Age-related changes A decline from the hypothetical peak with cognitive 
functioning still within the range of same-age peers 
Mild cognitive 
impairment (MCI) 
Forgetfulness and significantly worse performance than 
same-age peers without necessarily experiencing a 
disruption of daily living activities 
Dementia 
(clinical AD) 
A significant deterioration which reaches a level of severity 
that interferes with daily living activities and becomes 
consistent with the diagnostic criteria for dementia 
Adapted from Mesulam, 1999 
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seventh decade, whereas individuals with inherited AD often become demented in midlife. 
The precise onset of clinical AD is very difficult to discern. In general, subtle, intermittent 
difficulty with the acquisition and retention of new information is the earliest and most 
salient manifestation of AD (Small et al, 2003; Grundman et al, 2004). Many patients have 
purely episodic memory impairment with insidious onset for a number of years. When 
clinical neuropsychological tests are used to evaluate memory in AD patients, recall and 
recognition performance are impaired in both the verbal and nonverbal domains (Albert, 
1996). Several factors contribute to this disruption, including deficiencies in encoding and 
storing new information and increased sensitivity to disruptive effects of proactive 
interference.  
Impairment in spatial cognition is a common symptom in early AD (Monacelli et al, 
2003) and some variants of mild cognitive impairments (Mapstone et al, 2003). More than 
one-third of patients with AD exhibit visuospatial disorientation with prominent deficits in 
judging
 
spatial relations (Cogan, 1985) and constructional capacities (Henderson et al, 
1989). Patients often complain of “getting lost”, first in unfamiliar environments, 
subsequently in familiar places as well. Such topographical disorientation in AD has been 
ascribed to impaired visuospatial function (damage to parieto-occipital regions), to 
topographical agnosia (damage to parietal lobe) and to an impaired memory for places 
(damage to the hippocampus and the parahippocampal regions).  
Difficulty in speech and language may be also present in early AD (Emilien et al, 
2004). Word-finding difficulty is frequently noted and speech output is often diminished. 
Later in the disease impairment of word comprehension, neologisms and paraphasia occur, 
which reflects a breakdown in semantic memory function, and a decline in executive 
functions.  
Impairment of other cognitive functions becomes increasingly prominent during the 
course of the disease. In more affected patients, semantic and remote memory deficits are 
frequent, whereas procedural memory remains relatively preserved until the very late 
stages of the disease (Albert, 1996). Apraxia is present in most patients with mild to 
moderate AD, resulting from damage to parietal and frontal association areas, whereas 
visual agnosia is common in more advanced stages and results from damage to the visual 
association areas. The progressive implication of multiple cognitive domains reflects the 
accumulation of pathological changes in the frontal, temporal and parietal lobes. 
3.2 Mild cognitive impairments 
The introduction of the concept of “mild cognitive impairment” (MCI) stems from two 
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aspects of research. Firstly, whereas cognitive impairments characterize AD, a decline in 
cognitive performance, including difficulties with memory, learning, speed of performance, 
recall accuracy, and problem solving is also common in the aged population. To evaluate 
memory function in the aged population, a four-level classification has been suggested 
(Mesulam, 1999), after a stage of peak performance is reached at some point during the life 
span. Secondly, it is clear that the neuropathological changes in AD start from the 
entorhinal cortex, progress to the hippocampus, and affect the neocortex later (Braak and 
Braak, 1991). However, significant neocortical pathology is already present by the time 
dementia is clinically diagnosed.  
Therefore, AD may be associated with a prolonged preclinical phase, when the 
cognitive dysfunction is relatively subtle and insufficiently severe for a diagnosis of 
dementia (Almkvist et al, 1998). This prompted efforts to identify the clinical 
manifestations of AD in the earliest stage, when neuropathology is primarily restricted in 
the medial temporal lobe. This is why the concept of MCI generates a great deal of interest. 
It generally refers to a transitional clinical state of cognitive changes between normal aging 
and AD, when the subjects have a memory impairment that is out of proportion to that 
expected for age yet do not meet commonly accepted criteria for clinically probable AD 
(Petersen et al, 2001; Arnaiz and Almkvist, 2003). As for the relationship between aging, 
MCI and AD, there is still no consensus if the MCI group represents an inevitable feature 
of normal aging, an accompanying syndrome of an underlying disease, a separate entity, or 
simply an early-stage dementia. Also unclear is whether all subjects with MCI will develop 
AD, or whether the absence of MCI excludes subsequent AD. But one generally accepted 
conclusion is that individuals with MCI are at an increased risk for developing AD (Dawe 
et al, 1992; Arnaiz and Almkvist, 2003). Approximately 12% of cases of MCI convert to 
AD each year (Petersen et al, 1999). Thus MCI may represent a possible prodromal stage 
of AD (Petersen et al, 1999; Petersen and Morris, 2005).  
Despite intense research, the boundary area between aging and the very early stage of 
AD remains poorly delineated, because the transition from normal cognition to AD is 
gradual and many of the early cognitive signs of dementia overlap with modifications in 
normal aging and there are no definitive early diagnostic markers for AD. The current MCI 
diagnosis requires the presence of memory complaint. One often-used criterion for MCI 
include complaints of memory problems, memory performance below age-based reference 
norms, normal performance in other cognitive domains, absence of impairment in 
instrumental and basic activities of daily living and no diagnosis of dementia (Petersen et al, 
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1997; Petersen, 2000). However it has been recognized that there are several clinical 
subtypes of MCI that involve other cognitive domains, either in isolation or in combination 
with amnesia, such as language, attention, motivation, affect and executive function 
(Bozoki et al, 2001; Mapstone et al, 2003). Moreover, elderly subjects with MCI involving 
domains other than memory are two or more times as likely to develop AD within 2-5 
years compared to those with memory impairment alone (Bozoki et al, 2001). The subtypes 
attest to the heterogeneous nature of MCI with several causes leading to the same 
symptoms.  
3.3 Relationships between normal aging and AD 
Because of the similarities of cognitive decline in normal aging and AD, it is important 
to understand the relationship between these two states. Two frameworks have been 
proposed that differ as to whether aging and AD represent a neuropathological continuum 
or are dichotomous (Buckner, 2004). Within a unitary factor framework, cognitive decline 
falls along a single continuum so that only “quantitative” differences separate AD from 
healthy aging, with the former representing the acceleration or advanced stage of the same 
processes that lead to more minor cognitive changes in aging. This notion stems from the 
fact that neurofibrillary tangles and senile plaques, the two neuropathological hallmarks of 
AD, occur frequently in the brains of nondemented elderly individuals and follow the same 
pattern of hierarchical vulnerability (Price and Morris, 1999; Morris et al, 2001).  
An alternative point of view (multiple factor framework) proposes that aging and AD 
are not a continuum but are distinct processes that target different brain systems and may 
independently vary in their level of progression across individuals. Within a multiple factor 
framework, cognitive decline in nondemented aging may be mild because some individuals, 
while being influenced by certain aging processes, are spared from the most devastating 
changes caused by AD. This hypothesis is supported by considerable evidence showing 
that normal aging and AD can be differentiated both anatomically and clinically (Petersen 
et al, 1999; Buckner, 2004; Grundman et al, 2004).  
Pathologically, subjects of normal aging do not show pathology associated with AD 
(Buckner, 2004; Mattson, 2004). West et al reported that normal aging is related with losses 
in the hilus of the fascia dentate and the subiculum but not the dentate granule cell layer, 
CA3 or CA1, whereas AD is correlated with significant neuronal loss in CA1 in addition to 
the hilus and subiculum (West et al, 1994; West et al, 2000; West et al, 2004). Similarly, 
neurologically normal elderly individuals do not show neuronal loss in any layer of the 
entorhinal cortex, whereas in subjects with very mild AD (using a criterion similar to that 
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of MCI), there was already a quite extensive loss of neurons in the entorhinal cortex, as 
much as 50% of the neurons from layer II of entorhinal cortex. In severe AD, almost 90% 
of the neurons in layer II of entorhinal cortex are missing, with many presumably now 
having degenerated as end-stage NFT (Gómez-Isla et al,
 
1996; Price et al, 2001). Finally, 
Xu et al (2000) reported that measures of hippocampal volume, in addition to the volume 
of the entorhinal cortex, were able to discriminate between persons with mild AD and MCI, 
and those who were cognitively normal. Thus normal aging and AD bear different patterns 
of structural changes, which suggests that these two are not part of a continuous spectrum 
and do not share a common pathological substrate.  
Clinically, age-related memory impairment in humans is different from that seen even 
in early AD as well. Older adults free from dementia often show difficulties on tasks that 
stress attention and executive abilities, whereas early AD is characterized by an impairment 
in declarative memory although deficits on executive function can be present (Buckner, 
2004). This dissociation may arise from separate age-associated influences on frontal-
striatal circuits and on the medial temporal lobe memory system (Buckner, 2004). 
Additionally, the alterations in memory associated with early AD are substantially different 
from those associated with age-related changes in memory (Albert, 1996). Although 
subjects of normal aging may show significant declines in delayed recall performance, it 
simply results from the fact that it takes older individuals longer to learn new information, 
but once learned, it is retained well over numerous delay intervals (Albert, 1996).  
 
4 Diagnosis of Alzheimer’s disease 
There are no tests that definitively establish the diagnosis of AD in living subjects 
except brain biopsy. Current diagnosis of AD is most often based on the criteria formulated 
by the National Institute of Neurologic and Communicative Disorders and Stroke – 
Alzheimer's Disease and Related Disorders Association (McKhann et al, 1984; Table 1.3), 
according to which the diagnosis is classified as definite (clinical diagnosis with histologic 
confirmation), probable (typical clinical syndrome without histologic confirmation), or 
possible (atypical clinical features but no alternative diagnosis apparent; no histologic 
confirmation). Establishment of the diagnosis, which is most challenging early in the 
course of the illness, is based on clinical history, physical examination, neuropsychological 
testing, brain imaging, and a variety of assessments designed to exclude other causes of 
dementia. The clinical diagnostic accuracy for AD depends on the stage of the disease and 
can reach 90% in mid or late stages if standard clinical criteria are followed (Burns et al, 
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2002). However, since no neuroimaging or laboratory markers now exist for reliable 
presymptomatic diagnosis of AD, the diagnosis is often forced to wait until individuals 
become symptomatic.  
Clinical manifestation 
The classic clinical features of AD are an amnesic type of memory impairment, 
deterioration of language, and visuospatial deficits. Changes in executive functions also 
show significant declines early in the disease. Motor and sensory abnormalities, gait 
disturbances, and seizures are uncommon until the late phases of the disease (Cummings, 
2004). In a typical case, onset of AD is slow. Some individuals with incipient AD are aware 
of their declining abilities, but most patients with evolving AD never acknowledge that 
they have memory dysfunction. Eventually, recognition may occur because of an apparent 
sudden crisis, such as getting lost, an accidental fall, or discovery by neighbors or relatives 
of an unsafe, messy home environment, or acute confusion (delirium) during illness, after 
surgery or hospitalization, or environmental stress (Desai and Grossberg, 2005). Careful 
questioning will usually reveal that cognitive impairment and dysfunction have been 
present for several years before the acute crisis. A decline in calculation abilities is one of 
Table 1.3    Diagnosis of dementia, probable AD and MCI 
Dementia 
Loss of memory and one or more other cognitive abilities (aphasia, apraxia, 
agnosia, or disturbance in executive functioning) 
Substantial impairment in social or occupational functioning (decline from a 
previous level of functioning) 
Deficits that do not occur exclusively during the course of delirium 
 
Probable Alzheimer’s disease 
Typical history of Alzheimer’s disease 
Insidious onset of symptoms 
Gradual progression of symptoms 
Cognitive loss documented by neuropsychological tests 
No physical signs or neuroimaging or laboratory evidence of other diseases that 
could cause dementia (such as strokes, Parkinson’s disease, subdural 
hematomas, or tumors) 
 
Mild cognitive impairment 
Report (by the patient or an informant) of memory loss 
Abnormal memory performance for age (score >1.5 SD below mean for age) 
Normal general cognition 
Normal activities of daily living 
Criteria for dementia not met 
 
Adapted from Kawas, 2003 
 15 
the hallmark cognitive features of AD. Other clinical presentations of AD are psychosis, 
depression, and agitation/behavioral disturbances.  
The clinical phenotype of senile dementia can also be caused by a variety of other 
diseases, including dementia with Lewy bodies, frontotemporal dementia, Pick's disease, 
vascular dementia, and so on. Diagnosis of AD can be made only after these disorders have 
been excluded.  
Cognitive tests 
The diagnostic utility of memory tests in AD varies according to severity of cognitive 
impairment. In the preclinical phase, tests of verbal learning and immediate visual recall 
have the greatest accuracy in predicting the progression to AD (Albert, 1996). For 
established AD, tests of delayed recall are most sensitive for early AD but less useful for 
tracking disease progression because performance on these tests often declines rapidly to a 
plateau. Recognition memory tests, including verbal and visual subtests, are less sensitive 
than recall tasks for detecting early AD but are more useful for staging disease severity 
(Albert, 1996).  
Brain imaging 
Brain structural imaging, including computed tomography and magnetic resonance 
imaging, is particularly helpful and routinely used in the diagnosis of AD, to exclude 
alternative causes of dementia and to provide objective measures of preclinical disease and, 
when measured serially, the rate of change.  
Understanding the pattern of pathological changes in AD has prompted the assessment 
of regional brain volume instead of whole-brain volume. Generalized cortical atrophy with 
a thinning of medial temporal lobe structures is characteristic of AD, though not 
pathognomonic of the disease because of the overlap with “normal” aging. Of the many 
quantitative techniques, volumetric analysis has been shown to have greater diagnostic 
specificity and sensitivity than linear measurements of atrophy. Volumetric changes on 
magnetic resonance imaging are consistent with the patterns of neuropathological 
progression in AD, and the severity of volume loss is correlated with disease severity (de 
Leon et al, 1997). AD is associated with an increased rate of hippocampal atrophy (Jack et 
al, 1998), which is prominent even at the presymptomatic stage (Convit et al, 1997). A 
substantial number of studies have shown that MRI measurements of hippocampal atrophy 
can distinguish AD from cognitively normal elderly people with 80–90% accuracy (e.g. 
Blennow et al, 2007). Substantial neuronal loss has occurred by the time atrophy is 
detectable by MRI (Killiany et al, 2002). It must be mentioned that the absence of cortical 
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atrophy or medial temporal lobe changes is not sufficient to exclude a diagnosis of AD. In 
addition, the fact that there is an overlap between AD patients and healthy aged controls 
and that structural changes at visual inspection are not evident until late in the course of the 
disease, has prompted the development and refinement of serial MRI coregistration 
techniques. These techniques are capable of revealing and monitoring the progressive 
changes of brain volumes in an individual. AD cases show an average 2% atrophy rate, in 
contrast to 0.25–0.5% in control subjects (O’Brien et al, 2001).  
In recent years increasing attention has been devoted to the utility of positron emission 
tomography (PET), single photon emission computed tomography (SPECT) and functional 
magnetic resonance imaging (fMRI) in AD diagnosis, because they can detect the subtle 
pathophysiologic changes of surviving neurons before structural changes are present. 
(Silverman and Phelps, 2001). PET demonstrates bilateral temporoparietal 
hypometabolism and hypoperfusion in AD, which is correlated with hippocampal atrophy 
and the severity of dementia. In more advanced AD, hypoperfusion changes are more 
widespread and additional reductions in cerebral blood flow are seen in frontal lobes 
(Jagust, 1998). SPECT studies evaluating regional cerebral blood flow have shown a 
similar pattern as the one described for PET studies, with relative regional cerebral blood 
flow paucity in the temporoparietal regions (Camargo, 2001). Novel SPECT cholinergic 
markers, including muscarinic and nicotinic receptors and cholinesterase activity, have also 
attracted researchers (O’Brien et al, 2007).   
Other tests 
Investigators have begun to assess the diagnostic value of determining the levels of β-
amyloid protein (Aβ) peptides (soluble monomeric species decreased, multimeric species 
possibly increased) species and of tau (increased) in the cerebrospinal fluid and of 
establishing apoE genotypes. Currently, however, these assessments are not appropriate for 
routine diagnostic evaluations (Trojanowski and Growdon, 1998).  
MCI 
Recognition that MCI may represent a transition state between normal cognitive 
decline due to ageing and dementia offers possibilities for early diagnosis of AD. Without 
exhaustive questioning, MCI is often difficult to detect clinically. Patients with MCI should 
undergo the same laboratory studies as other patients with dementia (Table 1.3). It needs to 
be noted that MCI is heterogeneous and amnesic MCI subtype may not encompass all of 
the prodromal states of dementia.  
The best predictors of conversion from MCI to AD are functioning in everyday 
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situations requiring judgment and problem-solving, presence of depression, and 
hippocampal atrophy (Knopman et al, 2003; Desai and Grossberg, 2005). Prospective 
studies of people with amnestic MCI have shown that episodic memory (such as delayed 
recall of word lists and paired-associates learning), semantic memory, attention processing, 
and mental speed can consistently predict which patients will develop dementia (Chong 
and Sahadevan, 2005). Similarly, in a retrospective study of people with MCI who had 
developed AD, verbal and visual memory, associative learning, vocabulary, executive 
function and other verbal tests of general intelligence were impaired at baseline (Guarch et 
al, 2004). Longitudinal studies have shown that decreased entorhinal cortex (deToledo-
Morrell et al, 2004) and hippocampal volumes (Visser et al, 2002) can predict which 
patients with MCI will develop AD. Whole-brain, hippocampal, and entorhinal-cortex 
atrophy assessed by MRI are more common among patients with amnestic MCI who go on 
to develop AD than among non-converters (Jack et al, 2003; Apostolova et al, 2006).  
 
5 Treatment of Alzheimer’s disease 
There are no ways to cure AD at present. Current treatments focus on early application 
of cholinesterase inhibitors and/or NMDA receptor-targeted therapy and treating 
behavioural and psychological symptoms of AD (Desai and Grossberg, 2005).  
Cholinesterase inhibitors (ChEIs) are the first pharmacologic treatments for AD and 
are being prescribed for more and more people with mild to moderate AD, helping reduce 
behavioural disturbances, maintain cognitive abilities and delay first dementia-related entry 
into a nursing home (Doody et al, 2001). However the benefit is rapidly lost after 
discontinuation, suggesting that the primary benefit is symptomatic rather than 
neuroprotective. Another limitation is that efficacy may not be sustained in the long-term 
because of the development of drug tolerance and disease progression (Doody et al, 2001).  
Memantine is a non-competitive, moderate-affinity, phencyclidine-site, NMDA 
receptor antagonist that protects neurons from glutamate-mediated excitotoxicity without 
preventing physiological activation of the NMDA receptor (Parsons et al, 1999). It has 
been shown that Aβ enhances the toxicity of glutamate, while activation of NMDA 
receptors appears to enhance production of pathologic forms of tau and Aβ (Mattson et al, 
1997). The approval of memantine’s application in AD was the result of two randomized 
placebo-controlled clinical studies, where memantine treatment significantly improved 
symptoms and slowed the rate of cognitive and functional decline in moderate and severe 
AD (Winblad and Poritis, 1999; Reisberg et al, 2003). 
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Potential therapies under investigation target multiple aspects of the disease cascade, 
including aberrant inflammation, neurotrophic function, and processing of beta amyloid 
and tau proteins. These novel approaches hold promise for disease modification but are as 
yet unproven, and are outside the scope of this thesis.  
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Chapter 2   Alzheimer’s Disease: !europathology 
 
 
The heterogeneous clinical phenotype of AD probably results from the various 
molecular and cellular changes in this disorder. AD has a well-defined neuropathologic 
profile characterized by a surfeit of extracellular amyloid deposits and accretion of 
intracellular neurofibrillary tangles (NFTs), together with a degeneration of neurons and 
synapses (Selkoe, 2001). This chapter discusses in detail the neuropathology of AD, both in 
a macroscopic view – the vulnerable neural systems in AD, and in a microscopic view – the 
molecular and cellular changes in AD.  
 
1 Macroscopic pathology and regional hierarchy 
On macroscopic examination, a typical AD brain is severely atrophic, shown by 
widening of the sulci and ventricular enlargement (Figure 2.1A). This is more obvious in 
early-onset FAD cases. Despite generalized atrophy of the cerebral cortex, not all the brain 
regions are equally implicated. AD selectively affects brain regions critical for cognition 
and memory. Closer inspection of the mediotemporal lobes reveals a greater degree of 
atrophy in the hippocampus, parahippocampal region, and amygdala. Indeed, there appears 
to be a temporal and regional hierarchy with respect to neurodegeneration, with both 
pathological (Braak and Braak, 1991) and brain imaging (Smith and Jobst, 1996; Scahill et 
al, 2002) studies indicating that medial temporal lobe regions are affected early and 
relatively rapidly in the disease process followed by the spread of gradual degeneration to 
other neocortical areas. The pathological changes in AD are thought to start from the 
entorhinal cortex, progress to the hippocampus, and involve the neocortex at later stages 
(Braak and Braak, 1991). In the neocortical regions, higher-order association cortex is the 
principal site of brain pathology with evolving disease whereas primary sensory and motor 
regions show relatively little pathology. In contrast, regions of the brain such as the 
striatum and cerebellum may show some degree of plaque formation but do not develop 
significant neuronal pathology. The spread of pathology throughout these circuits reflects a 
general staging of the disease, which is consistent with clinical findings, from an early 
preclinical phase of deficits in memory formation to later stages with gradual deterioration 
of other cognitive abilities.  
 
Figure 2.1  Pathological changes of Alzheimer’s disease. (A) Compared with the brain of a 
healthy person, the brain of an Alzheimer's disease patient exhibits marked shrinkage of gyri in 
the temporal lobe (lower part of the brain) and frontal lobes (left part of the brain), both of 
which are involved in learning and memory. (B) Amyloid plaques detected with antibodies 
against Aβ (blue) and APP (brown). (C) Phospho-γ-immunopositive neurofibrillary tangles. 
Adapted from Mattson, 2004 (A) and Jin et al, 2004 (B) and (C)
Figure 2.1
A
B C
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2 Amyloid pathology 
One of the two defining pathological changes of AD is the amyloid plaque. Amyloid 
plaques contain extracellular deposits of toxic amyloid β-protein (Aβ) that are produced by 
aberrant processing of APP. They are complex lesions that vary in size, ranging from 10 to 
120 µm, best visualized with silver stains or immunohistochemical techniques using an 
antibody to Aβ (Figure 2.1B).  
2.1 Plaque types 
In AD brain tissue, amyloid plaques can be divided into two main types according to 
their maturation: neuritic plaques and diffuse plaques (Selkoe, 2001).  
Neuritic plaques, generally found in the limbic and association cortices, are 
microscopic foci of extracellular amyloid deposition with dystrophic neurites within and 
immediately surrounding this amyloid deposit. Microglia are usually seen within and 
adjacent to the central amyloid core of the neuritic plaque, whereas astrocytes often ring 
the outside of the plaque, with some of their processes extending centripetally toward the 
amyloid core. Neuritic plaques contain fibrillar Aβ and stain with Congo red.  
Many of the plaques found in limbic and association cortices, and virtually all of those 
in brain regions not clearly implicated in the typical symptomatology of AD (e.g., thalamus, 
caudate, putamen, cerebellum), lack the compacted, fibrillar appearance of the classical 
neuritic plaques, but show relatively light, amorphous Aβ immunoreactivity that occurred 
in a finely granular pattern. These lesions have thus been referred to as diffuse plaques or 
preamyloid deposits. Diffuse plaques are composed of homogeneous deposits of non-
fibrillary material and contain only scant numbers of amyloid fibrils and do not stain with 
Congo red.  
Later it was determined that the Aβ peptides deposited in Alzheimer brain principally 
ended at either Aβ40 or Aβ42. Diffuse plaques are primarily composed of Aβ42, with little 
or no Aβ40 immunoreactivity. In contrast, while much of the fibrillar Aβ found in the 
neuritic plaques is Aβ42, Aβ40, which is normally more abundantly produced by cells than 
Aβ42, is usually colocalized in the plaque (Iwatsubo et al, 1994; Selkoe, 2001).  
The earliest structural pathological changes in AD are diffuse Aβ deposits. They are 
also observed in normal aging individuals, but at a lower density (Perry et al, 1978). 
Furthermore, the detection of diffuse plaques in regions that also contained many neuritic 
plaques (limbic and association cortices) led to the hypothesis that diffuse plaques 
represent precursor lesions to neuritic plaques. This notion was later supported by studies 
of transgenic mice expressing mutant human APP. These mice usually showed diffuse 
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deposits before developing fibrillar, thioflavin S-positive, and Congo red-positive 
neuritic/glial plaques. The time that it takes to develop a plaque is unknown, but these 
lesions probably evolve very gradually over a substantial period of time. While senile 
plaques are associated with degeneration of neurites and neuronal cell bodies, the diffuse 
plaques can also induce morphological degeneration and kill neurons in the absence of 
fibrillar Aβ (Lambert et al, 1998). 
2.2 Genetics and molecular biology of amyloid pathology 
All known gene mutations leading to FAD influence APP processing and the 
production of Aβ. The first FAD-associated genetic mutations were found in APP gene 
(Chartier Harlin et al, 1991), whereas the majority (30-50%) of FAD cases are caused by 
mutations of the PS gene. The apoE4 allele of the apoE gene represents the most prominent 
genetic risk factor for the sporadic late-onset cases of AD, and also influences Aβ 
metabolism.  
APP gene 
Aβ-related peptides consist of 39–43 amino acids derived from the amyloid β-protein 
precursor (APP). The APP gene is localized to chromosome 21 (21q21.2–3) and encodes 
APP protein which is a single membrane-spanning protein possessing a large extracellular 
amino-terminal domain and a small intracellular cytoplasmic domain. There are three main 
isoforms of APP: APP770, APP751 and APP695, arising from the alternative splicing of its 
pre-mRNA. The APP splice forms containing 751 or 770 amino acids are widely expressed 
in nonneuronal cells throughout the body and also occur in neurons. However, neurons 
express even higher levels of the 695-residue isoform, which occurs at very low abundance 
in nonneuronal cells (Selkoe, 2001). The ubiquitous expression of APP gene throughout the 
body suggests that APP must serve critically important functions. A general observation 
regarding APP function is that it acts at the cellular level in diverse processes such as 
axonal transport, cell adhesion, cholesterol metabolism and gene transcription (De Strooper 
and Annaert, 2000). However, APP knockout mice are viable and often show near normal 
phenotypes except for decreased locomotor activity and forelimb grip strength (Zheng et al, 
1995). The absence of substantial phenotypes in these mice may result from functional 
redundancy provided by homologous amyloid precursor-like proteins (APLP1 and APLP2), 
which function in a similar manner to APP in many biochemical pathways (Heber et al, 
2000).  
Aβ is derived from APP by sequential proteolytic cleavages (Figure 2.2; Selkoe, 2001). 
The APP is processed by three proteases, which, starting from the amino terminus of the 
Figure 2.2  Schematic diagrams of the β-amyloid precursor protein (APP) and its principal 
metabolic derivatives. Top diagram depicts the largest of the known APP alternate splice forms, 
comprising 770 amino acids. Regions of interest are indicated at their correct relative positions. 
A 17-residue signal peptide occurs at the NH2 terminus (box with vertical lines). Two alterna-
tively spliced exons of 56 and 19 amino acids are inserted at residue 289; the first contains a 
serine protease inhibitor domain of the Kunitz type (KPI). A single membrane-spanning 
domain (TM) at amino acids 700-723 is indicated by the vertical dotted lines. The amyloid β
-protein (Aβ) fragment includes 28 residues just outside the membrane plus the first 12-14 
residues of the transmembrane domain. In the middle diagram, the arrow indicates the site (after 
residue 687; same site as the white dot in the Aβ region of APP in the upper diagram) of a 
constitutive proteolytic cleavage made by protease(s) designated α-secretase that enables secre-
tion of the large, soluble ectodomain of APP (APPs-α) into the medium and retention of the 83-
residue COOH-terminal fragment in the membrane. The C83 fragment can undergo cleavage 
by a protease(s) called γ-secretase at residue 711 or residue 713 to release the p3 peptides. The 
bottom diagram depicts the alternative proteolytic cleavage after residue 671 by a protease(s) 
called β-secretase that results in the secretion of the slightly truncated APPs-β molecule and the 
retention of a 99-residue COOH-terminal fragment. The C99 fragment can also undergo cleav-
age by γ-secretase to release the Aβ peptides.
Picture and text adapted from Selkoe, 2001
Figure 2.2
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protein, are known as the β, α, and γ secretases. The β-cleavage site occurs between 
residues 596 and 597 of APP695, which marks the N-terminus of the Aβ peptide, whereas 
the α-cleavage site lies between lys613 and leu614 (of the 695 isoform) within the critical 
Aβ peptide region and therefore precludes the release of the plaque-forming Aβ fragment. 
The α and β cleavages seem to be mutually exclusive events and each liberate a large 
extracellular domain of the protein, differing in size by only 17 amino acids at the carboxy 
terminus. The remaining portion of APP is tethered to the membrane and is referred to as 
the carboxy-terminal fragment (CTF), C99 for the β- and C83 for the α-generated product.  
The transmembrane cleavage event catalyzed by γ-secretase occurs subsequent to α or 
β cleavage at several sites in close proximity within the CTF sequence. After α cleavage, 
C83 can be processed by γ-secretase to generate a shortened Aβ-like fragment termed p3, 
plus the same C-terminal fragments. After β cleavage, C99 may be processed by γ-
secretase and, depending on the site of γ-secretase cleavage, produces “short” (Aβ1-40) or 
“long” (Aβ1-42, 43) Aβ fragment. Both forms assemble amyloid fibrils via analogous steps 
and elongate at comparable rates, but Aβ1–42 is populated more rapidly and to a greater 
extent than Aβ1-40 (Harper et al, 1999). The majority (90%) of the secreted soluble Aβ 
fragments are Aβ1-40. A shift to a higher proportion of the longer isoform may be crucial 
to the earliest stages of fibril deposition into plaques, because this form is far more prone to 
oligomerization and fibril formation than is the more abundantly produced Aβ1-40 (Bitan 
et al, 2003). Discrete intermediate Aβ species, designated protofibrillar Aβ, are formed 
before Aβ fibrils appear. Although protofibrillar Aβ appears transiently, its potential 
neurotoxic effects in vitro has led to the hypothesis that this form of Aβ, rather than fibrillar 
Aβ, is pathogenically important (Walsh et al, 2002).  
Initially it was believed that α-cleavage is the physiological one (Esch et al, 1990; 
Sisodia et al, 1990), and prevents amyloidogenesis in AD. In reality this is an 
oversimplification, because only part of the total pool of APP is cleaved by α-secretase in 
most cell types. In addition, β-secretase processing of APP also occurs under physiological 
conditions, though the levels and activity of β-secretases are increased in AD (Fukumoto et 
al, 2002). This indicates that all fragments of APP, including the Aβ peptide, are part of 
normal physiology (Haass et al, 1992; Seubert et al, 1992).  
More than 20 pathological mutations have been identified in the APP gene, all of 
which cluster at or near the proteolytic cleavage sites and increase the production of Aβ 
peptide or the proportion of the more amyloidogenic Aβ42. The fact that, despite 
substantial investigation, no other mutations in the large APP protein that cause AD have 
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been discovered strongly suggests that these missense mutations lead to AD by altering 
proteolytic processing at the three secretase sites in subtly different ways. 
Presenilin genes 
Establishment of a linkage of some of FAD cases to chromosome 14 led to the 
identification of a novel FAD-related gene on this chromosome, which came to be known 
as presenilin-1 (PS-1) (Sherrington et al, 1995). Shortly thereafter, a homologous gene was 
discovered on chromosome 1, which was designated presenilin-2 (PS-2) (Levy-Lahad et al, 
1995).  
The presenilin proteins PS-1 and PS-2 are polytopic integral transmembrane domain 
proteins that express throughout most peripheral tissues and all brain regions, primarily in 
neurons. The exact functions of these proteins remain unclear, but may include regulation 
of β-catenin stability and trafficking of membrane proteins. There is also substantial 
evidence that PS proteins are associated with the γ-secretase activity that generates the Aβ 
peptide (De Strooper et al, 1999). In PS-1/PS-2 double knock-out cells, Aβ secretion into 
the medium is completely inhibited. Mice with a targeted disruption of the PS-1 gene have 
also been generated (Shen et al, 1997; Wong et al, 1997). Homozygous mutant mice failed 
to survive the early postnatal period. The most striking phenotype observed in PS-1 
knockout embryos was a severe perturbation in the development of the axial skeleton, 
which may be related to abnormal somite patterns. In addition, PS-1 knockout embryos 
exhibited intraparenchymal hemorrhages after day 11 of gestation and massive neuronal 
loss in specific subregions after day 16.5. These observations have been interpreted to 
indicate that PS-1 is required for normal neurogenesis and neuronal survival (Shen et al, 
1997). Removal of PS-2 gene is not as harmful as PS-1. PS-2 knockout mice are viable but 
develop pulmonary fibrosis and hemorrhage with age (Herreman et al, 1999).  
The majority of FAD cases are linked to mutations within the PS genes. More than 150 
mutations have been reported in the PS-1 gene and 20 in the PS-2 gene that subsequently 
result in AD. The AD-causing missense mutations in both PS genes selectively increase the 
production of the 42-residue form of Aβ peptide that is particularly prone to precipitation 
and aggregation. This is because PS is the catalytic subunit of γ-secretase (De Strooper et al, 
1999). Its mutations alter the conformation of PS, enhancing coordination between the 2 
catalytic aspartates and the Aβ42 peptide bond in the transmembrane domain of APP.  
Apolipoprotein E 
ApoE is the most important genetic risk factor for late onset AD cases. ApoE plays a 
role in Aβ deposition because a lack of apoE dramatically reduces Aβ deposition in a 
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transgenic model (Bales et al, 1997; Holtzman et al, 1999). The human apoE gene is 
located in chromosome 19 and encodes a 34 kDa lipid transport protein. ApoE is normally 
present in oligodendroglia, astrocytes and microglia. As a lipid carrier protein involved in 
the transport of cholesterol and phospholipids, apoE is believed to play an important role in 
synaptic plasticity and tissue repair mechanisms, including control of neurite outgrowth 
and branching, microtubule depolymerization, adhesion to basal membrane components, 
immunomodulation and potentiation of the activity of ciliary neurotrophic factor (Poirier, 
1994; Weisgraber et al, 1994; Masliah et al, 1995).   
ApoE is polymorphic with three alleles, ε2, ε3 and ε4, encoding protein isoforms 
apoE2, E3 and E4, respectively. In many assays, E2 and E3 produce similar effects that 
vary only in amplitude whereas the presence of E4 often leads to a different outcome. For 
example, in primary neuronal cultures, the presence of E2 or E3 enhances neurite 
outgrowth and branching whereas E4 inhibits these processes (Nathan et al, 1994; 
Weisgraber et al, 1994). The presence of ε4 allele is more frequent in subjects with AD 
compared with the general population whereas inheritance of the ε2 allele may confer 
protection against AD (Corder et al, 1993; Corder et al, 1994). It should be emphasized that 
apoE4 is a risk factor for, not an invariant cause of, AD. Some humans homozygous for the 
ε4 isoform still show no Alzheimer symptoms in their ninth decade of life and beyond. 
Conversely, a great many humans develop AD without harboring ε4 alleles.  
Although the association of apoE with AD is well characterized, its role in the 
pathogenesis is still unclear. ApoE proteins have been shown to be components of AD 
neurofibrillary tangles and to bind to the beta-amyloid peptides that are involved in fibril 
formation (Haas et al, 1997). One view is that apoE, especially the E4 isoform, acts as a 
chaperone protein for Aβ and promotes the development of the insoluble fibrils in plaques 
(Wisniewski and Frangione, 1992; Irizarry et al, 2000). An alternative view is centred on 
the role of apoE in the remodelling and sprouting of axons and synaptic terminals 
following neural damage (Poirier, 1994). In this regard, inheritance of a particular apoE 
genotype may influence how the nervous system responds to injury. ε4 allele inhibits 
neurite growth and dendritic plasticity, whereas the ε3 allele promotes these processes 
(Nathan et al, 1994; Weisgraber et al, 1994; Poirier, 1994).  
2.3 7eurotoxicity of Aβ 
The gradual accumulation of Aβ42 leads to its aggregation into oligomers, polymers 
and fibrils. For a long time it has been assumed that only “aggregated” form of Aβ is 
neurotoxic (Lorenzo et al, 1994; Geula et al, 1998; Lambert et al, 1998; McKee et al, 1998). 
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However, more recent work emphasizes the importance of Aβ in the soluble form. A 
species of diffusible soluble Aβ oligomers has been shown to be primarily responsible for 
synaptic dysfunction and behavioural impairments (Westerman et al, 2002; Walsh et al, 
2002; Cleary et al, 2005; Lesne et al, 2006).  
How the soluble oligomers of Aβ induce neurotoxicity remains unclear but a general 
theme has emerged whereby the interaction of Aβ with lipid membranes is a necessary step 
in neurotoxicity (Masters et al, 2006). These interactions cause changes in membrane 
fluidity (Eckert et al, 2005), disrupted calcium homeostasis (Kawahara, 2004), lipid 
peroxidation via membrane-associated free radical formation (Butterfield and Boyd-
Kimball, 2004) and cholesterol oxidation (Puglielli et al, 2005). All of these events 
converge into similar pathways of synaptic disruption and neuronal necrosis or apoptosis, 
leading to progressive loss of specific neuronal cell populations (Vickers et al, 2000; Hardy 
and Selkoe, 2002; Mattson, 2004; Masters et al, 2006).  
Functional domains of Aβ involved in fibrillogenesis and neurotoxicity  
Studies on Aβ fragments have suggested several functional domains in the Aβ 
sequences (Tran et al, 2002; Figure 2.3). The peptide fragment Aβ25-35 is responsible for 
the neurotoxic effect of Aβ (Harkany et al, 1998; Tran et al, 2002). This fragment was 
reported to cause dendritic and axonal retraction followed by neuronal death in 
differentiated neurons and mature neurons in vitro (Yankner et al, 1990). For learning and 
memory, the Aβ18-20 sequence is important for the amnesic effect (Flood et al, 1991). The 
peptide fragment Aβ16-20 serves as a binding sequence during Aβ polymerization and 
fibril formation (Tjernberg et al, 1996). Aβ13-16 is necessary for an initial interaction of 
microglia with plaques through a cell-surface-binding site involving heparan sulfate 
(Giulian et al, 1996). Using an analogue of Aβ31-34, several investigators demonstrated 
that this putative antagonist prevented an Aβ1-42-induced elevation of intracellular Ca
2+
 
and extracellular aspartate and glutamate levels in rat astrocytes. Thus, the sequence of 
Aβ31-34 is considered a putative domain involved in cellular Aβ recognition and cell 
surface binding (Laskay et al, 1997).  
Oxidative stress 
Aβ is capable of generating free radicals and reactive oxygen species (Hensley et al, 
1994), which in turn initiate and promote neurodegeneration in AD. Free-radical-mediated 
molecular damage is particularly prominent in the environment of plaques and in NFT-
bearing neurons (Mattson, 2004). The aggregation of Aβ can attract inflammatory 
mediators which, in turn, stimulate nitric oxide (NO) production and expression of the 
Figure 2.3  Structure of Aβ and functional domains involved in fibrillogenesis and cytotoxicity. 
Processing of APP precludes the formation of Aβ. Two major species of full-length Aβ defined 
by their C-terminus lengths are Aβ1–42 and Aβ1–40. Several functional domains in the Aβ 
sequence are proposed, including the neurotoxic, aggregation, microglial activation, amnesic, 
and cell-surface binding domains.
Adapted from Tran et al, 2002
Figure 2.3
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high-output isoform, inducible nitric oxide synthase (iNOS) (Yates et al, 2000). This Aβ-
induced iNOS expression can result in an overproduction of NO, which may react with O2
−
 
to yield highly reactive peroxynitrite and may, therefore, increase the overall radical 
burden in Aβ-loaded brain regions (Tran et al, 2002). By an oxidative-stress-mediated 
mechanism, Aβ impairs the function of membrane ion and glutamate transporters, 
compromises mitochondrial function, and render neurons vulnerable to excitotoxicity and 
apoptosis.  
It needs to be mentioned that oxidative stress can also induce amyloidogenic processing 
of APP and accumulation of potentially neurotoxic forms of Aβ (Gabuzda et al, 1994). 
This could contribute to increased amyloid production in late-onset forms of AD, because 
oxidative stress and metabolic impairment increase with advancing age. Thus, a vicious 
circle exists where oxidative stress and Aβ promote each other in the course of AD.  
Calcium dysregulation and excitatoxicity 
In addition, Aβ may cause excitotoxicity by inducing a harmful elevation of 
intracellular calcium levels (Mattson et al, 1992). The calcium plays crucial roles in a 
variety of fundamental biological processes. The impairment of neurons to regulate 
calcium homeostasis is an aspect of AD pathogenesis that appears to be intimately involved 
in the dysfunction and death of neurons (Mattson, 2004). Aβ can promote Ca
2+
 influx by 
forming channels in membranes or by activating cell surface receptors coupled to calcium 
influx (Mattson and Chan, 2003). In natural cell membranes of hypothalamic neurons, 
soluble Aβ40 forms calcium-selective channels across excised membrane patches 
(Kawahara et al, 1997). Although the permeability for Ca
2+
 is selective to the channels 
formed by Aβ, the permeability of other monovalent cations such as K
+
, Na
+
, and Cs
+
 to 
these channels suggests that these Aβ-formed channels are not classical calcium channels. 
In addition, Aβ-induced oxidative stress may impairs membrane calcium pumps and 
enhances calcium influx through voltage-dependent channels and ionotropic glutamate 
receptors. Efforts to stabilize intracellular Ca
2+
 homeostasis provide a way to protect 
against Aβ neurotoxicity, and may represent therapeutic approaches for AD (Tran et al, 
2002).  
Glial cell changes and inflammation 
Aβ-induced alterations of glial cells (astrocytes, oligodendrocytes and microglia) in the 
brain have been documented in studies of AD patients, animal models and cell cultures 
(McGeer and McGeer, 2002). Abnormalities in astrocytes include impaired glutamate 
transport and perturbed calcium regulation. Astrocytes, together with microglial cells, are 
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also involved in the chronic inflammatory responses in AD through the up-regulated 
expression of phospholipase A2, leading to increased arachidonic acid/prostaglandin 
inflammatory pathway activity and production of a variety of potentially neurotoxic 
compounds, including superoxides, glutamate and NO (Brown and Bal-Price 2003). 
Blocking Aβ oligomers/fibrils formation prevents this toxicity (Meda et al, 1995). 
Similarly, a range of inflammation-related markers has been reported to be elevated in 
AD (Vickers et al, 2000). Inflammatory changes may promote plaque formation by 
increasing APP expression or enabling the transition from diffuse to neuritic forms of the 
plaque (Mrak et al, 1995), whereas stimulation of plaque formation would result in a 
further activation of microglia and astrocytes, resulting in a ‘vicious cycle' of increased 
inflammatory involvement and β-amyloid plaque formation (Vickers et al, 2000).  
It must be noted that whereas many of the changes in glial cells in AD promote 
neuronal degeneration, some of them may actually represent adaptive responses aimed at 
promoting neuronal and survival. For example, microglia may act to remove Aβ, a 
potentially beneficial action (Jantzen et al, 2002). Moreover, astrocytes associated with Aβ 
deposits may compensatively increase the production of neurotrophic factors so as to 
counteract the neurodegenerative process in AD (Cummings et al, 1993).  
Apoptosis 
It has been suggested that Aβ may cause DNA damage and/or signal apoptotic 
pathways (LaFerla et al, 1995). Pro-apoptotic proteins are associated with Aβ deposits in 
AD brains and exposure of neurons to Aβ induced an apoptotic cascade that include a 
number of well-known apoptotic proteins (Mattson, 2000). Importantly, apoptotic markers 
have been shown to be present in a larger proportion of neurons than those affected by 
NFTs, suggesting the presence of alternate pathways that lead to neurodegeneration (Su et 
al, 1997).  
Metal metabolism 
Several lines of evidence point to the participation of transition metals in Aβ 
neurotoxicity (Bush, 2003). Very high concentrations of Cu, Zn and Fe have been found in 
plaques of AD brains (Lovell et al, 1998). This would lead to high concentrations of 
soluble metallated Aβ, thereby promoting its toxicity (Lee et al, 2002). The high Zn 
concentrations also promote the aggregation of the Cu/Fe-metallated Aβ, creating a 
reservoir of potentially toxic Aβ that is in equilibrium with the soluble pool. The large 
polymeric deposits of misfolded proteins not only represent the end result of the 
aggregation process but may act as inactive reservoirs in equilibrium with the small 
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diffusible oligomeric toxic species responsible for the neurodegenerative pathology 
(Masters et al, 2006). Genetic ablation of the zinc transporter 3 protein, required for zinc 
transport into synaptic vesicles reduced plaque formation in tg2576 transgenic mice (Lee et 
al, 2002). 
Issues to be noticed 
There are some issues to be considered regarding the relevancy of experimental Aβ 
toxicity models. One important point is that some assays rely on an acute mechanism of 
neuronal damage being caused by Aβ whereas the degeneration of neurons in AD is likely 
to be a gradual event, perhaps occurring over years or decades. The case for true AD-like 
neuronal degeneration in experimental models, in which β-amyloid peptides are injected 
into the brain (or cerebral ventricles), is much less convincing, since the concentration of 
Aβ required to kills cells is often much higher than presumed physiological levels (Neve 
and Robakis, 1998). Neurons may take a long time to degenerate and eventually die. 
Indeed, neuronal loss is not obvious in a number of transgenic models of AD 
overexpressing mutated forms of APP, which better mimic the real condition in AD brains 
(Games et al, 1995; Irizarry et al, 1997; Sturchler-Pierrat et al, 1997; Urbanc et al, 2002). 
Similarly, the β-amyloid plaques that occur during the preclinical phase of the disease are 
also not associated with profound neuronal pathology (Vickers et al, 1996).  
2.4 Sequence of amyloid deposition in medial temporal lobe 
The evolution of Aβ-deposits in the human medial temporal lobe follows a distinct 
sequence. In contrast to the high degree of inter-individual variability in the number of 
plaques, the successive involvement of anatomically related regions exhibiting distinct 
types of Aβ-deposits shows no greater degree of inter-individual variability in a given 
phase. In a given phase Aβ-deposits always appear in distinct regions and all of the regions 
affected in an earlier phase always exhibit Aβ. Four phases of Aβ-deposition can be 
distinguished (Thal et al, 2000). In brief, the pathology progresses as follows: the basal 
temporal neocortex → entorhinal cortex, CA1 and subiculum → molecular layer of fascia 
dentate → CA4. The mechanisms responsible for this progression remain unclear.  
 
3 7eurofibrillary tangles (7FTs) 
Profound cytoskeletal changes occur in neurons and their processes in AD. Abundant 
neurofibrillary tangles (in cell bodies and apical dendrites, Figure 2.1C), neuropil threads 
(NTs, in distal dendrites) and plaque neurites constitute the neurofibrillary pathology of AD. 
They form in the nerve cells that undergo degeneration in the disease where their regional 
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distribution correlates with the degree of dementia. Ultrastructurally, each lesion contains 
paired helical filaments (PHFs) as its major fibrous component and straight filaments as its 
minor fibrous component (Kidd, 1963). PHFs are composed of two strands of filament 
twisted around one another with a periodicity of 80 nm whereas straight filaments lack this 
helical periodicity. Both PHFs and straight filaments are composed predominantly of the 
microtubule-associated protein tau in a hyperphosphorylated state (Grundke-Iqbal et al, 
1986).  
NFTs are usually intracellular fibrillar structures commonly flame-shaped in 
appearance and occupy the cell body and proximal portion of the apical dendrite of the 
affected neuron. Since the abnormal filaments are highly insoluble, NFTs remain in the 
extracellular space following the complete degeneration of the affected neuron and become 
extracellular ‘ghost’ tangles.  
3.1 Molecular biology 
NFTs are composed of tau, which is a microtubule-associated protein abundant in both 
central and peripheral nervous systems. In the brain it is found predominantly in nerve cells, 
where it is concentrated in nerve cell axons. This contrasts with the distribution of the 
neurofibrillary lesions in AD that are found in nerve cell bodies, axons, and dendrites. Tau 
protein appears as a series of polypeptides of differing lengths on electrophoresis gels, 
which is a characteristic phenomenon of alternative RNA splicing and/or various 
phosphorylation levels.  
The gene encoding tau, consisting of 16 exons, is located on chromosome 17 (Figure 
2.4; Neve et al, 1986; Lee et al, 2001). The adult brain expresses six isoforms of tau, which 
derive from alternative mRNA splicing of exons 2, 3 and 10 and differ by the presence of 
three (τ3L, τ3S or τ3) or four (τ4L, τ4S or τ4) tubulin binding domains (repeats) of 31 or 33 
amino acids in the C-terminal portion, and none (τ3, τ4), one (τ3S, τ4S) or two (τ3L, τ4L) 
inserts in the N-terminal region (Figure 2.4; Goedert et al, 1989).  
3.2 Physiology 
Neuronal morphology and structural integrity are maintained largely by the 
cytoskeleton, which is partially composed of microtubules. The assembly and stability of 
microtubules, in turn, are maintained by microtubule-associated proteins (MAPs). Tau, 
MAP1 (A/B) and MAP2 are the major microtubule-associated proteins of a normal mature 
neuron. These three MAPs perform similar functions, probably due to the essential 
requirement of microtubules for axoplasmic flow, which, in turn, is critical to neuronal 
activity. Physiologically, tau binds to and stabilizes microtubules, polymerizes actin, and 
Figure 2.4  Schematic representation of the human tau gene and the six central nervous system 
tau isoforms generated by alternative mRNA splicing. The human tau gene contains 16 exons, 
including exon (E)0, which is part of the promoter. Alternative splicing of E2, E3, and E10 
(gray boxes) produces the six tau isoforms. E6 and E8 (stippled boxes) are not transcribed in the 
human CNS. E4a (striped box), which is also not transcribed in the human CNS, is expressed 
in the peripheral nervous system, leading to the larger tau isoforms, termed big tau (see text). 
The black bars depict the 18–amino acid microtubule binding repeats and are designated R1 to 
R4. The relative sizes of the exons and introns are not drawn to scale. 
Adapted from Lee et al, 2001
Figure 2.4
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participates in intracellular trafficking (Buee et al, 2000; Lee et al, 2001). However, tau is 
not necessary for normal cell function. A tau-deficient mouse produced by gene targeting is 
viable and phenotypically similar to tau-containing mice, except for a reduction in the 
number and density of axons in parallel fibers from the cerebellum (Harada et al, 1994). 
This is largely due to compensation effects from another two MAPs.  
The microtubule binding domains of tau are localized to the C-terminal half of the 
molecule within the three or four microtubule binding motifs. It has been suggested that the 
four-repeat forms are more efficient at promoting microtubule assembly, have a greater 
microtubule binding affinity, and favour fibril formation, compared with three-repeat forms 
(Heutink, 2000; Lee et al, 2001). The binding of tau to microtubules is a complex process 
and highly regulated by phosphorylation (Lindwall and Cole, 1984). A variety of protein 
kinases and phosphatases have been implicated in the regulation of tau phosphorylation 
(Bree et al, 2000). There are 79 potential serine (Ser) and threonine (Thr) phosphate 
acceptor residues in the longest tau isoform, and phosphorylation at ~30 of these sites has 
been reported in normal tau proteins (Buee et al, 2000). The tau phosphorylation sites are 
clustered in regions flanking the microtubule binding repeats. Normal tau contains 2–3 mol 
phosphate/mol of the protein (Kopke et al, 1993), the level of phosphorylation for its 
optimal activity. Hypophosphorylated tau binds with high affinity to microtubules, whereas 
hyperphosphorylated tau, similar to that present in AD, depresses its microtubule assembly 
activity and its binding to microtubules (Garcia de Ancos et al, 1993).  
Tau phosphorylation is regulated by the balance between multiple kinases (eg, 
glycogen synthase kinase 3β and cyclin-dependent kinase 5) and phosphates (eg, protein 
phosphate-1 and protein phosphate-2A) (Lee et al, 2001).  
3.3 Tau pathology 
Tau pathology is not specific to AD and is also seen in a variety of other 
neurodegenerative disorders, such as frontotemporal dementia, subacute sclerosing 
panencephalitis etc. The discovery of mutations in tau gene and their cosegregation with 
the disease in the inherited frontotemporal dementia with Parkinsonism linked to 
chromosome-17 (FTDP-17) has established that abnormalities in tau protein as a primary 
event can lead to neurodegeneration and dementia (Hutton et al, 1998). 
In AD brains the levels of tau, but not its mRNA, are four- to eightfold increased as 
compared to age-matched control brains and this increase is in the form of the abnormally 
hyperphosphorylated tau (Khatoon et al, 1992). Furthermore, tau in healthy adult brain is 
located in axons, but in AD and other tauopathies, it is found in cell bodies and dendrites as 
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well as axons. The abnormally hyperphosphorylated tau is found in AD brain in two 
subcellular pools: as polymerized into NFTs of PHF mixed with straight filaments; and as 
non-fibrillized form in the cytosol (Iqbal et al, 1986; Köpke et al, 1993). The tau 
polymerized into neurofibrillary tangles is inert, whereas the cytosolic abnormally 
hyperphosphorylated tau does not interact with tubulin/microtubules but instead sequesters 
normal tau, MAP1 and MAP2, causing inhibition and disassembly of microtubules (del C 
Alonso et al, 1996). As a consequence, AD is associated with a loss of microtubule-binding 
capacity and a consequent accumulation in neuronal bodies, which further interfere with 
cytoskeletal integrity, intracellular transport, cellular geometry, and neuronal viability (Lee 
et al, 2001). The mechanisms underlying PHF formation in neurons are still unclear. But it 
is possible that hyperphosphorylation disengages tau from microtubules, thereby increasing 
the pool of unbound tau. Unbound tau may be more resistant to degradation and more 
prone to aggregate. After aggregation, PHF-tau undergoes posttranslational modifications, 
including ubiquitination (Mori et al, 1987), glycation (Yan et al, 1994) and oxidation 
(Schweers et al, 1995).  
3.4 7eurotoxicity of 7FTs 
PHF-tau may cause neurotoxicity in a loss of function and/or a gain of toxicity manner. 
Since phosphorylated tau inhibits microtubule assembly and causes the disassembly of 
microtubules (Alonso et al, 2001), PHF-tau compromises microtubule stability and 
function, resulting in a loss or decline in axonal or dendritic transport in disease (Salehi et 
al, 2003). Furthermore, PHF-tau disrupts intracellular compartments that are essential for 
normal metabolism. Cell culture studies show that the overexpression of tau causes a 
change in cell shape, retards cell growth and dramatically alters the distribution of various 
organelles transported by microtubule-dependent motor proteins (Stamer et al, 2002). 
Moreover, transgenic mice that overexpress the four-repeat human tau protein isoform 
specifically in neurons develop axonal degeneration in the brain and spinal cord and have 
notable axonal dilations due to the accumulation of neurofilaments, mitochondria and other 
vesicular structures (Spittaels et al, 1999).  
3.5 Braak staging 
The vulnerability to NFT formation is highest in the limbic areas of the medial 
temporal lobe. This vulnerability appears to become transferred along monosynaptic 
connections from limbic to paralimbic areas, then from paralimbic areas to association 
neocortex, and only terminally from association neocortex to primary sensory–motor areas. 
The putative role of axonal connections is highlighted by the fact that subcortical nuclei 
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monosynaptically interconnected with the cerebral cortex (such as the hypothalamus, 
brainstem raphe, and nucleus locus coeruleus) develop numerous NFT, whereas those with 
no cortical connections (such as the globus pallidus) do not. The interval between the initial 
appearance of the NFT in limbic areas and their widespread neocortical distribution in the 
terminal stages of the dementia may be as long as 50 years (Braak and Braak 1996).  
A hierarchical staging system for the neuropathological changes in AD has been 
elaborated based on the distribution of NFTs in the cerebral cortex (Braak and Braak, 1994). 
In stages I and II (the transentorhinal stages), NFTs and NTs are restricted to the entorhinal 
cortex and the CA fields of hippocampus. Stages III and IV (the limbic stages) are 
characterized by moderate numbers of NFTs and NTs in the hippocampus, basolateral 
amygdala, and limbic nuclei of the thalamus. In stages V and VI (the isocortical stages) all 
hippocampal subfields and isocortical association areas are severely affected. The principal 
consequence of these lesions is a diminution of synaptic inputs in these regions of the brain 
(DeKosky and Scheff, 1990; Terry et al 1991).  
 
4 7euronal and synaptic degeneration 
Although plaques and NFTs are hallmark changes, they are not the only significant 
pathological changes in the AD brain, additional structural changes occur in the AD brain, 
including inflammation and oxidative stress. The combined consequence of these changes 
is severe neuronal and synaptic degeneration. Many researchers have sought to establish 
correlations between cognitive impairments and pathological changes in AD. In general, 
the number of NFTs correlates better with severity of dementia than the number of amyloid 
plaques, but the best statistical correlates with degree of dementia are measures of synaptic 
density (DeKosky and Scheff, 1990; Terry et al, 1991). Quantification of synaptic markers 
has documented significant decreases in synaptic density in the association cortices and 
hippocampus of AD brain, which appear to precede neuronal degeneration (Davies et al, 
1987; DeKosky and Scheff, 1990; Terry et al, 1991; Masliah et al, 2001). Furthermore, 
studies from both AD patients and animal models indicate that the decrease in synapse 
number and density is disproportionate to the loss of neuronal cell bodies, suggesting that 
synaptic dysfunction is compromised prior to the physical degeneration of the synapses 
(Davies et al, 1987; DeKosky and Scheff, 1990; Westphalen et al, 2003). Extensive 
neuronal loss in circuits critical for learning and memory characterizes AD. Neurons that 
remain also undergo extensive morphological changes: dystrophic neurites form, dendritic 
and axonal trees are remodeled, and synapse and dendritic spine densities change (Spires 
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and Hyman, 2004). Such changes, both functional and structural, disrupt neuronal circuitry 
and represent early and pivotal events in the emergence and progressive development of 
dementia.  
This loss of populations of neurons would have a variable time course between 
individuals, but is likely to take months to years for individual nerve cells to degenerate. 
Importantly, neuronal degeneration is highly selective for certain brain regions and types of 
nerve cells. Neocortical interneurons, many of which would be GABAergic and inhibitory, 
are relatively unaffected, whereas a subset of pyramidal cells in layers II, III and V in the 
entorhinal cortex, hippocampus, frontal, parietal and temporal cortices, that use excitatory 
amino acids as transmitters, show a high degree of vulnerability (Vickers et al, 2000). 
Neuronal loss in AD brains is associated with the presence of amyloid plaques and NFTs 
(Khatchaturian, 1985). In general, AD essentially attacks the integrity of cortical circuitry, 
affecting both intracortical pathways as well as neurons in other regions of the brain that 
project to the cerebral cortex (Vickers et al, 2000). In this respect, there are numerous 
subcortical pathways affected, involving catecholaminergic, seritonergic and cholinergic 
transmission. Neurons in layer II of the entorhinal cortex and hippocampal CA1 neurons 
are particularly vulnerable. The pattern of neuronal loss in AD overlaps with, but is not 
identical to, that of normal ageing -- suggesting that AD pathogenesis is not simply an 
acceleration of normal brain ageing (Mattson, 2004).  
Among various neurotransmitter systems affected, one neural system that needs special 
attention is the cholinergic system. The central cholinergic transmitter system is involved in 
learning and memory. Cholinergic afferents innervate all cortical regions, with particular 
projections to the limbic and paralimbic cortices (Mesulam et al, 1983). Most of the 
cholinergic afferents to the hippocampal formation arise from the medial septal nucleus and 
the nucleus of the diagonal band, with a smaller portion from the basalis of Meynert. By 
contrast, the cerebral cortex receives its major cholinergic input from the basalis of 
Meynert, with additional projections from the pedunculopontine and lateral dorsal nuclei.  
Basal forebrain cholinergic neurons are vulnerable in AD (Geula, 1998). Amyloid 
plaques and NFTs are observed in the basalis of Meynert, the nucleus of the diagonal band, 
and the medial septal nuclei, with marked neuronal loss is in the first two regions and 
selective loss of nicotinic receptor subtypes (Whitehouse et al, 1981; Doody et al, 2004). 
The severity of the neuropathological changes in the basalis of Meynert has been found to 
correlate with clinical disease severity (Davies and Maloney, 1976). These findings 
underpin the “cholinergic hypothesis of AD”, which proposes that the cognitive 
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dysfunction in AD at least partly attribute to impairment of cholinergic neurotransmission 
(Coyle et al, 1983). Aβ may induce cholinergic dysfunction via three mechanisms: 
impairing Ach synthesis and release; functioning as an antagonist of the nAChR system; 
and oxidative stress (Tran et al, 2002). However, the cholinergic system is not selectively 
affected in AD, and there is relative preservation of the cholinergic neurons of the nucleus 
basalis in MCI and early AD (Gilmor et al, 1999), casting doubt onto the hypothesis. 
Currently the cholinergic deficiency in AD is considered to be a secondary event (Albers 
and Beal, 2000). But cholinesterase inhibitors remain important pharmacologic treatments 
for mild to moderate AD.  
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Chapter 3   Alzheimer’s Disease: Pathogenesis 
 
 
Understanding of the etiology and mechanisms of cognitive impairment in AD is 
pivotal for the development of effective treatments that prevent or ameliorate symptoms of 
the disease. AD clearly has a complex etiology, existing in early-onset familial forms in 
addition to manifestation in a common sporadic form. This chapter focuses on the 
pathogenetic theories and current animals models of AD.  
 
1 Alzheimer’s disease at the molecular level: Aβ hypothesis 
As discussed in the previous chapter, amyloid plaques and NFTs are two hallmark 
pathological changes in AD. The relative importance of these two changes in the 
development of AD has been intensely debated, with proponents of two camps dubbed as 
‘baptists’ and ‘tauists’, respectively.  
1.1 Amyloid hypothesis 
The Aβ hypothesis of AD stipulates that altered amyloid processing is the key 
pathogenic factor in disease progression, and that the rest of the disease results from 
amyloid-induced changes. According to the hypothesis first formulated over 10 years ago, 
overproduction and aggregation of Aβ in amyloid plaques trigger neurotoxic events, 
leading to progressive neurodegeneration underlying the typical cognitive decline 
associated with AD (Hardy and Allsop, 1991; Hardy and Higgins, 1992). Later, however, 
attention is turning away from the deposits of extracellular insoluble Aβ in plaques to 
soluble, oligomeric and intracellular Aβ peptides. These smaller aggregates exert a number 
of physiological effects that are sufficient to induce synaptic dysfunction and to account for 
much of the symptomatology in AD animal models and patients (Walsh et al, 2002; Cleary 
et al, 2005; Lesne et al, 2006). Furthermore, APP itself, its other fragments, and Aβ, are all 
physiologically involved in modulating neuronal and synaptic functions (Turner et al, 
2003). These findings led to a modified Aβ hypothesis (Figure 3.1; Hardy and Selkoe, 
2002), which shifts its emphasis away from the dense core amyloid to smaller, pre-fibrillar 
aggregates and the functional balance between different APP fragments, as major 
contributors to neural and cognitive dysfunction in AD.  
Supporting evidence 
There is a wealth of evidence to support this hypothesis.  
Figure 3.1  The sequence of pathogenic events leading to AD proposed by the amyloid cascade 
hypothesis. The curved violet arrow indicates that Aβ oligomers may directly injure the 
synapses and neurites of brain neurons, in addition to activating microglia and astrocytes.
Adapted from Hardy and Selkoe, 2002
Figure 3.1
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1. The strongest
 
evidence comes from molecular genetic studies
 
showing that all FAD-
causing mutations, either to APP itself or to presenilins, affect the processing of Aβ from 
APP and lead to proportionally greater production of the more neurotoxic “long” form of 
Aβ (Chapman et al, 2001; Selkoe, 2001). 
2. The ε4 allele of apoE, a major risk factor for sporadic AD, promotes the 
precipitation of Aβ into insoluble plaques. Crossing APP transgenic mice with apoE-
deficient mice markedly reduces cerebral Aβ deposition
 
in the offspring (Bales et al, 1997), 
suggesting that
 
the pathogenic role of genetic variability at the human apoE locus is very 
likely to involve Aβ metabolism.  
3. Patients of trisomy 21 (Down's syndrome), who possess an additional copy of the 
APP gene, invariably show an early emergence of AD-like neuropathology (Wisniewski et 
al, 1985).  
4. Aβ is neurotoxic both in vitro and in vivo.  
5. Transgenic mice overexpressing AD-causing mutants of APP and PS show AD-like 
pathological, electrophysiological and behavioural changes (see below).  
6. In patients with PS-1 mutations or individuals with Down’s syndrome who died 
prematurely from other diseases, the presence of Aβ precedes the appearance of NFTs 
(Lippa et al, 1998). Additionally, APP transgene accelerates
 
NFT formation in APP/tau 
double transgenic
 
mice (as compared with mice overexpressing tau alone) whereas NFTs 
do not influence the structure and number of amyloid plaques (Lewis et al, 2001). Similarly, 
injection of synthetic Aβ42 into somatosensory cortex and contralateral hippocampus of 
P301L mice caused a 5-fold increase in NFT numbers in the amygdala (Gotz et al, 2001). 
Results of these studies strongly suggest that Aβ accumulation precedes and accelerates the 
development of neurofibrillary lesions, although the exact mechanism of this interaction is 
unknown.  
7. Aβ immunization in multiple lines of APP transgenic mice reduces cerebral Aβ 
levels and plaque burden and/or alleviate memory impairment (Schenk et al, 1999; Bard et 
al, 2000; Chen et al, 2000; Morgan et al, 2000; Dodart et al, 2002).  
Refuting evidence 
Despite these supporting findings, there are also observations arguing against the Aβ 
hypothesis. The strongest challenge is that a specific neurotoxic species of
 
Aβ and the 
nature of its effects on synaptic function in vivo
 
remain ill-defined. However, several lines 
of evidence have converged to
 
demonstrate that soluble oligomers of Aβ, but not 
monomers or
 
insoluble amyloid fibrils, are toxic to cultured neurons and responsible for 
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synaptic dysfunction
 
in the brains of AD patients and animal models. This will be 
discussed in detail in a later section.  
Another frequently voiced objection is that spatial and temporal patterns of amyloid 
deposition do not correlate very well with the clinical degree of dementia in AD (Arriagada 
et al, 1992; Braak and Braak, 1998). Some humans without symptoms of AD
 
have many 
cortical Aβ deposits (Neve et al, 1998). However, the extent of β-amyloid deposition in 
“healthy” elderly is less than in AD and these plaques are almost
 
exclusively diffuse forms 
of amyloid plaques that are indicative of an early stage of the disease (Troncoso et al, 
1998). More importantly, a study by Morris et al (1996) demonstrated that aged non-
demented individuals who demonstrate neocortical β-amyloid deposits do show specific 
minor cognitive impairments that indicate that they were in an early stage of AD. 
Moreover, the degree of dementia in AD correlates much
 
better with Aβ assayed 
biochemically than with histologically
 
determined plaque counts, and the concentration of 
soluble Aβ
 
species (which are invisible to immunohistochemistry) appears
 
to correlate with 
cognitive impairment (Lue et al, 1999; McLean et al, 1999; Wang et al, 1999; Naslund et 
al, 2000).
 
The aggregated plaques may be either a reservoir for the soluble oligmers or the 
sequestered pool of soluble and precipitated Aβ representing the end stage or final product 
of the Aβ cascade. 
Finally, whereas transgenic mouse models bearing the FAD mutations show an 
increase in Aβ42 levels and subsequent plaque pathology, most of these models do not 
show significant neuronal loss or tangle formation as predicted by the amyloid cascade 
hypothesis. The reasons for this lack of neuronal loss and tau pathology are unclear but 
could result from the difference in tau sequence between mouse and human, species 
differences in neuronal vulnerability, the relatively short duration of exposure to Aβ and 
the lack of certain inflammatory mediators necessary for a full complement inflammatory 
response. 
Overall, the amyloid cascade hypothesis comprehensively articulates the current 
available knowledge regarding the cellular and behavioural alternations in AD and has had 
few compelling challenges. Nonetheless, there remain areas of doubt that Aβ by itself is 
both necessary and sufficient for AD. Its most robust test will come with the ‘amyloid 
vaccine’. Both passive and active immunization against Aβ has been shown to arrest, and 
even reverse, plaque pathology and/or behavioural phenotypes in the transgenic animals 
(Schenk et al, 1999; Bard et al, 2000; Chen et al, 2000; Morgan et al, 2000; Dodart et al, 
2002). However, studies on AD patients are lacking and if the same result is obtained in 
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human studies the Aβ hypothesis is all but proven. On the other side of the coin, if clearing 
amyloid neither reverses dementia nor affects tangles then the hypothesis needs 
considerable revision. 
1.2 Tau and tangle hypothesis 
Despite the great persuasiveness of the amyloid hypothesis, there is a persistent group 
of researchers arguing that tau and tangles are central to AD. The tau and tangle hypothesis 
argues that in AD the normal role of tau in stabilizing microtubules is impaired and, 
induces other pathological changes. 
Supporting evidence 
Support for tauists mainly comes from the fact that cognitive decline in the elderly has 
a good correlation with tangle formation but correlates poorly with amyloid burden (Nagy 
et al, 1995; Cummings et al, 1996) and that the process of tangle formation starts with 
increased phosphorylation and then aggregation of tau in those areas known to be critical 
for memory (Braak et al, 1994; Braak and Braak, 1998).  
Refuting evidence 
However, there is no known genetic linkage between AD and tau-processing 
abnormalities that might lead to NFT formation. Indeed, tau gene mutations have been 
reported to associate with the development of frontotemporal dementia with parkinsonism 
(Heutink, 2000). Furthermore, the fact that NFTs composed of altered, aggregated tau 
proteins occur in disorders (e.g., subacute sclerosing panencephalitis, Kuf's disease, 
progressive supranuclear palsy, etc.) in the absence of Aβ deposition suggests that tangles 
are not sufficient
 
to induce amyloid plaques characteristic of AD, and may arise 
secondarily during the course of a variety of etiologically distinct neuronal insults, 
including the gradual accumulation of Aβ and Aβ-associated molecules.  
Whatever the mechanism, the fact that mutations in tau give rise to tau-inclusion 
tangles but not plaques and yet mutations in APP or in the probable APP-proteases (PS-1 
and -2) give rise to both plaques and tangles almost proves that amyloid pathology occurs 
upstream of tau pathology. Two double-pathology models have also been created that come 
tantalizingly close to harmonizing the tauist and baptist camps. A transgenic mouse 
overexpressing both mutant APP and mutant tau has both plaques and tangles (Lewis et al, 
2001). Interestingly, the double mutant has more tangles than tau-mutant mice alone and 
tangles appear in areas of the brain that are unaffected in single mutant-tau transgenic mice. 
In a parallel experiment another group showed that injection of amyloid into the cerebrum 
of mutant tau transgenic mice exacerbated tangle pathology in another brain region from 
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where neurons project to the injection site (Gotz et al, 2001). These models together show 
that tangles and plaques are related pathogenetically.  
1.3 AD as a neuroplasticity failure: A unifying theory for AD?  
Amyloid hypothesis is the dominant etiologic paradigm at present. However, one 
important limitation of both hypotheses is the assumption that one of the pathological 
hallmarks directly induces the other, even though the development of both pathologies is 
temporally and spatially separated in AD (Thal et al, 2000). Indeed, amyloid plaques and 
NFTs can occur independently of each other. Tangles composed of tau aggregates that are 
biochemically similar to or, in some cases, indistinguishable from those in AD have been 
described in more than a dozen less common neurodegenerative diseases (Heutink, 2000), 
in almost all of which one finds no Aβ deposits and neuritic plaques. Conversely, Aβ 
deposits can be seen in the brains of cognitively normal-aged humans in the virtual absence 
of tangles. An alternative proposal would be that both pathologies, instead of developing 
interdependently, might be prompted by the same mechanism.  
AD as a neuroplasticity failure 
AD selectively attacks those neural systems that play a crucial role in “higher cognitive 
functions” such as hippocampus, neocortical association areas, and the cholinergic basal 
forebrain neurons. A common feature of these brain regions is that they retain a high 
degree of structural plasticity throughout life (Arendt et al, 2001). Neuroplasticity is a life-
long process that mediates the structural and functional reaction of dendrites, axons, and 
synapses to experience, attrition, and injury. The manifestations of neuroplasticity in the 
adult brain include alterations of dendritic ramifications, synaptic remodeling, long-term 
potentiation (LTP), axonal sprouting, neurite extension, synaptogenesis, and neurogenesis. 
Multiple lines of evidence indicate that the potential for neuroplasticity is distributed 
unevenly in the adult brain so that it is higher in the limbic system that in other parts of the 
cerebral cortex (Arendt et al, 2001). The fact that the spatial and temporal distribution of 
AD pathology follows the uneven pattern of neuroplasticity in the adult brain suggests that 
a breakdown of mechanisms regulating neuroplasticity is likely to be central in the 
pathogenesis of this disorder.  
Mesulam (1999) proposed that AD represents a form of neuroplasticity failure. 
Neuroplasticity depends on the strengthening of existing synapses, formation of new 
synapses, and destabilization of previously established synapses. With the increasing 
complexity of brain structures in evolution, these dynamic processes may become more 
and more important. Meanwhile, the delicate balance between stabilization and 
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destabilization might also provide the basis for an increasing rate of failure (Arendt, 2004). 
The core idea of the hypothesis is that, AD-promoting factors create a setting where 
neurons must work harder to keep up with the increasingly more burdensome plasticity 
needs. Over many years, such compensatory processes would result in chronically high and 
eventually unsustainable levels of plasticity-related cellular activity and finally 
neurodegeneration and neuronal death. In other words, neuronal modifications that are 
supposed to facilitate neuroplasticity may also have detrimental effects that lead to 
neurodegeneration. 
Support for this hypothesis comes from several pieces of evidence.  
First, all AD-related risk factors potentially perturb neuroplasticity. Age, the single 
most important risk factor for AD, and all known genetic linkages of AD are associated 
with a decrease in the biological capacity for plasticity (previous chapter). Under these 
conditions, a chronically high demand for plasticity-related activity would lead to 
prolonged elevation of plasticity related cellular activities. In vivo and in vitro experiments 
show that high levels of neuroplasticity tend to be associated with increased expression and 
phosphorylation of tau (Black et al, 1996; Lovestone and Reynold, 1997). Similarly, 
animal experiments show that injury- and denervation-induced
 
neuroplasticity can also lead 
to an upregulation of APP (Wallace et al, 1993; Beeson et al, 1994; Turner et al, 2003). In 
this way, the two principal pathological changes of AD become linked up by a single 
mechanism – neuroplasticity failure. These changes should initially appear within limbic-
paralimbic neurons because these neurons have the highest baseline levels of plasticity and 
would thus have the highest exposure to compensatory upregulations of plasticity-related 
cellular activity. The resultant cytoskeletal dysfunction and neuronal degeneration in these 
regions would promote both “horizontal (within the tightly interconnected
 
components of 
limbic-paralimbic cortices)” and “vertical (to the reciprocally interconnected association 
cortices)” expansion of the disease (Mesulam, 1999). Therefore, genetic mutations or risk 
factors do not cause AD – they simply operate through a common downstream mechanism 
and accelerate the temporal course of events that lead to plasticity failure. This helps to 
explain how the numerous genotypes of AD cause an identical clinical and 
neuropathological disease phenotype. In addition, the advanced cognitive and mnemonic 
activities of the human brain impose a very high plasticity burden, which helps explain 
human’s unique susceptibility to AD.  
Additionally, evidence also exists that Aβ and NFTs, instead of “causing” AD, may 
actually represent protective or compensatory responses to cellular stress. Oxidative 
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damage is one of the earliest events in AD and activates several kinases, including 
glycogen synthase kinase-3 and mitogen-activated protein kinases, which are activated in 
AD and are capable of phosphorylating tau and neurofilaments (Reynolds et al, 2000). The 
regulation of tau phosphorylation in the adult mammalian brain is a naturally occurring 
process associated with neuroprotective mechanisms. The AD hyperphosphoralated-tau 
readily self-assembles into tangles in vitro under physiological conditions of protein 
concentration, pH, ionic strength and reducing conditions (del C. Alonso et al, 2001). 
Embryonic neurons that survive after treatment with oxidants have more phospho-tau 
immunoreactivity relative to those that die (Ekinci and Shea, 2000). In addition, cellular 
antioxidant induction and tau expression are opposing, suggesting that the reduced 
oxidative damage in neurons showing tau accumulation might be a direct consequence of 
an antioxidant function of phosphorylated tau (Wataya et al, 2002). Thus, the presence of 
NFTs may protect crucial cellular components from attack by reactive oxygen species. The 
fact that the tangle-bearing neurons seem to survive for many years (Morsch et al, 1999) is 
consistent with such a self-defense role of the formation of tangles. As for amyloid 
pathology, it has been reported that in AD cellular stress precedes increases in Aβ 
(Nunomura et al, 2001) and that a reduction in stress consequentially leads to lowered 
levels of Aβ (Yan et al, 1996; Lim et al, 2001). More interestingly, stress-induced increases 
in Aβ are associated with a decrease in stress (Nunomura et al, 2001), suggesting that the 
upregulation of Aβ could play a protective function.  
In this way, the dilemma of amyloids and tau in AD pathogenesis can be solved by 
assuming that these two markers of AD are independent manifestations of a
 
common 
underlying phenomenon -- a prolonged perturbation
 
of neuroplasticity and the resulting 
compensatory response. An important inference of this hypothesis is that, treatment for AD 
may not be entirely successful unless the underlying plasticity failure is also addressed. 
One of the most important goals in AD research will be to understand the processes that 
influence plasticity in the adult human brain and to determine whether their vulnerability to 
aging and to the other AD-causing factors can be modified.  
 
2 Alzheimer’s disease at the synaptic level: AD as a synaptic failure 
Synaptic loss in the hippocampus and neocortex is the major structural correlate of 
cognitive dysfunction in AD. (Davies et al, 1987; DeKosky et al, 1996). The degree of 
cognitive decline in patients with AD has been correlated with changes in the presynaptic 
vesicle protein synaptophysin
 
in the hippocampus and association cortices (Terry et al, 
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1991; Dickson et al, 1995; Sze et al, 1997). Even at the end of the disease, quantitative 
correlations of postmortem cytopathology with premortem cognitive deficits indicate that 
synapse loss is more robustly correlated than are numbers of plaques or tangles, degree of 
neuronal perikaryal loss, or extent of cortical gliosis (Terry et al, 1991).  
2.1 Synapses as the initial target in AD 
Many biochemical and morphological studies suggest that early AD represents an 
attack on synapses (Small et al, 2001). Synaptic pathology is reflected by a loss of all 
major components of small synaptic vesicles and most peptides, stored in large dense core 
vesicles accompanied by extensive pathological changes of the synapse (Lassmann et al, 
1993). Although deficits in numerous neurotransmitters (including corticotropin-releasing 
factor, somatostatin, GABA, and serotonin) accrue as the disease progresses, the early 
symptoms appear to correlate with dysfunction of cholinergic and glutamatergic synapses. 
This is consistent with the facts that the defining lesions of AD – the Aβ-containing 
neuritic plaques and the tau-containing NFTs – first attack septal-hippocampal and basal 
forebrain-neocortical pathways (Whitehouse et al, 1982). A quantitative morphometric 
study of temporal and frontal cortical biopsies performed within an average of 2 to 4 years 
of the onset of clinical AD revealed a 25 to 35% decrease in the numerical density of 
synapses in biopsied AD cortex, and a ~15 to 35% decrease in the number of synapses per 
cortical neuron (Davies et al, 1987). Synaptophysin immunoreactivity has also been 
reported to be decreased ~25% in the cortex of patients with MCI or very mild AD 
(Masliah et al, 2001). In some APP transgenic mouse lines, a decrease in the numbers of 
synaptophysin-positive presynaptic terminals and MAP2-positive neurons is the first 
histological change and appears at an age prior to Aβ plaque formation (Hsia et al, 1999).  
It must be emphasized that AD is a chronically progressing disorder preceded by a 
clinically silent period of several years or even decades. Similarly, synaptic degeneration is 
a slow process progressing from an initial reversible stage to later stages irreversibly 
associated with marked synaptic loss. While massive loss of neurons and synapses can 
undoubtedly produce behavioural deficits, structural changes (loss of neurons and 
synapses) are not key factors for the physiological or behavioural deficits (Small et al, 
2001), as these deficits can occur in the absence of cell death in AD models (Hsiao et al, 
1996). In contrast, dysfunction of existing neurons and synapses may be sufficient to 
explain the behavioural deficits in AD.  
Support for this notion comes from a large number of electrophysiological studies. 
Exogenously applied Aβ inhibits hippocampal LTP both in vitro and in vivo (for reviews, 
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see Selkoe, 2002; Rowan et al, 2003; Turner et al, 2003). Moreover, disrupted basal 
synaptic transmission and/or plasticity have been demonstrated in each of the APP-
overexpressing mouse models that have been thoroughly tested (eg, Chapman et al, 1999; 
Larson et al, 1999; Janus et al, 2000a; Fitzjohn et al, 2001). In many cases, this synaptic 
dysfunction develops before plaque formation thus may result from soluble species of Aβ, 
especially soluble oligomers (Walsh et al, 2002), instead of amyloid deposits. Thus, AD 
has been proposed to be an Aβ-induced synaptic failure and such effects could contribute 
to the cognitive dysfunction (Selkoe, 2002). 
2.2 Aβ-induced synaptic dysfunction 
The concept that progressive accumulation of Aβ in brain regions important for 
memory and cognition initiates AD is currently
 
the leading theory of causation. Several 
electrophysiological studies of young mice
 
transgenic for human APP with AD-causing 
mutations have revealed
 
significant deficits in basal synaptic transmission and/or LTP in 
the hippocampus, well before the development of
 
microscopically detectable Aβ deposits 
(next section). Although the use of different electrophysiological protocols and mouse lines 
has led to some variability, all these studies support the concept that mutant APP transgenic 
mice undergo synaptic dysfunction. However, the presence of a mixture of Aβ forms 
(monomers, soluble oligomers, insoluble oligomers, and some insoluble amyloid fibrils) 
that are likely to exist in dynamic equilibrium in the brain of AD patients and animals has 
made it difficult to ascribe the specific synaptotoxic Aβ species.  
Recently, there is evidence that soluble oligomers of Aβ, but not monomers or 
insoluble amyloid fibrils, are both necessary and sufficient for synaptic dysfunction
 
in the 
brains of AD models (Walsh et al, 2002; Cleary et al, 2005; Lesne et al, 2006). Impaired 
LTP has been observed in APP-V717 (PD-APP) mutant transgenic mice before the 
development of Aβ deposits (Larson et al, 1999). In certain cultured cell lines expressing 
mutant human APP, natural oligomers of human Aβ are formed soon after generation of 
the peptide within intracellular vesicles and are later secreted from the cell at low 
nanomolar levels (Walsh et al, 2002). Intracerebroventricular microinjection of cell 
medium containing these oligomers in the absence of monomers and amyloid
 
fibrils 
potently inhibited hippocampal LTP in adult rats. Pretreatment of the medium with a 
protease that selectively degrades Aβ monomers but not oligomers failed to prevent the 
LTP inhibition. Conversely, treatment of the cells with an inhibitor of β-secretase (one of 
the two proteases that generate Aβ from APP) markedly decreased oligomer formation at 
doses that still allowed appreciable monomer production, and such medium no longer 
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disrupted LTP (Walsh et al, 2002). Such findings indicate that neurodegeneration in AD 
may arise from injury caused by small,
 
diffusible oligomeric assemblies of Aβ, whereas 
large polymeric aggregates (amyloid plaques)
 
represent inactive reservoirs of species that 
are in equilibrium
 
with the smaller, putatively neurotoxic assemblies (Selkoe, 2002). This 
animal work fits nicely with growing evidence that memory and cognitive deficits in MCI 
and AD patients correlate far better with cortical Aβ levels than with plaque numbers 
(Naslund et al, 2000) and correlate best with the soluble pool of cortical Aβ, which 
includes soluble oligomers (Kuo et al, 1996; Lue et al, 1999; McLean et al, 1999). Even in 
very mildly impaired patients, soluble Aβ levels in the cortex show a significant correlation 
with degree of synaptic loss (Lue et al, 1999).  
 
3 Animal models of Alzheimer’s disease 
3.1 Criteria for a successful AD model 
Animal models of AD greatly improve our understanding of the disease. However, it is 
important that the created animal models mimic AD both pathologically and behaviourally. 
Janus et al proposed 5 expectations for a credible rodent model of AD (Janus et al, 2000a).  
1. Mice should exhibit progressive neuropathology culminating in at least one or more, 
of the accepted pathologic hallmarks of AD. 
2. Mice should exhibit robust cognitive deficits evident in different behavioural 
paradigms targeting the same memory system. Ideally, behavioural paradigms employed to 
test mice should address neuroanatomic structures that are affected in AD (e.g. the 
hippocampus). 
3. In the case of experiments employing FAD mutations, phenotypic changes should be 
correlated with the presence of the FAD mutations, and should be absent or less overt in 
age-matched mice expressing wt gene alleles expressed at equal (or greater) steady-state 
levels.  
4. Key facets of the phenotype as per 1–3 should be confirmed in independent tg lines 
harboring the same construct, to exclude the contribution of insertional mutations.  
5. Key facets of the phenotype as per 1–3 should have been confirmed in several 
laboratories. 
Despite intensive efforts, a fully authentic mouse model has not been created. Early 
models focused on reproducing specific aspects of neuropathology. In the past decade, 
several strains of transgenic mice overexpressing FAD-related mutated genes have been 
created. These animals show a variety of phenotypes that are similar to AD but none of 
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them represent a full scene of AD. However, studies of these mice have begun to define the 
character and spatial/temporal evolution of cellular/biochemical abnormalities in brain, to 
delineate the pathogenesis that causes these lesions, to identify a variety of new therapeutic 
targets, and to evaluate potential therapeutic intervention of AD.  
3.2 Early models 
Before the identification of AD-related gene mutations, animal models focused on 
reproducing more specific aspects of neuropathology. For example the hypothesis that a 
cholinergic deficit is responsible for the cognitive impairments seen in AD led to the 
models with destroyed forebrain cholinergic nuclei, initially by electrolytic lesions, then by 
excitotoxins and finally by the selective immunotoxin 192 IgG-saporin. Another commonly 
used model is aging animals. Although informative, these models are too restricted and 
could not recapitulate the overall neuropathological picture of AD. In the past decade, with 
the identification of several genes directly linked to AD, it has been possible to develop 
transgenic mouse models to test many of the observations and hypotheses established from 
in vitro experiments and to evaluate therapeutic concepts. 
3.3 APP transgenics 
Transgenic mice are
 
created by expressing variants of APP,
 
PS-1, PS-2, apoE, or tau 
genes. Mice that overexpress mutated forms of APP gene were the first transgenic models 
of AD developed. Now there are over a dozen APP models. As
 
a family, these mice 
develop a wide variety of behavioural, biochemical,
 
pathological, and physiological traits 
simulating AD, although
 
not all traits have been represented within an individual mouse
 
line. One of these models, the tg2576 line, is used in the current study and its features will 
be discussed in detail in a separate section.  
The earliest transgenic models of AD overexpressed full-length (Lamb et al, 1993; 
Pearson et al, 1993) or C-terminal fragments (Kammesheidt et al, 1992) of wild-type APP 
(Mucke et al, 2000). However, even high-level expression of wild-type human APP was 
insufficient to produce significant plaque deposition (Mucke et al, 2000) until very high Aβ 
concentrations had been achieved (Czech et al, 1997; Lamb et al, 1999). Thus the key 
factor in producing APP transgenic mice that do form plaques appears to be a high 
concentration of Aβ, which can be obtained by the use of a strong brain specific promoter 
driving high levels of protein expression or inserting an APP gene with an FAD mutation. 
Another crucial factor for plaque formation is age; all the APP-overexpressing mouse lines 
that develop AD pathology are apparently normal at birth, and begin to develop 
histopathology by approximately the middle of the normal mouse lifespan.  
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7europathology 
There is some consistency among APP transgenic mouse lines in terms of 
histopathological profiles. Three different promoters (PDGF, PrP and Thy-1) and at least 
three mutations [V717I (Moechars et al, 1999), V717F (the PDAPP line, Games et al, 1995) 
and K670N/M671L (Hsiao et al, 1996)] all produce age-dependent increases in Aβ 
concentration and, eventually, deposition into dense-core amyloid plaques with reactive 
astrocytes, dystrophic neuritis and gliosis. Diffuse plaques also exist. The plaque 
distribution is not uniform throughout the brain, but has a similar regional distribution of 
plaques which mimics that in AD patients. There are differences, however, that could 
prove to be significant regarding the nature of the deposits. For example, mice expressing 
the V717F mutation produce vast amounts of Aβ42 but little Aβ40 and a greater proportion 
of diffuse plaques (Games et al, 1995), whereas K670N/M671L mutants demonstrated 
elevated concentrations of both types of Aβ and most of the amyloid load consists of dense 
cored plaques with relatively few diffuse deposits (Hsiao et al, 1996; Sturchler-Pierrat et al, 
1997).  
However, none of these models demonstrate all the pathological changes seen in human 
AD. Overt NFTs were absent in all these models, though hyperphosphorylated forms of tau 
are detectable. Another important difference regards the loss of neurons and synapses. A 
severe loss of neurons and synapses characterizes human AD, even in its early stages, 
whereas it is not prominent, if not absent, in APP transgenics (Games et al, 1995; Irizarry 
et al, 1997; Sturchler-Pierrat et al, 1997; Urbanc et al, 2002; but see Calhoun et al, 1998). 
In contrast, synaptic degeneration and dysfunction has been reported in nearly all the 
models studied, despite marked variability among them. Structural changes include 
reduced synaptophysin immunoreactivity, altered neurite trajectory, dendritic spine loss 
and thinning of dendrites (Games et al, 1995; Hsia et al, 1999; Mucke et al, 2000; Tsai et 
al, 2004; Spires et al, 2005; Jacobsen et al, 2006). However, in some models, these 
structural changes only occur at very late stage (>20 months), suggesting that synaptic 
dysfunction may underlie the cognitive deficits seen in younger subjects (>12 months) 
(Spires et al, 2005). Consistent with this idea, some forms of synaptic dysfunction, either 
basal synaptic transmission, or synaptic plasticity, or both, have been demonstrated in each 
of the APP-overexpressing lines that have been thoroughly tested (Chapman et al, 1999; 
Fitzjohn et al, 2001). It is currently uncertain how the synaptic changes observed in 
transgenic mice relates to the process of neurodegeneration in human AD, and whether it 
could be a precursor of neuronal cell death given longer time periods than are possible in a 
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mouse. However, it is clear, from the absence of neuronal loss in some models, that 
physiological Aβ accumulation does not cause rapid neuronal cell death in vivo. 
Behaviour 
It is difficult to compare the behavioural phenotype of a rodent model of AD with 
human patients, because of the significant differences in human and rodent cognition. 
Indeed, many of the diagnostic features of AD, such as language disturbance and loss of 
judgement, are impossible to examine in rodents. However, hippocampal dysfunction is the 
earliest and most prominent feature of AD, so behavioural testing of mouse AD models has 
focused on spatial learning and memory.  
Before testing learning and memory, some measure of general activity and 
sensorimotor ability needs to be performed so as to exclude potential gross impairments of 
neurological function in these animals. No severe impairments in these domains have been 
reported, although some transgenic lines show hyperactivity, anxiety and neophobia (Hsiao 
et al, 1995; Moechars et al, 1999).  
Multiple lines of APP transgenics have been shown to develop deficits in spatial 
learning and memory in a variety of behavioural test paradigms, though the onset time 
differs across models and tasks (Moran et al, 1995; Hsiao et al, 1996; Chapman et al, 1999; 
King et al, 1999; Moechars et al, 1999; Chen et al, 2000; Janus et al, 2000c; Morgan et al, 
2000; Jacobsen et al, 2006). One important issue in modelling the cognitive deficits of AD 
is the age dependence of the behavioural impairments. To date, each of the mutations that 
cause behaviour deficits produce a component that is essentially age-independent, and 
another that is age-dependent. Interestingly, although the onset of amyloid deposition 
coincides with significant increases in the severity of some behavioural deficits, others do 
not appear to require the formation of amyloid plaques, indicating the possible involvement 
of soluble forms of Aβ in the development of cognitive decline (Moran et al, 1995; 
Chapman et al, 1999; King et al, 1999; Lamb et al, 1999; Westerman et al, 2002; Walsh et 
al, 2002a).  
3.4 PS transgenics 
The majority of FAD cases are caused by mutations in PS genes. These mutations, both 
PS-1 and PS-2, have also been used to generate animal models (Duff et al, 1996; Borchelt 
et al, 1996; Borchelt et al, 1997; Herreman et al, 1999). These models only show increased 
production of Aβ42 without formation of neuritic plaques or neuronal loss (Borchelt et al, 
1996; Duff et al, 1996; Borchelt et al, 1997; Citron et al, 1997). Similarly, they do not 
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display significant sensorimotor- or age-dependent cognitive impairment (Janus et al, 
2000b).  
PS-1 null mice fail to survive but this lethality can be rescued by crossing these mice to 
human PS-1 transgenic lines (Davis et al, 1998). Interestingly, not only transgenic lines 
expressing the wild-type, but also the mutant PS-1 gene carrying the human PS-1 (A246E) 
mutation can rescue the severe phenotype of the knockout mouse to similar degrees. 
Moreover, the level of Aβ1-42 and the ratio of Aβ1-42/40 are significantly increased in the 
human mutant PS-1 rescued PS-1 knockout mice than in the mutant PS-1 transgenics alone 
(De Strooper et al, 1998). These findings indicate that the mutation of the PS-1 gene does 
not lead to a loss of function during mouse development. Rather, it comprises a gain of 
function, which can be suppressed by competition of normal functioning murine PS-1 
alleles, which are present in the human mutant PS-1 transgenic, but are absent in the PS-1 
rescued mice. 
When mutant PS1-overexpressing mice are crossed with the APP transgenics, the 
Aβ42/Aβ40 ratio in the brain is greatly enhanced and amyloid deposition is accelerated 
(Borchelt et al, 1996; Borchelt et al, 1997; Citron et al, 1997; Holcomb et al, 1998). Large 
numbers of amyloid deposits in the cerebral cortex and hippocampus were found already 
starting at 6 months of age in the double transgenics in comparison to 9–12 months in the 
single APP695(K670N+M671L) mutant APP line alone. However, stereological 
investigation of the hippocampus and frontal cortex of these mice indicate that there is still 
no dramatic cell loss despite the increased severity of the model (Takeuchi et al, 2000). PS-
1–APP double transgenics do show behavioural impairments, but the severity is not 
significantly greater than that seen in the APP single transgenics (Holcomb et al, 1998; 
Holcomb et al, 1999).  
Evidence that PS-1 coexpression with APP accelerates plaque deposition and that PS-1 
expression alone is not sufficient to induce amyloid pathology supports the role for PS-1 as 
a modifying gene (Spires and Hyman, 2005). Moreover, FAD-associated mutations of 
presenilins cause an increased probability of producing the highly fibrillogenic 42 amino 
acid version of Aβ instead of the less harmful 40-amino acid peptide.  
3.5 ApoE transgenics 
ApoE knockout mice have decreased synaptophysin and microtubule-associated protein 
2 staining, supporting a role for apoE in the maintenance of synapses and dendrites 
(Masliah et al, 1995). Evidence also exists for the involvement of apoE in Aβ fibrillization 
and clearance (Irizarry et al, 2000).  
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Recently, the effects of apoE on amyloid deposition have been tested by mating apoE 
knockout mice with APP transgenics (PDAPP or tg2576 mice). These mice show only 
sparse, diffuse plaque deposition and almost no dense, thioflavine S (thioS)-positive 
plaques or neuritic degeneration normally associated with these dense plaques (Bales et al, 
1997; Bales et al, 1999; Irizarry et al, 2000; Holtzman et al, 2000a; Holtzman et al, 2000b). 
There was no obvious influence of the apoE-/- state on APP mRNA or protein or on levels 
of Aβ, suggesting that neither reduced expression of the transgene nor the processing of 
APP to Aβ accounts for the absence of Aβ deposits in these mice.  
It was hypothesized that apoE isoforms may differentially promote the aggregation, 
fibril formation, or influence the clearance of Aβ. In APP-expressing mice on an apoE null 
background, overexpression of apoE3 or apoE4 “rescues” Aβ deposition in dense, neuritic 
plaques that are absent in apoE knockout mice expressing APP (Holtzman et al, 2000a). 
ApoE4 expression induced a 10-fold higher density of neuritic plaques than expression of 
apoE3. In contrast, overexpressing apoE2 in both PDAPP and tg2576 mice ameliorates 
amyloid-induced dendritic spine loss, providing a mechanism by which the apoE2 allele 
might exert its protective effect in AD (Lanz et al, 2003).  
3.6 Tau transgenics 
The above models mainly target amyloid pathology and none of them show NFTs. To 
model the NFT pathology, tau transgenic mice have also been developed. Early transgenic 
tau models expressing wild-type human tau resulted in hyperphosphorylation of tau and 
somatodendritic localization without formation of NFTs (Gotz et al, 1995; Probst et al, 
2000; Ishihara et al, 2001). Thus overexpression of human wild-type tau is insufficient to 
induce NFT formation, but the somatodendritic localization of tau in neurons does 
resemble the “pre-tangle” state observed in AD. 
Later, many groups turned to the newly discovered pathogenic tau mutations for 
producing animal models. Expression of the FTDP-17-associated mutation P301L in the 
shortest four repeat tau isoform caused massive NFT formation in the spinal cord, 
brainstem, cerebellum, diencephalon, and basal telencephalon. These mice also show 
significant neuronal loss in affected brain regions and spinal cord (Lewis et al, 2000; Gotz 
et al, 2001; Santa-Cruz et al, 2005; Ramsden et al, 2005). Furthermore, the progression of 
neurofibrillary pathology and neuronal loss is also correlated with the progression of 
deficits in spatial reference memory as assessed by the Morris water maze, indicating a 
detrimental effect of NFTs on memory (Arendash et al, 2004; Santa-Cruz et al, 2005).  
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One important finding from these animals is that the formation of NFT lesions could be 
dissociated from tau-induced neuronal loss and memory decline (Santa-Cruz et al, 2005; 
Ramsden et al, 2005). In the inducible rTg4510 model, onset of memory deficits (2.5–4 
months) precedes the development of significant NFT pathology or neuronal loss (5.5 
months). Furthermore, suppressing inducible transgene expression after initial NFT 
formation has occurred (>4 months) did not halt the continuing increase in NFT numbers 
but halted the loss of neurons and enabled at least partial recovery of spatial reference 
memory function (Santa-Cruz et al, 2005). These findings suggested that NFT formation is 
not directly responsible for neurodegeneration and memory loss in rTg4510 and a toxic 
intermediate tau species is more likely to underlie these processes. This is similar to the 
finding that soluble oligomeric Aβ species, rather than insoluble amyloid, drives memory 
loss in APP mice and implies that reversible neuronal dysfunction, as opposed to structural 
neurodegeneration, explains much of the early memory loss in AD. 
3.7 Multiple-transgenic models 
With the availability of both amyloid and tau transgenic models, intense interest 
became focused on how Aβ would affect NFT formation. Crossing tg2576 mice that 
produce Aβ with JNPL3 tau mice (P301L mutation) resulted in a double-transgenic strain 
that developed both plaques and tangles. Whereas the presence of tau did not affect 
amyloid pathology, the presence of amyloid greatly enhanced NFT formation in the 
amygdala, entorhinal cortex, and olfactory bulb of double transgenic mice (Lewis et al, 
2001). Importantly, the enhanced NFT pathology in the TAPP mice was also associated 
with evidence of neuronal loss in the entorhinal cortex. Similarly, injection of synthetic 
Aβ42 into somatosensory cortex and contralateral hippocampus of P301L mice caused a 
fivefold increase in NFT numbers in the amygdala (Gotz et al, 2001). Results of these 
studies strongly suggested that Aβ accumulation accelerated the development of 
neurofibrillary lesions, although the exact mechanism of this interaction was unknown. 
Oddo et al (2003a) developed a 3xTg-AD mice harboring mutations of APP (Swedish), 
PS1 (M146V), and tau (P301L). This model accumulates intraneuronal Aβ, and 
subsequently forms amyloid plaques and MAPT lesions in an age-dependent fashion: 
plaques first develop in the neocortex (around 3 months of age) and spread to the 
hippocampus by 6 months; tangles develop after amyloid pathology, appearing first in the 
hippocampus (at 12 months) and spreading to the cortex (Oddo et al, 2003b). The 
appearance of amyloid pathology before tau pathology despite similar levels of expression 
also supports the amyloid cascade hypothesis of AD pathogenesis. 3xTg mice also exhibit 
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age-dependent synaptic dysfunction, including LTP deficits that surprisingly precede 
plaque and tangle formation. (Oddo et al, 2003a) Instead, LTP deficits and memory deficits 
correlate with the accumulation of intraneuronal Aβ (Oddo et al, 2003b; Billings et al, 
2005).  
In subsequent studies, treatment of 3xTg mice with anti-Aβ antibodies, or antibodies 
specific for oligomeric forms of Aβ led to the rapid clearance of accumulated Aβ 
deposition and early tau lesions in the cell body (Oddo et al, 2004; Oddo et al, 2005). The 
removal of both Aβ and tau lesions proceeded in a hierarchical, time-dependent manner, 
with clearance of accumulated Aβ occurring before a reduction in the tau pathology. 
Furthermore, after clearance of the injected Aβ antibody, Aβ pathology re-emerged before 
the appearance of tau lesions. However, later stage hyperphosphorylated tau lesions were 
resistant to clearance by Aβ immunotherapy  (Oddo et al, 2004). This mimics the findings 
of Santa-Cruz et al (2005) that NFTs are stable and resistant to transgene suppression.  
3.8 Summary 
Studies in mice expressing APP, PS and tau transgenes have provided clear evidence of 
Aβ and tau interaction in the pathogenesis of AD. Moreover, the results clearly support a 
central role of Aβ in these processes. However, it seems likely that Aβ accumulation does 
not lead directly to neuronal cell death in AD but promotes the accumulation of toxic tau 
species or other secondary pathological events. The close link between NFT formation and 
neuronal loss observed in multiple tau transgenic lines strongly suggests that in AD the 
development of pathological tau species is a major pathway to neurodegeneration, which, 
by extension, accounts for most of the clinical syndrome.  
3.9 Tg2576 model 
The tg2576 mice line was one of the first successful mouse models of AD. It was 
developed by insertion of the human APP695 construct with the double ‘Swedish’ 
mutation (Lys670→Asn, Met671→Leu) and hamster prion protein cosmid vector into a 
C57B6/J*SJL host (Hsiao et al, 1996).  
7europathology 
The mutant gene has been shown to induce a 5-fold overexpression of APP695 in the 
brains of mice over 2 months of age, and consequently, elevated brain levels of Aβ (Hsiao 
et al, 1996). It is important to note that different forms of Aβ are present in varying 
amounts throughout the lifetime of these mice. Detergent-soluble Aβ is present since birth, 
whereas insoluble Aβ becomes elevated by 6–8 months of age and Aβ-containing neuritic 
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plaques begin to form in the neocortex and hippocampus by 10–16 months (Hsiao et al, 
1996; Irizarry et al, 1997; Kawarabayashi et al, 2001; Jacobsen et al, 2006).  
In addition to amyloid pathology, tg2576 mice also show activated microglia, reactive 
astrocytes and neuritic dystrophy, which mimic what is observed in AD (Frautschy et al, 
1998). The presence of hyperphosphorylated tau has also been reported in dystrophic 
neuritis close to neuritic plaques yet no NFTs are observed (Tomidokoro et al, 2001). 
Another important difference of these mice from AD patients is, despite similar Aβ 
burdens as those in AD, there is minimal or no neuronal loss within the hippocampus and 
cortex of aged tg2756 mice (Irizarry et al, 1997; Dong et al, 2007).  
Behaviour 
Sensorimotor functions have been intensively studied in tg2576 mice. Shorter latencies 
to fall from a beam and increased activity in the open-field and Y-maze have been reported 
for young but not aged transgenic mice (Hsiao et al, 1995; King et al, 1999). These altered 
exploratory behaviours could result from emotional or motor changes in young transgenics.  
Learning and memory abilities of these mice have also been measured using a number 
of behavioural tasks. In the conventional Morris water maze task, aged transgenic mice 
showed significantly longer escape latencies to the hidden platform and spent less time in 
the target quadrant during probe trials, when compared with age-matched controls (Hsiao 
et al, 1996; Morgan et al, 2000; Westerman et al, 2002). As for spatial working memory, 
Chapman et al (1999), Corcoran et al (2002) and Barnes et al (2004) all reported an age-
dependent (>10 months) performance deficit of tg2576 mice in the forced T-maze 
alternation task. Similar results have been reported in the spontaneous alternation task in 
Y-maze and radial maze (Hsiao et al, 1996; Morgan et al, 2000).  
Thus, it is clear that transgenic mice develop memory impairments with age. However, 
reported onset of these deficits ranges from 3 months to 15 months in different studies 
(Hsiao et al, 1996; Holcomb et al, 1999; King et al, 1999; Morgan et al, 2000; Westerman 
et al, 2002; Jacobsen et al, 2006). Possible explanations for these discrepancies may 
include different genetic background of the mice, different training protocols or the varied 
sensitivity to hippocampal damages of each task. Another potential reason may lie in the 
age-independent performance
 
deficits related to both mutant and wild-type human APP 
overexpression, reported by Westerman et al (2002) after studying transgenic mice 
overexpressing comparable levels of wild-type and mutant human APP695. When mice with 
these deficits not specifically
 
related to the expression of mutant APP695 were excluded 
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from
 
the analysis, spatial memory loss was first detected at ~6 months, which coincided 
with the appearance of detergent-insoluble Aβ aggregates.  
Synaptic function 
Massive neuronal loss can undoubtedly cause behavioural deficits. However, as 
discussed earlier, neuronal loss is not apparent in tg2576 mice, suggesting that neuronal 
and synaptic dysfunction may account for the cognitive deficits in these mice when they 
get aged. Evidence for progressive synaptic degeneration and dysfunction has been 
reported in tg2576 mice. No evidence of synaptic degeneration has been reported in this 
line before robust amyloid plaque deposition (<12 months) (Irizarry et al, 1997), However, 
recent studies have shown that in older tg2576 mice (21–25 months) synaptophysin 
immunoreactivity is reduced only around dense cored amyloid plaques and this is 
associated with electrophysiological changes indicating abnormalities in synaptic function 
(Spires et al, 2005). In addition, 3D multi-photon microscopy has been used to demonstrate 
altered neurite trajectory, dendritic spine loss and thinning of dendrites in a zone around the 
dense cored plaques in tg2576 (Spires et al, 2005). These findings further support the view 
that AD represents a synaptic failure.  
Three groups have measured synaptic transmission and/or plasticity in tg2576 mice. 
However, these three studies produced different results. Chapman et al (1999) did not 
detect changes in basal synaptic transmission
 
in young (2 to 8 months) or aged (15 to 
17 month) mice, but demonstrated severely impaired LTP deficits in dentate gyrus in vitro 
and in vivo and, to a much lesser extent in CA1 in vitro, by the latter age. Furthermore, 
there was a positive correlation between the magnitude of LTP recorded
 
in vitro in CA1 
and dentate gyrus and the performance of the same mice on the forced T-maze alternation 
task.  
In contrast, Fitzjohn et al (2001) reported decreased baseline synaptic transmission but 
normal LTP in vitro at ages 12 and 18 months. One possible explanation for the difference 
between the in vitro LTP results in these two studies could be the application of the 
neuroprotective kynurenate (glutamate receptor antagonists) during the preparation of 
slices by Chapman et al., suggesting increased
 
vulnerability of tg2576 hippocampal slices 
to NMDA-mediated excitotoxic
 
damage with age. However, this would not explain
 
the 
diminution of LTP recorded in vivo in the dentate gyrus of
 
13 to 15-month-old tg2576 mice 
(Chapman et al. 1999). There are
 
several possible reasons for the disparity between in vitro 
and
 
in vivo LTP results in tg2576, including the presence of a diffusible
 
factor disrupting 
cognition that might be diluted in slice preparations,
 
the involvement of modulating 
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afferent pathways to the hippocampus
 
that would be severed in slice preparations, or the 
contributions
 
of synaptically mediated cerebrovascular responses that would
 
make no 
contributions in vitro. (Ashe, 2001) 
More recently, Jacobsen et al (2006) reported impaired basal synaptic transmission and 
LTP of tg2576 mice at 5 months of age, before the measurable rise of insoluble Aβ levels 
at 6 months. This synaptic dysfunction coincided with decreased dendritic spine density 
and impaired performance in contextual fear conditioning.  
It is difficult to fully reconcile the discrepancies of these three studies. But all of them 
have confirmed synaptic dysfunction in this model.  
7ature of cognitive impairment in tg2576 mice 
Cognitive impairments have been repeatedly reported in aged tg2576 mice. It is 
important to identify the nature of these deficits. One commonly used task is the T-maze 
alternation task. Several groups have reported performance deficits of tg2576 mice in this 
task (Chapman et al, 1999; Corcoran et al, 2002). Theoretically, such deficits may result 
from either a more rapid decay of trial-specific information or an impairment of encoding 
extramaze (spatial) cues necessary for successful navigation. Both types of deficits are 
present in AD patients (Foldi et al, 2003; Monacelli et al, 2003). Recently, Barnes et al 
(2004) examined this issue in their study. They found that introducing an interval delay had 
similar effects on the performance of transgenic and wild-type animals. Thus adult tg2576 
mice were no more sensitive than control mice to temporal delays or interference between 
trials on this task. In contrast, when the T-maze was rotated 180
o
 between sample and test 
trials, control mice, but not tg2576 mice, were able to use extramaze cues to encode the 
goal location. Tg2576 mice were, however, capable of using intramaze and extramaze cues 
to acquire a visual discrimination task and a context discrimination task at the same rate as 
control mice. These results suggested that aged tg2576 mice were able to process at least 
some features of the environmental cues but failed to use this information to solve the T-
maze task.  
Two later studies by the same group (Hale and Good, 2005; Good and Hale, 2007) 
examined the effect of an APP mutation on object recognition memory processes in tg2576 
mice. They reported normal object novelty detection and relative familiarity judgments in 
aged tg2576 mice. In contrast, tg2576 mice showed impaired visuospatial recognition 
memory, indicated by their failure to investigate objects that had changed their relative 
spatial positions. These results suggest that the formation of representations involving a 
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combination of object identity and spatial information are particularly sensitive to amyloid 
pathology in adult APPswe mutant mice.  
Molecular correlates of cognitive deficits in tg2576 mice 
Tg2576 mice have been shown to develop cognitive deficits in a variety of behavioural 
test paradigms. Determining the onset and progression of memory deficits, as well as their 
molecular correlates, in these animals helps understand the pathogenesis of AD and 
develop effective treatments. However, this is a potentially difficult task, not only because 
of the subtlety of initial memory deficits and lack of sufficiently sensitive behavioural tasks, 
but also because various forms
 
of Aβ, characterized by their aggregation states, are present
 
in the brains of transgenic mice at different ages (Kawarabayashi et al. 2001). Multiple 
studies in APP transgenic mice have shown that memory loss and Aβ are correlated (Hsiao 
et al, 1996; Chen et al, 2000; Janus et al, 2000c; Morgan et al, 2000; Gordon et al, 2001; 
Dodart et al, 2002). However there is no consensus on which form of Aβ is primarily 
responsible (Ashe, 2001).  
The first study on this topic in tg2576 mice assigned the onset of deficits to ~6 months, 
coinciding with the appearance of detergent-insoluble
 
Aβ aggregates but prior to mature 
plaque deposition (Westerman
 
et al, 2002). The simplest interpretation for these 
observations is that memory loss in tg2576 mice
 
is associated with insoluble Aβ 
aggregates. Genetically accelerating the formation
 
of detergent-insoluble Aβ aggregates 
resulted in an earlier onset
 
of memory loss in these mice (Westerman et al, 2002), further
 
corroborating this association. However, further research argued against such a simple 
relationship (Westerman et al, 2002). Analysis of tg2576 mice over a broader age range (4–
22 months) failed to show any overall correlation between memory function and levels of 
insoluble Aβ, although a correlation was observed when the mice were stratified into 
several age groups. These observations suggest that the insoluble Aβ may be a surrogate 
measure for one or more small soluble Aβ assemblies that cause memory dysfunction in 
tg2576, explaining why some cognitively
 
intact aged tg2576 mice have very high levels of 
detergent-insoluble Aβ. A role for soluble Aβ in memory dysfunction has been supported 
by both clinical and experimental studies. Elimination of Aβ in APP and PS/APP mouse 
models with either active or passive immunization with anti-Aβ antibodies could fully 
reverse memory deficits in these mice, but resulted in minimal clearance of pre-existing 
amyloid plaque pathology or total Aβ load (Janus et al, 2000c; Morgan et al, 2000; 
Kotilinek et al, 2002). Additionally, several studies have focused on identifying such small 
Aβ assemblies. Walsh et al (2002) identified a population of stable Aβ oligomers, 
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predominantly trimers, in the media of APP-transfected cells that produced deficits in LTP 
in rats in vivo, and further studies showed that the same type of oligomers were sufficient 
to induce memory deficits when injected into the brains of rats (Cleary et al, 2005). The 
memory deficits induced by Aβ oligomers were dissociated from any signs of 
neurodegeneration in the treated rats, indicating that memory loss is probably caused by 
reversible neuronal dysfunction. Thus, early cognitive decline in pre-clinical AD might 
also reflect the impact of small oligomeric Aβ aggregates on neuronal function and might 
therefore be reversible. Recently a study by Lesne et al (2005) identified one specific 56-
kDa oligomeric Aβ species that consistently correlates with memory function in tg2576 
and also disrupts cognitive function when administered to rats.  
The proposed role of soluble Aβ also explains a puzzling inconsistency in the 
relationship between amyloid load and memory in AD (Ashe, 2001). Several early
 
reports 
showed little or no correlation between amyloid load and
 
dementia (Terry et al, 1991; 
Arriagada et al, 1992; Berg et al, 1993). More recently, when more sensitive antibody-
based methods
 
were used to measure Aβ deposits and subject pools that represented
 
a broad 
range of cognitive impairment were examined, highly significant
 
and robust correlations 
were found (Cummings et al, 1996; Bartoo et al, 1997; Naslund et al, 2000). Despite these 
methodological
 
improvements, it has remained difficult to explain why
 
some individuals 
with high plaque loads are cognitively normal.
 
One possibility is that small
 
Aβ assemblies 
formed during the conversion of detergent-soluble
 
to -insoluble Aβ are primarily 
responsible for the cognitive decline. Certain individuals with low levels of
 
these Aβ 
assemblies could be cognitively intact but would nevertheless
 
accumulate large amounts of 
deposits or Aβinsol over time.  
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Chapter 4   Anatomy of the Hippocampus 
 
 
Given the early implication of the hippocampus and related structures in AD, it is 
crucial to understand the anatomy, physiology and function of this brain. The following 
chapters focus on these areas. 
 
1 7omenclature 
There is some confusion in the literature regarding what is meant by “the 
hippocampus” or “the hippocampal formation”. In this thesis I will follow the 
nomenclature proposed by Scharfman et al (2000) as below.  
 
The hippocampus is defined as the dentate gyrus (DG) and the cornu ammonis (CA) 
fields (CA1, CA2, CA3).  
The hippocampal formation includes the hippocampus and the subiculum.  
The parahippocampal region comprises the pre- and parasubiculum, the entorhinal, 
the perirhinal and the postrhinal (in nonprimate mammalians) or 
parahippocampal (in primates including human) cortex.  
 
This segregation is based on connectivity and laminar organization. The hippocampal 
formation shows a continuous trilaminar organization, which defines the allocortex. This is 
different from the neocortex, which comprises six layers. The parahippocampal region can 
be thought of as the transition from allocortical to neocortical organisation. As for general 
connectivity, hippocampal formation connectivity is much simpler, and more serial 
compared with that of neocortex: the connections between different hippocampal formation 
fields are overwhelmingly in one direction only, lacking much of the strong, reciprocal 
innervation between different areas. In contrast, the parahippocampal region shows a more 
“neocortical” pattern of connectivity, including at least two sets of reciprocal connections, 
one between peri- and postrhinal cortices and entorhinal cortex, the other between pre- and 
parasubiculum and entorhinal cortex.  
 
2 Gross morphology 
In rodents, the hippocampal formation can be revealed by the removal of occipital and 
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temporal neocortex (Figure 4.1). It is an elongated structure with the long axis extending in 
a C-shaped manner from the septal nuclei of the basal forebrain rostrally and bending 
caudo-ventrally into a cashew-nut shape to the temporal lobe. This axis is referred to as 
septo-temporal (or dorso-ventral) axis, and orthogonal to this, running medial to lateral, is 
the transverse axis. These two axes represent important landmarks in the structural 
connectivity of the hippocampal formation. It is arbitrally divided into a dorsal portion 
(located just behind the septum), a posterior portion (located at the commencement of the 
structure’s ventrolateral curvature) and a ventral portion (located within the temporal 
portion of the brain).  
The horizontal section in Figure 4.2, through the hippocampal formation and the 
parahippocampal region, reveals the shape of its basic components. This section illustrates 
the trilaminar organization of the structures that make up the hippocampal formation and 
shows the emergence of new layers at the border between subiculum and presubiculum. 
The darkly stained material that defines two interlocked, C-shaped structures represents the 
granule cell layer of the DG, and the pyramidal layers of fields CA1-3. Below lies the 
polymorph layer or stratum oriens, whilst layer I is continuous with the molecular layer of 
isocortex and contains the well aligned dendrites of the principal cells. It also shows how 
the deep layers of pre- and parasubiculum appear to be a continuation of the pyramidal cell 
layer of the subiculum. The border between the subiculum and the presubiculum is 
characterized by a sudden emergence of a more superficially positioned cortical sheet. This 
increase in number of layers indicates the border of the hippocampal formation with the 
parahippocampal region. This sheet consists of the superficial layers of pre- and 
parasubiculum, which are strictly separated from their deep layers by a cell-free zone, the 
lamina dissecans. At the border between the entorhinal and perirhinal or 
postrhinal/parahippocampal cortex, the lamina dissecans disappears, giving way to a more 
homogeneously layered cortex that resembles the six-layered neocortex, with the only 
difference being that peri- and postrhinal cortices lack a marked granular cell layer IV.  
The major fibre bundle associated with the hippocampus is the fimbria-fornix. The 
deep surfaces of the hippocampal formation are covered in a thin sheet of efferent and 
afferent fibres, the alveus. These fibres collect in a bundle along the lateral edge of the 
hippocampal formation, named the fimbria. At the septal extreme of the hippocampal 
formation, these fibres descend into the basal forebrain, at which point the bundles are 
referred to as the fornix (Figure 4.1). The fornix then splits into several components, 
innervating different regions including medial and lateral septal nuclei, anterior and 
Figure 4.1
Figure 4.1  Three-dimensional drawings indicating the position of the hippocampal formation 
in the rodent brain, seen from a lateral frontal view. The septo-temporal axis (blue) runs 
between the poles of the hippocampal formation marked septal and temporal. The transverse 
axis (red) runs medial to lateral. 
Adapted from Amaral and Witter, 1995
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Figure 4.2  Horizontal section through hippocampal formation and parahippocampal region of 
the rodent brain. The trilaminar structures that compose the hippocampal formation are the 
Dentate Gyrus (DG), CA1-3 pyramidal cell layers, and the subiculum (SUB). The parahippo-
campal region is composed of  the Presubiculum (PrS),  Parasubiculum (PaS), Entorhinal 
cortex (ENT) and Perirhinal cortex (Per). The transition to the parahippocampal region is 
marked by an abrupt increase in the number of layers. The newly appearing layers form the 
superficial parts of these structures (II-III), while the deep layers (V-VI) are a continuation of 
the Subiculum. The transition between the Entorhinal and Perirhinal layers is marked by the 
disappearance of the cell-free zone, lamina dissecans (LD). 
Adapted from Witter et al, 2000
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posterior hypothalamic areas and anterior thalamic nuclei (Gloor, 1997). It should be 
emphasized that fornix fibres are both afferent and efferent to the hippocampal formation, 
and therefore represent subcortical input to, and output from, the hippocampal formation.  
 
3 General connectivity of the hippocampal formation 
Figure 4.3 illustrates the major connections of the parahippocampal-hippocampal 
regions. While connections between other parts of the hippocampal formation and various 
association areas of the neocortex are generally reciprocal, within the hippocampus they 
are largely unidirectional.  
3.1 Afferents to the hippocampal formation 
Cortical afferents 
The entorhinal cortex plays a critical role in the hippocampal-parahippocampal 
network, in that it forms the gateway connecting the neocortex and the hippocampal 
formation. The major input to the hippocampal formation comes from the superficial layers 
of the entorhinal cortex, through the perforant pathway, whose organization will be 
discussed in detail in a later section.  
Sub-cortical afferents 
Some subcortical afferents directly innervate all fields of the hippocampal formation, 
while others are channelled through pre- and parasubicular cortices, via the entorhinal 
cortex.  
Four major subcortical inputs to the hippocampal formation, not including thalamus, 
come from the medial septum, supramammillary hypothalamus, brain stem, and amygdala. 
The first three may be related to motor and arousal information. One of the most important 
inputs to the hippocampal formation, which may act as a pacemaker in the generation of 
the theta oscillation, is from the medial septum and the vertical limb of the Diagonal Band 
of Broca. Septal fibers terminate in all areas of the hippocampal formation, and are 
particularly prominent in the dentate gyrus (Amaral and Witter, 1995). The termination 
patterns of the supramammillary nuclei are much more specific, and target the dentate 
gyrus and CA2 in particular (Amaral and Witter, 1995). Monoaminergic input from the 
brain stem is primarily restricted to noradrenergic and serotonergic input. Noradrenergic 
input is quite dense to all regions of hippocampus proper and subiculum, while 
serotonergic input is densest to lateral entorhinal, dentate gyrus, and layer I of pre and 
parasubiculum (Amaral and Witter, 1995).  Basolateral amygdalar input to hippocampus is 
largely restricted to CA1 and to its temporal third (Amaral and Witter, 1995). Finally, it 
Figure 4.3
Figure 4.3  Diagram showing the internal connections of the hippocampal-parahippocampal 
regions, plus cortical input and output to these regions. The dashed boxes demarcate the hippo-
campal formation (HF, red box) and the parahippocampal network (PHN, green box). For 
details of cortical outputs of subiculum and CA1, see main text. 
Adapted from Wills, 2005
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should be added that CA1 receives a direct and massive input from the nucleus reuniens of 
the thalamus (Wouterlood et al, 1990), largely directed at the stratum lacunosum-
moleculare and to CA1’s middle septo-temporal levels. 
An important sub-cortical input enters the hippocampal-parahippocampal network via 
the pre- and parasubiculum. These are afferents from dorsal thalamic nuclei, specifically 
the antero-dorsal, antero-ventral and latero-dorsal, which terminate in layers I, III and V of 
pre- and parasubiculum (van Groen and Wyss, 1990a; 1990b; 1995). The functional 
significance of this projection is that cells encoding the allocentric head direction of the 
animal have been found in dorsal thalamic nuclei (Mizumori and Williams, 1993). This 
input reaches the hippocampal formation mainly via the entorhinal cortex. Both pre- and 
parasubiculum send efferents to entorhinal cortex, presubicular efferents terminating in 
medial entorhinal area layer III, and parasubicular efferents terminating in layer II of 
medial and lateral entorhinal areas (Swanson and Cowan, 1977; Kohler, 1985; van Groen 
and Wyss, 1990a). There is also, however, a direct projection from parasubiculum to the 
dentate gyrus (Kohler, 1985).  
3.2 Intrinsic connectivity of the hippocampal formation 
Within the hippocampal formation, the major connections include:  
(1) mossy fibres from dentate gyrus to CA3;  
(2) CA3/CA2 to CA3/CA2 recurrent collaterals;  
Strong associational/commissural projections to itself characterize the CA3 
hippocampal field (MacVicar and Dudek 1980). The recurrent collaterals of CA3 
pyramidal cells are highly divergently distributed along the hippocampal septo-temporal 
axis (Ishizuka et al, 1990; Li et al, 1994). In the rat (but not in primates), there is also a 
similarly widespread commissural projection to the contra-lateral CA3 (Blackstad, 1956). 
This organisation means that the CA3 system can be viewed functionally as a single 
network, within which each CA3 pyramidal cell can transmit information to every other 
pyramidal cell within a small number of synaptic steps. Such a CA3 recurrent network has 
been suggested to provide a mechanism for maintaining coherent information for short-
term duration and to serve as a temporary storage site for short-term, episodic or working 
memories by reverberating activity in the recurrent collateral connections (Wiebe et al. 
1997) and for pattern completion (Nakazawa et al, 2002).  
(3) Schaffer collaterals from CA3/CA2 to CA1; 
(4) projections from CA1 to subiculum.  
However, as we shall see later, after discussing the organization of the perforant 
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pathway and the layout of the hippocampal intrinsic connections, the classical view of the 
information flow through the tri-synaptic loop is an oversimplification, and that the 
hippocampal connectivity should be viewed more as a series of parallel circuits.  
3.3 Efferents from the hippocampal formation 
CA1 and the subiculum are the only fields of the hippocampal formation that give rise 
to cortical efferents. The subiculum projects to a number of cortical and subcortical regions, 
and, in the parahippocampal region, to the deep layers of entorhinal cortex, perirhinal 
cortex, pre- and parasubiculum. The CA1 field also projects to deep layers of entorhinal 
cortex, perirhinal cortex, and, though not as strongly as the subiculum, to a number of 
cortical and subcortical regions. In this way, information processed within the hippocampal 
formation is relayed to the deep layers of entorhinal cortex. From there, it can be either fed 
back to the hippocampus, by way of the associational connections from deep to superficial 
layers of entorhinal cortex, or channelled to the cortical mantle, directly (from a very 
restricted area of entorhinal cortex) or through peri- and postrhinal cortices. 
 
4 The entorhinal cortex 
The entorhinal cortex (EC) plays a pivotal role in the function of the hippocampal 
formation. It is not only the main entrance for much of the cortical inputs, but also the main 
conduit for processed information to be relayed back to the neocortex. That means, the EC 
is both the beginning and the end point of an extensive loop of information processing 
within the hippocampal formation.  
The EC can be divided into the lateral entorhinal area (LEA) and the medial entorhinal 
area (MEA) (Figure 4.4). These are cyto-architectonically defined regions of the entorhinal 
cortex. Briefly, LEA has a more clearly demarcated layer II, as compared to MEA, and 
LEA layer II cells are smaller, more densely packed and clustered into islands (Amaral and 
Witter, 1995). They are also differentiated in terms of their inputs and outputs, and are 
therefore relevant to the discussion below.  
4.1 Afferents to the entorhinal cortex 
The EC channels cortical inputs from the perirhinal and postrhinal cortices, and gives 
rise to most of the cortical input into the hippocampal formation via the perforant pathway. 
The origin of EC afferents is therefore crucial for understanding the nature of input to the 
hippocampal formation. 
Afferents through peri- and postrhinal cortex 
Much of the entorhinal input to hippocampus comes via the postrhinal and perirhinal 
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Figure 4.4
Figure 4.4  Diagram showing an unfolded map of the perirhinal (PR), postrhinal (POR) and entorhinal 
(EC, coloured) cortices. Black line within EC demarcates lateral entorhinal area (LEA) and medial ento-
rhinal area (MEA). Shades of blue show the approximate location of the dorsal, intermediate and ventral 
dentate-projecting bands in the entorhinal cortex. Note that each band includes portions of both LEA and 
MEA. 
Adapted from Burwell & Amaral (1998a).
EC
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cortices. The peri- and postrhinal cortices, in turn, receive most of their inputs from uni-
modal and poly-modal neocortical association areas, suggesting that the hippocampus 
receives abstracted, highly-processed information from neocortex, but there is also some 
specialisation of inputs associated with each cortical area. Of the uni-modal input, 
particularly prominent efferents are olfactory (originating in piriform cortex) and visual. 
Visuo-spatial input, originating in the retrosplenial, cingulate, and posterior parietal 
cortices, also forms a robust projection (Burwell and Amaral, 1998a). There is some 
differentiation between peri- and postrhinal cortices: postrhinal cortex receives stronger 
visual and visuo-spatial inputs, whereas perirhinal cortex receives a stronger projection 
from olfactory areas.  
However, the bulk of cortical input to rhinal cortices comes from polymodal 
associational cortices, in particular from ventral temporal areas. Perirhinal cortex receives 
from the whole extent of ventral temporal areas, while post rhinal cortex mainly from its 
most caudal aspect, which in turn receives visuo-spatial inputs. 
Projections from the peri- and postrhinal cortices differentiate between MEA and LEA, 
with the postrhinal cortex sending more efferents to the MEA, and the perirhinal cortex 
preferentially projecting to the LEA (Burwell and Amaral, 1998b).  
Direct afferents to entorhinal cortex 
The EC also receives direct neocortical inputs. Similarly to peri- and postrhinal 
afferents, most projections are from uni-modal or poly-modal association areas. A 
particularly dense projection is from the piriform cortex (Burwell and Amaral, 1998a). 
Interestingly, there is a differentiation between inputs to MEA and LEA, with the MEA, 
similar to postrhinal cortex, receiving a higher proportion of cortical afferents from visual 
or visuo-spatial areas (Burwell and Amaral, 1998a) whereas the LEA, like perirhinal cortex, 
receiving predominantly olfactory information.  
Thus, the pattern of differentiation between MEA and LEA is similar both for direct 
neocortical inputs to entorhinal cortex, and inputs via the peri- and postrhinal cortices. This 
strengthens the idea that there are two parallel streams of information coming from the 
peri- and postrhinal cortices, carrying distinct, highly-processed information to fields CA1 
and subiculum in the hippocampal formation, by way of the medial and lateral components 
of the perforant pathway.  
Afferents from pre- and parasubiculum 
Another source of cortical inputs to the hippocampal formation via the entorhinal 
cortex is represented by the pre- and parasubiculum. Presubiculum receives strong 
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projections from visuo-spatial neocortical areas, including retrosplenial cortex (Swanson 
and Cowan, 1977; van Groen and Wyss, 1990a; 1990b), visual area 18b (Vogt and Miller, 
1983) and cingulate cortex (van Groen and Wyss, 1990b).  Cortical inputs to the 
parasubiculum are similar, but lighter than those to presubiculum and include occipital 
visual areas and retrosplenial cortex (Van Groen and Wyss, 1990a, Vogt and Miller, 1983). 
In addition, both pre- and parasubiculum receive a substantial input from the subiculum. 
Pre- and parasubicular intrahippocampal connectivity suggest that they lie at the crossroad 
between output and input, given that they receive strongly from the subiculum and project 
heavily to the entorhinal cortex and, in the case of parasubiculum directly to the dentate 
gyrus. This functional loop might be important in re-channelling into the hippocampus 
information already processed by the hippocampus itself. 
4.2 Perforant pathway: entorhinal efferents to the hippocampal formation 
Because the EC is the major relay for incoming sensory information in the 
hippocampal formation, the topographical organisation of the perforant pathway 
connections has strong functional implications for the kind of processing that will take 
place in the hippocampus. All fields of the hippocampal formation have a direct input from 
the perforant pathway. The organisation of the pathway is somewhat complex, however, it 
being possible to classify the projections according to three orthogonal divisions.  
Layer II projections vs layer III projections 
The EC gives rise to the “perforant pathway” to the hippocampal formation, which can 
be subdivided into two streams:  
(1) Fibres originating in layer II of the EC project to the dentate gyrus, CA3 and CA2. 
The projections to the dentate gyrus terminate in the most superficial two-thirds of the 
dentate molecular layer, mainly on granule cell dendrites, but also on some GABA-ergic 
cells (Nafstad, 1967). Entorhinal layer II efferents to CA3/CA2 terminate in stratum 
lacunosum-moleculare (Nafstad, 1967; Steward and Scoville, 1976; Witter, 1993).  
(2) Projections originating in entorhinal layer III, by contrast, project to CA1 and the 
subiculum. As in CA3/CA2, projections to CA1 terminate in stratum lacunosum-
moleculare (Steward and Scoville, 1976). Projections to the subiculum terminate in the 
molecular layer (Witter, 1993). 
MEA projections vs LEA projections 
A further level of complexity is added by the fact that the perforant pathway comprises 
two components, orthogonal to the ones just described, which originate from two 
cytoarchitactonically defined subdivisions of the entorhinal cortex. These subdivisions 
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have been referred to as the lateral and medial entorhinal areas (LEA and MEA; Figure 4.4). 
The lateral and medial perforant pathways carry different information and show distinct 
terminal distributions in their respective hippocampal targets, depending on whether they 
originate in layer II or III. 
Projections from cells in layer II discriminate along the radial axis of DG and CA3. 
LEA originating fibres terminate in the outer one-third of the molecular layer/stratum 
lacunocum-molecolare of the DG and CA3, while MEA originating fibres terminate in the 
middle one-third of these layers. However, they do not discriminate between transverse 
levels. In the dentate and CA3/CA2, therefore, the same cells are likely to be influenced by 
both MEA and LEA inputs (McNaughton and Barnes, 1977).  
By contrast, MEA and LEA components of the layer III perforant path show a non-
overlapping terminal distribution in CA1 and the subiculum along the transverse axis. 
Projections from the MEA terminate in the proximal part of CA1 (that closest to CA3) and 
the distal part of the subiculum (that closest to the presubiculum), whereas fibres 
originating in the LEA terminate in the distal part of CA1 and the proximal part of the 
subiculum (Witter et al, 2000).  
This organisation is likely to have functional value, because inputs channeled through 
the medial and lateral portions of the entorhinal cortex are qualitatively different. Both the 
LEA and MEA receive strong inputs from the perirhinal and postrhinal cortices. While the 
LEA receives a stronger input from perirhinal cortex and anterior associational regions 
such as the medial and orbital frontal cortex, the MEA receives a more robust projection 
from the postrhinal cortex, and posterior associational regions like retrosplenial cortex 
(Burwell and Amaral, 1998b). It must be stressed that layer III neurons of MEA are also 
heavily influenced by presubicular input (Caballero-Bleda and Witter, 1993), which 
conveys more visuo-spatial information from retrosplenial and visual cortices, and dorsal 
thalamic inputs (head-direction cells which code for the allocentric direction of the 
animal’s head have been found in the presubiculum of the rat; Taube et al, 1990). If we add 
that projections from CA1 to the subiculum and from CA1 and subiculum back to 
entorhinal cortex preserve this columnar organisation, we realise that two parallel streams 
of information can be recognised within the hippocampal formation, one originating from 
the MEA and most likely involved in coding of spatial orientation, the other from LEA, 
processing object-context relations (Witter et al, 2000; Bannerman et al, 2002; Moser et al, 
2003). These parallel streams remain segregated at the CA1 and subicular level, while they 
are integrated at the dentate and CA3 levels. 
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Projections to septal vs temporal hippocampal formation 
The EC can be further subdivided into three longitudinal strips, based on where 
perforant path fibres terminate along the septo-temporal axis of the hippocampal formation 
(Witter et al, 1989; Fyhn et al, 2004). Each of these strips contains portions of both MEA 
and LEA (Figure 4.4).  
The most lateral and caudomedial portions of the EC, which receive major inputs from 
the adjacent perirhinal and postrhinal cortices, project predominantly to the septal third of 
the hippocampal formation. These include prominent olfactory, auditory, visual and visuo-
spatial inputs. The most rostromedial portions of the EC, which receive prominent inputs 
from the limbic and periamygdaloid cortices, project more temporally in the hippocampal 
formation. The intermediate zone of the EC projects to the intermediate parts of the 
hippocampal fields. It is also interesting that the organisation of the entorhinal intrinsic 
connectivity preserves the segregation of the three longitudinal strips (Witter, 1989). 
Within the hippocampal formation, the projections from DG to CA3, CA1 to subiculum 
and subiculum back to entorhinal cortex, show a similar topographical organisation into 
three septo-temporal strips (Amaral and Witter, 1995). However, the CA3-CA3 auto-
associative connections and the Schaffer collaterals show a highly divergent organisation, 
not preserving the septo-temporal organisation outlined above (Li et al, 1994).  
The pattern of connectivity just described, suggests that septal levels (dorsal) of the 
hippocampal formation most likely process sensory-related information whereas the 
temporal hippocampus is more involved in visceral-related processing (Witter et al, 2000). 
Both behavioural and electrophysiological studies are beginning to demonstrate functional 
differences along the septotemporal hippocampal axis. Behaviourally, it has been shown 
that rats with lesions restricted to the septal extent of the hippocampus exhibit longer 
escape latencies in the Morris water maze task than rats with lesions restricted to the 
temporal portion of the hippocampus (Moser et al, 1993). A more recent paper (Bannerman 
et al, 2002) showed that ventral hippocampal lesions had no effect on T-maze alternation 
and on a working memory version of the water maze, even when task difficulty was 
increased by introducing delays. Moreover, place cells recorded from dorsal hippocampus 
show place fields with higher spatial selectivity than place cells recorded from more 
temporal portions of the hippocampus (Jung et al, 1994).  
4.3 Entorhinal efferents to other regions 
Entorhinal efferents: cortical 
Deep entorhinal layers receive input from CA1 and subiculum; accordingly neurons in 
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these entorhinal layers may be very important in acting as the hippocampal conduits to the 
rest of the cortex. Most of the hippocampal-cortical connections in the rat are mediated by 
way of entorhinal-perirhinal-cortical connections, while only a very restricted part of the 
entorhinal cortex sends projections that can reach widespread portions of the neocortex 
(Insausti et al, 1997).  
Entorhinal efferents: subcortical 
The entorhinal subcortical efferents overlap those described for the subiculum and 
CA1. Like these two regions, but not the para- and presubiculum, entorhinal cortex projects 
to the septum, primarily to lateral septum. Entorhinal cortex also projects widely to the 
amygdala, especially to the basal nucleus. Other important efferents are those to the 
nucleus accumbens and olfactory tubercle. There have been no reports of entorhinal 
projections to the thalamus or brain stem (Amaral and Witter, 1995).  
 
5 Summary 
The unique anatomy of the hippocampal formation implies that its function is likely to 
be quite different from that of other cortical areas. For example, the neo-cortical inputs to 
the hippocampal formation originate in a variety of sources. Thus the hippocampal 
formation is one of the few brain regions that receive highly processed, multimodal sensory 
information. Within the hippocampal formation, its anatomical organisation allows for both 
serial and parallel information processing, which is ideally suited for mixing or comparing 
information. The output of the hippocampus is directed at many different areas, cortical 
and sub-cortical. Its ability to integrate, process and distribute information suggests that the 
hippocampal formation is most likely involved in general, abstract functions, for example 
memory or spatial cognition. Moreover, as discussed in chapters 1-3, the hippocampus is 
one of most vulnerable brain regions in AD. In this way research in this structure would 
undoubtedly provide crucial information about the pathogenesis of this disorder, especially 
at its earliest stage.  
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Chapter 5   Physiology of the Hippocampus 
 
 
This chapter focuses on the physiological properties of the hippocampal network. The 
first part deals with the characteristics, the hypothesized generation mechanisms, and the 
behavioural and functional significance of the global electroencephalograph (EEG) states 
in the hippocampal system. The next sections look at two important aspects of the 
hippocampal network: long-term potentiation (LTP), as a form of synaptic plasticity, and 
hippocampal place cells, as its basic units. Finally, physiological changes of place cells, 
LTP and spatial behaviour in aging are briefly reviewed.  
 
1 Electroencephalograph 
Various EEG states have been recognized in the hippocampal formation. Four 
rhythmical patterns include theta (5-12 Hz), beta (12-30 Hz), gamma (30-100 Hz) and 
ripple (100-200 Hz) waves. Nonrhythmical patterns include large irregular amplitude 
activity (LIA) and small irregular amplitude activity (SIA). These oscillations are the 
product of synchronous activity within the hippocampal network, reflecting different 
functional states of the system, each correlating with a specific set of behaviours. Theta 
oscillations occur in the rodent during voluntary motion, exploratory activity, alert attention 
and rapid eye movement sleep. In contrast, during immobility, consummatory behaviours, 
and slow-wave sleep, the hippocampus enters LIA and ripples (Vanderwolf, 1969). The 
SIA state occurs during behavioural transitions, often when the animal awakens from rapid-
eye-movement sleep or when it abruptly stops running. Little is known about the exact 
behavioural correlates of beta and gamma, but they may be associated with olfactory 
stimuli.  
1.1 Theta 
Basic properties 
Theta activity consists of large amplitude (1-2 mV) oscillations in the frequency range 
of 5-12 Hz, which is the largest synchronous signal that can be recorded in the normal EEG 
of the mammalian brain. Theta has been observed in various animals, including rats, cats 
and dogs, and recently, in humans (Tesche, 1997; Kahana et al, 1999), and in various brain 
areas, including the hippocampal formation (Buzsaki et al, 1983), the entorhinal cortex 
(Mitchell and Ranck, 1980), and numerous cortical structures (Steriade, 2000).  
Two components of theta 
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Theta can be classified into two components on the basis of behavioural correlates and 
pharmacology. The atropine-resistant component (t-theta) occurs during a class of 
“translational” movements that change the spatial relation between the animal’s head and 
the environment, such as running, turning, rearing, jumping, climbing, struggling when 
held, swimming, head movements, postural changes, manipulation (such as pressing a lever 
in a Skinner box), and digging in sawdust. The correlates of the atropine-sensitive theta (a-
theta) are less well defined and may be related to arousal, attention and intention of 
movement.  
Mechanisms of theta generation 
The mechanisms of theta generation in the hippocampal-parahippocampal region 
appear to depend on three factors.  
(1) External control circuits in the medial septum/diagonal band of Broca complex 
(MS/DBB) and other areas: Reversible or irreversible lesions of this region permanently 
abolish theta rhythm both in hippocampal and parahippocampal areas (Mizumori et al, 
1990; Lawson and Bland, 1993). The majority of MS/DBB cells fire rhythmically at theta 
frequency and continue to do so even after deafferentation (Vinogradova, 1995).  This 
septal population of bursting neurons likely includes both cholinergic and GABAergic 
neurons and both are important for theta generation in hippocampal and parahippocampal 
areas (Lee et al, 1994). 
(2) Network properties within the hippocampal formation: The idea results from 
current density analysis of electrical activity in the hippocampus. A study by Buzsaki et al 
(1986), looking at current sink positions along the radial axis in CA1, proposed that 
hippocampal theta rhythm is the result of two inputs: one from the medial septum, and one 
from a theta generator in the entorhinal cortex. A later study by Brankack et al (1993) 
proposed that, in addition to the excitatory inputs from the entorhinal cortex, the excitatory 
connections between cells in the ‘tri-synaptic loop’ (the dentate gyrus to CA3 to CA1 
pathway) also provide rhythmic inputs. 
(3) Cells’ intrinsic oscillatory properties: In vitro work on hippocampal slices suggests 
that application of carbachol (a cholinergic agonist) to hippocampal slices induces 
membrane potential oscillations at theta frequencies in pyramidal cells in region CA1 
(Bland et al, 1988) and CA3 (MacVicar and Tse, 1989). However, how this relates to the 
situation in the intact animal remains unclear.  
Hippocampal cell firing and theta 
The firing of cells throughout the hippocampal-parahippocampal formation is 
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modulated by the theta rhythm. In the hippocampus proper Ranck (1973) subdivided 
extracellularly recorded neurons into two broad classes: complex spike cells and theta cells.  
Complex spike cells are mainly hippocampal pyramidal neurons. These cells fire at 
low rates (generally around 2 Hz and not greater than 30 Hz), have long duration action 
potentials (0.4-1.2 ms), and show complex spikes (bursts of two to ten spikes of decreasing 
amplitude and an interspike interval between 2 to 6 ms). An interesting phenomenon of 
complex spike cells is that they fire at progressively earlier phases of the concurrent locally 
recorded theta wave, as the animal crosses the place field of the cell (O’Keefe and Recce, 
1993). O’Keefe and Recce (1993) proposed that this “phase-precession” phenomenon was 
generated by two oscillators of slightly different periods converging onto the hippocampus 
and that hippocampal pyramidal neurons (place cells) might encode information using both 
a rate (rate of firing) and a temporal (phase of theta oscillation at which firing occurs) code. 
This will be discussed in detail in the next section.  
In contrast to pyramidal neurons, some hippocampal interneurons increase their firing 
rates in the presence of theta rhythm and thus have been termed “theta” cells. Theta cells 
fire at high rates (10 Hz to > 30 Hz), have short action potentials (<0.35 ms), and fire 
single spikes in bursts, preferentially at the negative peak of the extra-cellularly recorded 
CA1 theta wave (Fox et al, 1986; Csicsvari, 1999).  
Functional significance 
Three possible functions can be attributed to theta. Firstly, it acts as a synchronizing 
mechanism that locks the entire hippocampal formation into a global processing mode. 
Simultaneous recordings of EEG from different hippocampal subregions have shown that 
theta activity at comparable locations is in synchrony and coherent across large areas of the 
hippocampal formation (Buzsaki et al, 1983). Thus two cells, even if far apart in the 
hippocampus, have systematic temporal relations to each other if their firing patterns are 
related to the local theta cycle. However, recent research suggests that there is a systematic 
phase shift in theta across the dorsal-ventral axis of the hippocampus (Siapas et al, 
unpublished data).  
Secondly, theta oscillation has been implicated in gating or facilitating synaptic 
modifications, which underlie LTP. It has been shown that theta-pattern stimulation induces 
LTP in vitro (Rose and Dunwiddie, 1986). This stimulation protocol has been referred to as 
primed burst stimulation and consists of a single priming pulse, followed 140-170 ms later 
by a high-frequency (100 Hz) burst of 2 to 10 pulses. It has also been reported that LTP is 
preferentially induced by burst stimulation on the positive phase of the theta rhythm in 
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urethane-anaesthetised rats (Pavlides et al, 1988).  
Finally, the phase precession phenomenon allows for accurate location of one’s 
position within a place field. During theta activity, all active hippocampal cells fire in 
bursts with the same frequency as or close to that of the theta rhythm. Theta cells do so 
whenever there is theta activity in hippocampal EEG, and they always maintain a fixed 
correlation to a particular phase of the sinusoidal EEG wave. In contrast, the phase 
correlation of complex spike cells does not remain constant, but change in a systematic way. 
These cells always began to fire on the same phase of theta, but the bursts of spikes occur 
at an earlier phase of each successive cycle. This phenomenon is named phase precession 
and allows for accurate location of position within a place field (section 3.3 of this chapter). 
Jensen and Lisman (2000) have elegantly shown that use of the phase precession data 
allows an increase in the accuracy of positional localization by around 43% if there is no 
error in estimation of an animal’s position by monitoring its head position. In the more 
likely case that this estimate is somewhat inaccurate the value of phase coding increases 
further.  
1.2 Gamma 
Gamma oscillatory activity was first reported, in the rat hippocampus, in the hilar 
region of the dentate gyrus (Bragin et al, 1995), and has been later described in the 
superficial layers of entorhinal cortex (Chrobak and Buzsaki, 1998). Like theta, gamma 
oscillations show a high degree of coherence along the longitudinal axis of the 
hippocampal formation, along distances of up to several mms, but their average coherence 
decreases rapidly along the CA3 to CA1 direction.  
Gamma oscillations occur during theta-associated behaviours (exploration, sniffing, 
rapid-eye-movement sleep), and are nested to the concurrent theta waves, their frequencies 
span from 40-100 Hz and there is a high correlation between theta and gamma frequency 
shift. This suggests that similar, still obscure, mechanisms modulate the frequency of both 
gamma and theta rhythms. Unlike theta, gamma oscillations persist after removal of all 
subcortical inputs to the hipppocampal formation (Buzsaki et al, 1987), demonstrating that 
they are generated within the hippocampal circuits. A definite source of gamma rhythm is 
the entorhinal cortex, but after bilateral removal of this input gamma activity is still present 
in the hippocampus and is most likely sustained by the CA3 region (Bragin et al., 1995). 
The function of gamma oscillations might be synchronising the activity among 
different subset of neurons within very short time windows (10-25 ms), complementing the 
role that theta waves have over longer time scales. 
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1.3 Large irregular activity (LIA) and ripples 
LIA consists of large irregular, slow waves (slower than theta), which, in the deep 
layers of entorhinal cortex and in stratum radiatum of CA1 (just below the pyramidal layer), 
translates into a large amplitude (1-3 mV), aperiodic field potential also called the sharp 
wave (SPW; Buzsaki et al, 1983). They are thought to arise from a burst of activity in CA3, 
that produces a large depolarization in the Schaffer collaterals’ targets, the dendrites of 
CA1 neurons and interneurons. Sharp waves coincide with a high frequency (140-200 Hz) 
oscillatory activity in the somatic layers of these structures, generally referred to as 
“ripples”, which result from synchronous depolarization of CA1 neurons and inhibitory 
interneurons (O’Keefe and Nadel, 1978). LIA occurs when there are no changes of the 
animal’s location in the environment: most frequently during slow-wave sleep and quiet 
sitting, less frequently during eating, drinking and grooming. Thus, LIA may represent a 
resting state of the hippocampal formation and is often inhibited by arousing stimuli.  
Both interneuronal and pyramidal firing is phase locked to the rhythmic ripple 
oscillation. Pyramidal cells tend to fire a single action potential per ripple, phase locked to 
the troughs of the ripple oscillation. Interneurons generally fire several spikes during one 
ripple event with different populations showing different relationships to ripple events. The 
mechanism by which this highly coherent discharge of pyramidal neurons is brought about 
along the whole extension of the dorsal CA1 region is still unknown, but may be achieved 
through axo-axonic gap junctions (Draghun et al, 1998).  
As for the functional role that ripples might have, Buszaki (1989) has suggested a 
model of memory trace formation in the entorhinal-hippocampal region, in which the LIA, 
during rest or slow-wave sleep, plays an important role in potentiating memory traces of 
information acquired during exploration (the theta state).  
 
2 Long-term potentiation (LTP) and synaptic plasticity 
How the nervous system acquires, stores, and retrieves information derived from the 
external world has long been an attractive question in neuroscience. With the establishment 
of the neuron doctrine by Cajal, it has been proposed that modifications between neurons, 
or neuroplasticity, might underlie developmental, regenerative, as well as cognitive 
processes (Cajal et al, 1966). The manifestations of neuroplasticity in the adult CNS 
include alterations of dendritic ramifications, synaptic remodeling, long-term potentiation 
(LTP), axonal sprouting, neurite extension, synaptogenesis, and neurogenesis (Mesulam, 
1999). Neuroplasticity is a life-long process that mediates the structural and functional 
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reaction of neurons and synapses to experience and injury. Experience-induced 
modifications of synaptic strengths, for example, enable the accumulation of knowledge 
that is unique to each individual and provide the critical substrates for adaptation and 
individuation (Mesulam, 1999).  
The idea that memories are stored as changes in synaptic strength was first formalized 
by Hebb (1949), who suggested that coincident activity in two connected neurons leads to 
strengthening of their connection, thus providing a mechanism for the association of 
activity patterns.  
The discovery of LTP (Bliss and Lomo, 1973) provided the first experimental support 
for Hebb’s theory on the neural representation of memory. LTP is defined as a long-lasting 
increase of synaptic efficacy following a brief high-frequency stimulation. Since its first 
discovery in the rabbit dentate gyrus, LTP has been observed in many pathways of the 
brain. Within the hippocampus, LTP has been observed in all the three major excitatory 
synapses: the perforant pathway from the entorhinal cortex to the dentate gyrus (dentate 
LTP); the mossy fibers from the dentate to the CA3 (CA3 LTP); and the Schaffer collateral 
pathway from the CA3 to the CA1 (CA1 LTP) (for a good review, see Chen and Tonegawa, 
1997). Now there is overwhelming evidence that LTP is engaged in spatial learning and 
memory (see below).  
It must be made clear that LTP is not the only form of synaptic plasticity in the 
hippocampus and that Hebb’s rule only applies to some forms of such plasticity. Various 
forms of synaptic potentiation exist with different temporal duration and induction and 
expression mechanisms (Bliss and Collingridge, 1993). Post-tetanic potentiation (PTP) 
refers to synaptic enhancement that decays within minutes. Short-term potentiation (STP) 
presumably lasts for 10-20 min. LTP can last at least 1 hour.  
2.1 Properties 
LTP can be either associative (Hebbian) or non-associative. CA1 LTP is Hebbian. It 
can be studied in hippocampal brain slices by intracellular or extracellular recording from 
CA1 neurons whilst electrically stimulating a bundle of Schaffer collaterals. In response to 
a brief tetanic burst of high frequency stimulation (typically 100 Hz for 0.5 s), subsequent 
low frequency pulses can elicit a larger excitatory postsynaptic potential (EPSP), which is 
LTP.  
LTP has several features that make it suitable as a cellular substrate for learning and 
memory. The 3 most important features include its input specificity, cooperativity and 
associativity. 
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Input specificity 
LTP is input-specific, which means that when generated at one set of synapses by 
repetitive activation, delivery of low frequency stimuli via a different untetanized afferents 
does not elicit LTP on the same cell. This property is advantageous because it greatly 
increases the storage capacity of individual neurons.  
Cooperativity 
The probability of producing LTP increases with the number of afferent fibers 
tetanically stimulated. While weak high frequency stimuli often fail to generate LTP 
because they excite only a few afferents, strong tetanic stimuli are successful because they 
recruit many afferent.  
Associativity 
LTP needs paired activity of multiple neurons. The majority of synapses that support 
LTP require NMDA receptors, which are thought to be a molecular coincidence detector 
because its activation requires simultaneous presynaptic activity (glutamate release) and 
postsynaptic depolarization. Depolarization is usually accomplished experimentally by 
repetitive tetanic stimulation of synapses or by directly depolarizing the cell while 
continuing low-frequency synaptic activation (a "pairing protocol"). It has been shown that 
synaptic activity in a “weak” afferent pathway that is unable to induce LTP due to 
insufficient postsynaptic depolarization can be made to do so if paired with stimulation of a 
“strong” pathway, which provides postsynaptic depolarization strong enough to activate 
NMDA receptors.  
This property may be relevant (a) to associative or relational features of learning and 
memory (because associative induction implies the capacity to relate two arbitrary patterns 
of pre- and postsynaptic neural activity); (b) to storage capacity (because a synapse-
specific mechanism endows greater storage capacity than would changes in cell 
excitability); and (c) to the permanence of memory (because the synaptic enhancement 
must last as long as the memory).  
2.2 Molecular mechanisms 
The above various properties of LTP arise from a complicated interplay of biological 
processes at the molecular and cellular levels. In recent years, there have been considerable 
advances in our understanding of these mechanisms. For convenience, we distinguish 
between LTP induction, which includes the events that trigger changes of synaptic weight 
without affecting them, and LTP expression, which comprises all the mechanisms that 
directly enhance synaptic efficacy.  
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It must be made clear that several types of LTP with varied mechanisms exist in the 
brain. Types of LTP can be distinguished whether they are associative, or more specifically, 
whether they depend on NMDA receptors (Bliss and Collingridge, 1993). Within the 
hippocampus, CA3 LTP is nonassociative, independent of NMDA receptors and thought to 
be initiated presynaptically (Zalutsky and Nicoll, 1990). In contrast, dentate and CA1 LTP 
are associative and are initiated postsynaptically by the activation of NMDA receptors. 
Even these two sets of synapses have different signalling mechanisms. For instance, 
CaMKII signalling is required at the latter but not the former (Zhang et al, 2005).  
Thus, there is no generalized picture for the molecular mechanisms supporting LTP 
induction and expression. The following discussion will mainly focus on CA1 LTP, which 
has been shown to play an important role in spatial and contextual learning and whose 
physiology has been well studied (Chen and Tonegawa, 1997).  
Induction 
In general, LTP induction in the hippocampus is accomplished by applying brief trains 
of rhythmic high-frequency stimulation to excitatory axons that project to hippocampal 
neurons.  
The triggering of LTP requires synaptic activation of postsynaptic NMDA receptors 
(Morris et al, 1986). Under normal conditions, hippocampal synaptic responses elicited by 
low-frequency stimulation are mediated primarily by the interaction of glutamate with 
AMPA receptors. Because the amount of glutamate released is low, few AMPA receptors 
are activated and the resulting EPSP is too small to open NMDA receptors. However, 
during high-frequency stimulation of excitatory afferents, strong postsynaptic 
depolarization coupled with presynaptic glutamate release results in the activation of 
NMDA receptors by releasing the voltage-dependent Mg
2+
 blockade of their associated 
ionic channels (Mayer et al, 1984). The combination of depolarization and binding of 
glutamate to synaptic NMDA receptors leads to the opening of these heteromeric voltage- 
and ligandgated ion channels and Ca
2+
 influx into postsynaptic structures (MacDermott et 
al, 1986). Calcium influx triggers a series of enzymatic cascades and immediate early 
genes encoding transcriptional factors that lead to a persistent modification of synaptic 
efficacy. The nature of these cascades is still under investigation, but involves protein 
kinases (such as protein kinase C and calcium-calmodulin kinase II), proteases (calpain) 
and phospholipases (phospholipase A2) (Maren and Baudry, 1995; Lynch, 2004).  
Expression 
Once induced, LTP is expressed as a persistent and synapse-specific increase in the 
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amplitude of synaptic responses elicited by low-frequency stimulation of the excitatory 
afferents. It is generally accepted that both pre- and postsynaptic mechanisms are involved.  
Postsynaptically, LTP causes the phosphorylation of AMPA receptors (Barria et al., 
1997) and an increase in their single-channel conductance (Benke et al, 1998). But an 
increased expression of AMPA receptors is likely to be the primary requirement for the 
expression of LTP, which occur at both synapses that already contain functional AMPA 
receptors and those that do not express these receptors. AMPA receptor expression on cells 
is a dynamic process and is modulated by NMDA receptor activation. Incoming Ca
2+
 ions 
bind to calmodulin, which in turn activates Ca
2+
/calmodulin-dependent protein kinase II 
(CaMKII), the beginning of a biochemical cascade that results in the net addition of AMPA 
receptors to the synapse. With more postsynaptic AMPA receptors available, subsequent 
presynaptic release of glutamate elicits a larger depolarization (Lynch, 2004).  
In addition to the postsynaptic changes, LTP also involves an increase in the 
probability of presynaptic glutamate release. Quantal analysis in CA1 has demonstrated 
increases in quantal size, potentially reflecting increased probability of quantal release or 
changes in the number of release sites (Oliet et al, 1996). A further possibility is that 
glutamate release can be regulated by the time of vesicular fusion or the size of the fusion 
pore. Indeed, studies using a fluorescent marker of presynaptic activity, FM 1-43, have 
shown LTP in acute hippocampal slices to be associated with elevated glutamate release at 
single synapses (Zakharenko et al, 2001).  
The evidence for postsynaptic induction mechanisms yet presynaptic expression 
mechanisms suggests communication between the two sides of the synapse. Postsynaptic 
activation of enzymatic cascades produces the synthesis and release of retrograde 
messengers which diffuse to the presynaptic terminals and interact with presynaptic 
enzymatic cascades to produce changes in transmitter release. Candidate retrograde 
messengers include nitric oxide, carbon monoxide and arachidonic acid, although other 
means of communication are possible, for example, through adhesion molecules binding 
the presynaptic and postsynaptic elements. 
Late phase LTP 
Similar to memory storage, LTP has both short- and long-term phases. One single 
stimulus train produces a short-term early phase of LTP that lasts 1-3 hours. Four or more 
stimulus trains induce a more persistent late phase of LTP that lasts for more than 24 hours. 
Persistent activity of synaptic kinases and posttranslational modifications are not sufficient 
to maintain LTP over the long term. Instead, this phase of LTP requires new gene 
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transcription, protein synthesis and formation of new synaptic connections (Nguyen et al, 
1994). The cAMP-responsive element-binding protein (CREB) is a candidate that mediates 
late-LTP. CREB is a constitutively expressed transcription factor that, once phosphorylated, 
forms homodimers or heterodimers with other members of the B-Zip family of 
transcription factors (Herdegen and Leah 1998). This transcription factor binds to genes 
with the cAMP-responsive element (CRE) sequence, thereby stimulating the expression of 
these genes and leading to the generation of new dendritic spines, the primary targets of 
excitatory synaptic inputs associated with long-term morphological modifications during 
LTP (Murphy and Segal, 1997).  
2.3 Functional considerations 
The hippocampus is a major component in the medial temporal lobe, which plays an 
important role in declarative memory. Lesion studies in rodents confirmed that two forms 
of declarative memory, spatial and contextual fear memory, depend on the intact 
hippocampus (Morris et al, 1982; Philips and LeDoux, 1992). There are many parallels 
between LTP and memory. For example, both can be induced rapidly and once induced, 
persist for various periods of time. Both require CREB activation and new protein 
synthesis in their late phase. Optimal LTP induction conditions mimic naturally occurring 
theta rhythm that dominates the hippocampal EEG during information-gathering 
behaviours (section 1 of this chapter). There is also extensive evidence that LTP formation 
can be disrupted by a variety of manipulations such as hypoxia, seizure activity, cooling 
shocks and so on, prior to its stabilization, mimicking the consolidation period frequently 
observed in behavioural studies of learning and memory. Molecularly, LTP and memory are 
supported by similar mechanisms. Blocking NMDA receptors with APV prevents induction 
of LTP and impairs some types of learning. Similarly, gene mutations of the NMDA-
receptor or of enzymes downstream of those receptor channels prevent LTP in CA1, 
prevent the formation of normal or stable place fields, and impair spatial learning. These 
mutations include NMDA receptor knockouts (McHugh et al, 1996), NMDA receptor 
knockouts only in area CA1 (Tsien et al, 1996 a,b) and CamKII mutations (Rotenberg et al, 
1996; Cho et al, 1998; Giese et al, 1998).  
If LTP is the neural basis of learning and memory, it (or other activity-dependent 
synaptic plasticity) should be induced at coactive synapses during memory formation. 
Later reactivation of these altered connections causes patterns of cell firing that collectively 
constitute the experience of memory for these events or the expression of learned changes 
in behaviour triggered by them. This is the core of the synaptic plasticity and memory 
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hypothesis (Morris et al, 2003).  
However, it is not easy to verify or refute this hypothesis experimentally. Martin et al 
(2000) proposed four criteria for a rigorous test of the hypothesis: detectability (in 
association with the formation of memory, LTP must occur at certain synapses in one or 
more brain areas and should be detectable), anterograde alteration (blocking the 
mechanisms that induce or express changes in synaptic weights should have the 
anterograde effect of impairing new learning), retrograde alteration (altering the pattern of 
synaptic weights after learning should affect an animal’s memory of past experience), and 
mimicry (artificial induction of LTP should give rise to a memory for a stimulus or event 
that did not actually occur). A detailed review on these topics is outside the scope of this 
thesis but can be found elsewhere (eg, Martin et al, 2000; Lynch, 2004). In brief, the first 
three criteria have been successfully fulfilled, but no studies have adequately met the 
mimicry criterion. In addition, LTP at different regions contributes differently to learning 
and memory. Most of the results from transgenic mice support the view that CA1 LTP is 
the primary synaptic mechanism for hippocampal learning, whereas dentate and CA3 LTP 
seems to be dispensable for these forms of learning (Chen and Tonegawa, 1997). Overall, 
LTP is necessary at least for some forms of spatial learning and memory. However, there is 
no evidence by now that LTP by itself is sufficient for spatial cognition.  
 
3 Hippocampal place cells 
In 1971, O’Keefe and Dostrovsky made the remarkable discovery that hippocampal 
pyramidal neurons in rats increased their firing rates over limited portions of an 
environment through which the animal passed (the “place field” of the cell) (O’Keefe and 
Dostrovsky, 1971). This obvious correlation leads these cells to be named “place cells”.  
Anatomically, place cells are pyramidal cells of the hippocampus and have been shown 
to be the complex spike cells (Muller et al, 1987). They are found in both the CA3 and 
CA1 regions of the hippocampus. Neurons with properties similar to place cells are found 
in other parts of the hippocampal formation (see below), but here the term "place cell" is 
reserved for the principal cells of CA3 and CA1. 
3.1 Place field properties 
A place field is cell specific and refers to the portion of any given environment within 
which a place cell fires at a high rate. Peak firing rates reported are very variable, ranging 
from 2-20 Hz. This is due to the intrinsic properties of place cells (some fire at higher rates 
than others) but also to the varied choice of methods and parameters used to display place 
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fields (smoothing, bin size etc.). Outside the place field, the discharge rate drops 
dramatically to virtually 0 Hz in well isolated cells.  
Basic properties 
It is possible, though not common, that a single place cell has more than one place 
field in an environment (Muller et al, 1987). A typical place field is continuous and 
compact, showing a single peak that falls off smoothly in all directions, approaching a 2-
dimensional Gaussian distribution (Muller et al, 1987; O’Keefe and Burgess, 1996). 
However, not all place fields can be approximated to a two dimensional Gaussian, but can 
be influenced by the shape of the enclosure the animal is in. For instance, it is common to 
observe crescent shaped fields at the edge of cylindrical environments as well as elongated 
fields (linear) that “hug” the walls of rectangular or square walled enclosures (Muller et al, 
1987; O’Keefe and Burgess, 1996).  
The size of place fields vary considerably, due to the threshold used for separating 
signal from noise and the recording site. With a 1 Hz threshold as the minimum firing rate 
within a place field, field sizes ranged from 4% to 62% of the surface area in a cylinder of 
76 cm radius (Muller et al, 1987). Within the hippocampus, the size of place fields expands 
as the electrodes are moved to more ventral portions (Jung et al, 1994).  
Spatial distribution 
The field centers are fairly evenly distributed over the surface of the cylinder and 
similar apparatuses, although there may be some tendency for fields to be more common 
near walls and proximal to prominent stimuli on the apparatus wall (Hetherington and 
Shapiro, 1997). 
A very important question is if there is an anatomical-topographic relationship between 
place cells and place fields in the hippocampus.  The vast majority of studies have not 
found any such relationship (O’Keefe and Nadel, 1978; Muller and Kubie, 1987). 
Neighbouring cells are as likely to code for distant regions of an environment as they are to 
code for nearby regions. Thus, there are no systematic relationship between the anatomical 
location of cells within the hippocampus and the places that they represent in an 
environment.  
Field directionality 
In open apparatuses like the cylinder, place cell firing depends only on the position of 
the animal’s head and is independent of the head orientation. However, when the animal 
traverses repeated paths in a stereotyped manner, by environmental restrictions or reward-
shaping or both, place fields can be directionally selective. For instance, where the rat 
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repeatedly runs back and forth between the rewarded ends of a linear track, the majority of 
place cells fire only when the animal runs either on the outward or the inward journey, 
showing marked directionality (O’Keefe and Recce, 1993; Huxter et al, 2002).  
Markus et al (1995) investigated this question in two experiments. First they recorded 
place cells in two differently shaped environments: a cylindrical open field where place 
fields were omnidirectional, and a plus maze, where the rat trajectory is constrained by the 
shape of the environment and place fields were very directional. Next, place cells were first 
recorded while the rats were sampling the environment uniformly, chasing randomly 
scattered food, then recorded when the rats where trained to run stereotypically between 
four locations in the cylinder, where the food was sequentially placed. The proportion of 
directional fields grew from less than 20% to nearly 40%. This study suggests that the 
directionality seen in place fields is primarily attributable to the rat’s restricted behaviour 
and, only secondarily, to environmental constraints.  
3.2 Determinants of place fields 
Why do place cells fire in particular locations in an environment? One possibility is 
that each cell has its simple sensorimotor or behavioural firing correlates: it responds to a 
simple sensory characteristic of the environment, such as a localized odour, or fires only 
when the subject is doing a peculiar behaviour, such as eating. The nondirectional mode of 
place cell activity rules out this possibility, as such particular scenes change radically as a 
function of the heading direction. Other evidence also supports this view. For example, 
place fields are frequently maintained even if significant landmarks are removed or 
recording is performed in the dark (O'Keefe and Dostrovsky, 1971; O'Keefe, 1976; 
O’Keefe and Speakman, 1987; Quirk et al, 1990). Indeed, the primary correlate of place 
cells is the animal’s location in an environment, and it seems that place cells constitute an 
abstract, high-level cognitive representation of the environment, which is triggered by a 
combination of stimulus features, so that most cells fire in only one place because the 
combination occurs at that place in the environment. The sensory input necessary for this 
cognitive map can be obtained from both external (visual, somatosensory, auditory, 
olfactory) and internal (self-motion, proprioceptive, vestibular) systems.  
External and internal cues 
External or exteroceptive cues convey information about the proximal and distal 
features and landmarks in the environment. Internal or interoceptive information is derived 
from idiothetic or path integration system based on the animal’s own movement. It has 
been suggested that distal, proximal, and idiothetic cues interact to determine place-cell 
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activity (O’Keefe, 1976; O’Keefe and Nadel, 1978; Best et al, 2002).  
Place cells use information from different sensory modalities to identify landmarks. Of 
the various types of external information, stable distal visual cues, when present, exert a 
particularly powerful influence over place cell activity (O’Keefe and Conway, 1987; 
Muller and Kubie, 1987; Jeffery, 1997; Jeffery and O’Keefe, 1999). It has been repeatedly 
shown that place fields’ angular location may almost be totally controlled by salient distant 
landmarks, for instance, a single large white card either on the wall of the recording 
environment (O’Keefe and Conway, 1987; Muller and Kubie, 1987; Jeffery, 1997; Jeffery 
and O’Keefe, 1999). In such circumstances, when the distal cues are rotated by a given 
amount, place fields can be observed to rotate both in unison and by a similar amount to 
the controlled cues. Furthermore, simultaneously recorded place cells rotate in union 
(O’Keefe and Conway, 1978; O’Keefe and Speakman, 1987; Muller et al, 1987; Jeffery et 
al, 1997; Jeffery and O’Keefe, 1999). This is a well-established finding, and it is true of all 
the situations where the cues are not in conflict with the other sensory systems (vestibular, 
motor feed-back, olfactory etc).  
Though important, visual cues are neither necessary nor sufficient for place field 
formation and maintenance. Place fields stay unchanged in darkness (O'Keefe and 
Dostrovsky, 1971; O'Keefe, 1976; Quirk et al, 1990) or when the experimentally controlled 
visual cues are removed (Muller and Kubie, 1987; O’Keefe and Speakman, 1987). Thus, 
non-visual information is capable of maintaining place fields when visual sensory input is 
removed. Research suggests that, under these circumstances, the fields are maintained by 
olfactory and tactile cues on the floor and walls of the enclosure, and by internal idiothetic 
cues, in particular vestibular and proprioceptive ones, providing information about the 
animal’s own movement. Save et al (1998) examined place cell activity in animals that 
were blinded shortly after birth. Place cells were recorded in a cylindrical arena containing 
three objects (a wooden cone, a plastic cylinder, and a bottle of wine) near the wall of the 
apparatus. Both blind animals and sighted controls showed stable place fields. The 
difference was, while place field appeared during the subject's first pass through the field in 
sighted animals, blind rats did not show place field until at least one of the three objects 
was approached and explored. Hill and Best (1981) also found reliable place fields in rats 
that were both blind and deafened. After maze rotation, the place fields of the majority of 
the cells rotated with the physical apparatus. Because these subjects were receiving no 
visual or auditory information, it appears that they were relying on idiothetic information to 
track changes in location in an internal map of the environment.  
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What will happen if external and internal cues are in conflict? Jeffery and O’Keefe 
(1999) showed that distal visual cues could lose their control over place cell activity when 
the animal learned that the cues were unstable. They recorded place cells as rats explored a 
platform located in a curtained enclosure containing a single, prominent visual cue. After 
the locations of place fields were determined, the cue was moved to a new location. When 
rats were not able to see the experimenter move the cue, the place fields rotated with the 
cue. However, when rats were able to see the experimenter move the cue, place fields did 
not reliably rotate with the cue. Similar findings have been reported in other studies (e.g. 
Knierim et al 1995). Such evidence suggests that, external and internal cues compete to 
control the location of place fields.  
Shape of immediate environments 
Another important determinant of place fields is the distance of the animal to some of 
the walls of the immediate environment. O’Keefe and Burgess (1996) recorded place cells 
in four rectangular boxes that varied in the length of one or both dimensions. Interestingly, 
the location of place fields seemed to follow a subset of the box walls, and each individual 
cell is governed by its own particular combination of two or more walls in orthogonal 
directions, firing maximally when the subject is at the optimal distance from that particular 
subset of walls. For some cells, moving a wall moved the field without changing its shape, 
while for others, increasing the distance between two opposite walls shifted the field center 
so that it maintained the correct distance to both walls. This distorted the field shape, 
causing it to expand along that dimension, and it sometimes resulted in double peaks or the 
splitting of the field into two. This distance might be estimated either visually or by path 
integration. The influence of immediate environments on place cell firing was further 
demonstrated in Lever et al (2002). In this study, when rats were exposed to two 
geometrically different environments (cylindrical and square walled enclosures), the 
locations of place fields in these two environments were similar at the beginning, and 
diverged gradually and incrementally with more experience.  
7on-spatial correlates 
According to the cognitive map theory, the fundamental firing correlate of place cells 
is the location of the subject. But there are other correlates such as the existence or absence 
of objects in places (O’Keefe and Nadel, 1978) and the future action of the subject (Markus 
et al, 1995; Wood et al, 2000). In one study (Wood et al, 2000), rats performed a spatial 
alternation task in a T-maze. Each trial began with the rat at the base of the stem of the T 
and commenced, when the rat traversed the stem and then selected either the left- or the 
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right-choice arm. Rewards were available at the end of each arm according to an 
alternation sequence, requiring the rat to distinguish between their left- and right-turn 
experiences and to use their memory for the most recent previous experience to guide the 
current choice. Individual hippocampal cells fired as the rats passed through a sequence of 
locations within the maze during each trial. The key observation in this experiment was 
that the firing patterns of many of the cells depended on whether the rat was in the midst of 
a left- or right-turn episode. Thus, these cells fired selectively on either a left- or a right-
turn trial, even when the rat was in the same segment of the stem of the T and running 
similarly on both types of trials.  
3.3 The phase shift phenomenon 
O’Keefe and Recce (1993) observed an interesting relationship between the theta wave 
of the EEG and place cell firing in rats running on a linear track. They found that as the rat 
traversed the place field of any given place cell, the cell fired at progressively earlier 
phases of the local EEG theta oscillation. They were recording from CA1 pyramidal cells. 
Since then the phase shift phenomenon has been observed in DG/CA3 cells, although the 
phenomenon is less pronounced (the precession occurs over more restricted phase ranges 
per any given run within the field; Skaggs et al, 1996; Huxter et al, 2002). Recently, phase 
precession has also been demonstrated in two-dimensional open fields (Huxter et al, 2008).  
O’Keefe and Recce (1993) proposed that the phase precession observed in CA1 was 
generated by two oscillators of slightly different periods converging onto the hippocampus. 
One of these oscillators was the theta wave, whereas the other has still to be identified. 
They also proposed a functional role for phase precession, postulating that it could 
represent a temporal code which improves the ability of the hippocampus to represent 
space. Given that place fields on a linear track can be modeled in terms of symmetric 
Gaussians, firing rates do not distinguish between various portions of the edges of a field. 
Thus phase coding could in principle disambiguate the entry and exit portions of a place 
field. Jensen and Lisman (2000) showed that the position reconstruction accuracy of an 
ensemble of place cells recorded on a linear track can be improved by more than 43% 
using phase data and rate data as compared to using rate data alone. These findings 
strengthen the hypothesis that phase contributes to hippocampal spatial representation.  
However, if this claim is correct, one should expect that temporal and rate codes 
should be independent of each other. Two studies failed to such a functional independence. 
Harris et al (2002) claimed that the theta phase of pyramidal cell firing is best predicted by 
the instantaneous firing rate of the cell, and therefore proposed that phase shift results from 
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the dynamics of the spike train. Mehta et al (2002) reported that, during initial runs through 
the place field, place firing became more asymmetric, and phase shift strengthened (Mehta 
et al, 2000). However, when Huxter et al (2003) looked at phase shift on sub-sections of 
the place field, and on individual runs through the place field, they found that the strongest 
correlation of phase shift was still the animal’s position. They therefore maintained that 
place cells could represent position with independent rate and time codes. 
3.4 Formation, stability and plasticity of place fields 
It is important to understand how place fields are formed, developed and maintained in 
an environment. Some models of the hippocampal function (Wilson and McNaughton, 
1993; McNaughton et al, 1996) suggest that path integration is the initial metric of the 
hippocampal map, and cues and landmarks are bound to the map secondarily. Indeed, the 
firing patterns of place cells remain stable in a familiar environment for extended periods 
and new map representations emerge over time in a novel environment (Wilson and 
McNaughton, 1993; Lever et al, 2002). A candidate mechanism responsible for such 
stability and respective change of neuronal firing patterns is a use-dependent synaptic 
plasticity, such as LTP.  
Emergence of place fields in novel environments 
Place fields develop rapidly when the subject is exposed to a novel environment. 
However, there is no general consensus about how place fields emerge in new 
environments.  
Hill (1978) reported that initial fields (the first time an animal passes through the field) 
are indistinguishable from fields recorded later on, when the animal is familiar with the 
environment. This is in contrast with a study by Wilson and McNaughton (1993), which 
showed that place fields took 6 to 10 minutes to be established, and that these initial fields 
were not as stable as those in a familiar environment. Frank et al (2004) reported that about 
one-quarter of the new fields in a novel environment developed rapidly within the first 2 
min and that most fields stabilized after 5-6 min of experience.  
More recently, one study clarified the importance of CA3 sub-field in the formation of 
place fields in a novel environment. This study was performed in a knockout mouse (CA3-
NR1 KO) in which the deletion of the NR1 gene is restricted to the CA3 pyramidal cells of 
an adult mouse (Nakazawa et al, 2003). It was reported that the specificity of spatial tuning 
in the CA1 place cells of mutants was reduced during the first 15 min of exploration in the 
novel space compared with the same period in the familiar space. By contrast, no space 
shift-associated change of spatial tuning was observed when the mutant mice were returned 
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1 day later to the pair of spaces experienced on the previous day. Behaviourally, these mice 
were impaired in the spatial delayed-matching-to-place task when the platform was placed 
in a novel location, but were normal when the platform location employed a few days 
earlier was reused. This behavioural deficit was highly specific in that the mutants were 
normal in the acquisition of spatial reference memory as tested by the standard version of 
the Morris watermaze task. These results suggest that CA3 NRs, most probably those in the 
recurrent network, play a crucial role in rapid hippocampal encoding of a novel encounter 
and in one trial- or one experience-based rapid learning. 
Stability of place fields 
Place cell recordings are usually made in a continuous "session" that starts when an 
animal is put in an apparatus and ends when it is removed. There is a general consensus 
that, once place fields are established and sensory stimuli are kept constant, they are stable 
both during sessions that last for minutes and across sessions separated by hours, weeks, or 
months. If sessions are run in two or more apparatuses over extended times, fields are 
stable in each (Muller et al, 1987; Muller and Kubie, 1987). The long-term stability of 
firing fields implies that the representation is recalled and not created de novo each time 
the rat enters a familiar environment. The stability of different fields in different familiar 
environments implies that many representations can be stored without interference and 
represents a form of memory.  
Place cell plasticity 
The hippocampus is a brain region with high capacity for plasticity. There is increasing 
evidence of experience-dependent change in hippocampal cells that might suggest a 
learning process (Bostock et al, 1991; Mehta et al, 1997; 2000; Lever et al, 2002).  
Place fields develop asymmetries (an elongation of the field in the direction from 
which the animal is moving) and increase in size over a series of trials in which the animal 
travels repeatedly along a given path in the same direction (such as when rats run along 
linear tracks) (Mehta et al, 1997). However, place fields return to their original shapes by 
the next day (Mehta et al, 2000), indicating that the change is only temporal. An NMDA-
function antagonist blocked these experience-dependent changes  (Ekstrom et al, 2001), 
suggesting that this phenomenon might involve an asymmetrically associative LTP-like 
process, and that such plasticity mechanisms might be engaged in spatial behaviours of 
freely behaving animals.  
Another type of plasticity takes the form of a long-term incremental change in the 
place fields and may underlie long-term incidental spatial learning and memory. In the 
 85 
Lever et al. (2002) study, rats were exposed to two geometrically different environments 
(cylindrical and square walled enclosures) and place cell representations were shown to 
diverge gradually and incrementally. The divergence occurred in a totally incidental 
manner, in the absence of explicit reward. The changes were long-lasting, persisting for at 
least one month, in the absence of exposure to the environments during the delay period. 
Moreover the “cylinder” and “square” representations were shown to generalize across two 
environments of similar shape but different material, implying that the hippocampus had 
encoded the geometric features of the environments it was exposed to. These results have 
not only confirmed the view that the distance from two or more walls in particular 
directions is one of the major determinants of the location and shape of place fields 
(O’Keefe and Burgess, 1996), but also suggested that place cells might underlie the long-
term incidental learning in the hippocampus. 
3.5 Remapping 
One important feature of the place cell is that, a dramatic change of sensory cues or 
moving the animal to a new environment result in a reconfiguration of place fields. This 
phenomenon is named ‘remapping’. In remapping, place fields can change in magnitude, 
shift in position, appear or disappear. The last two phenomena are worth particular 
attention. A robust place cell in one environment may stop firing in another. This suggests 
that every "sufficiently different" environment is represented by an independent subset of 
place cells chosen, with replacement, from the pyramidal cell population.  
The remapping phenomenon suggests that the hippocampus learns and holds distinct 
maps for distinct contexts, with each specific map being reactivated as the subject switches 
between the different contexts. There is currently no consensus for predicting which kind 
of environmental changes will produce remapping. This is not surprising as some subjects 
may judge two environments to be quite similar while others judge the environments to be 
quite different. This issue is further complicated with the discovery of partial remapping.  
Complete remapping vs partial remapping 
A sufficiently large environmental manipulation may cause an ‘all-or-none’ switch in 
the responses of place cells, with almost all cells in one environment being either silent or 
having unrelated fields in a second environment. Such a dramatic change of spatial 
representation is called “complete remapping”. One example of complete remapping was 
given by Muller and Kubie (1987), who trained rats to forage for food pellets scattered 
randomly over the floor of either a circular or a rectangular box in the same curtain-
enclosed environment. Under these conditions, place cells fields in one box did not predict 
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fields in the other (Muller and Kubie, 1987). Of a sample of 22 CA1 place cells, 12 had 
fields in only one environment and 9 had fields in both that could not be related by any 
‘simple’ (rotational or radial) transformation. Later, however, this “complete” model of 
remapping was challenged by several other studies.  
Skaggs and McNaughton (1998) recorded CA1 place cells in two visually identical 
environments connected by a corridor, through which the rat walked between them. When 
place fields in the two boxes were compared, cells were fairly evenly split into those which 
had similar fields, and those whose fields were completely different. There was, therefore, 
‘partial’ remapping between environments. Another study investigated systematically 
changing stimuli across modalities: the colour (black/white) and odour (vanilla/lemon) of 
the recording environment (Anderson and Jeffery, 2003; Jeffery and Anderson, 2003). 
Place cells were found to have heterogeneous responses, with some remapping in response 
only to colour changes, some only to odour changes, and some to both. There did not 
appear to be any relationship between the responses of individual cells: remapping 
appeared to occur on a cell-by-cell basis. Taken together, in partial remapping, significant 
proportions of simultaneously recorded place cells are both remapped and non-remapped.  
The reason why some manipulations produce complete remapping whereas others 
produce partial remapping is unclear. It seems which response is seen depends on the exact 
nature of the manipulation, and on the individual animal being studied.  
Global remapping vs rate remapping 
In addition to complete and partial remapping, Leutgeb et al (2005) identified another 
form of remapping – rate remapping, which may account for encoding different episodes 
occurred in the same place.  
In that study, place cells were recorded under two different conditions: (1) two 
recording chambers with different shapes but always placed in the same location of the 
same room; and (2) the same recording chamber located in two different rooms. In the 
second condition, both the spatial locations of activated place cells and their discharge rates 
were statistically independent, representing a complete (or “global”, applied by the authors) 
remapping, as expected from previous studies. In contrast, in the first condition, virtually 
all the activated hippocampal neurons remained anchored to the same Cartesian 
coordinates, but the firing rate of the individual neurons varied more than an order of 
magnitude in the different chambers (rate remapping). A further study from the same group 
reported that hippocampal rate remapping was associated with stable grid cell firing 
patterns whereas as global remapping was accompanied by a coordinate shift in the firing 
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vertices of grid cells (Fyhn et al, 2007). Based on these findings, the authors suggested a 
dual coding scheme of spatial vs episodic information: global remapping permits the 
distinction between similar experiences that occur in different places, whereas rate 
remapping permits the generation of representations of unique episodes of experience 
independent of the ensemble-coded place. 
However, some studies with similar aims have generated different results. For example, 
Wills et al (2005) reported abrupt and simultaneous switch of place cell ensembles (global 
remapping, according to Leutgeb et al) when rats explored either square or circular 
chambers at the same location of the room. One possible reason for such discrepancies is 
the subjects’ varied familiarity with the testing conditions in different studies. One 
subject’s “similar environments” may be judged to be significantly “different” by another 
with more experience. Indeed, Lever et al (2002) has shown that with more experience, 
place cells slowly and incrementally discriminate two similar environments.  
3.6 Place cells as a coherent representation of space 
An important component of the cognitive map theory (O’Keefe and Nadel, 1978) is 
that the hippocampus holds a holistic map-like representation of space. If that were the case, 
place cells should show a tendency to stably retain their field positions relative to each 
other, despite perturbations to the environment. In such a model, changes in the 
environment will not cause the positional firing patterns of individual cells to change 
independently of each other unless the change is big enough. At this point, the positional 
firing patterns of all cells and their relationships to each other in two-dimensional space 
will change all at once, as seen in complete remapping. The term ‘coherent’ will be used to 
describe place cells displaying these properties. 
Pattern completion 
Much evidence supports such a model. In a study by O’Keefe and Conway (1978), 
place cells were recorded on a 3-arm maze inside a curtained environment. Apart from the 
maze itself, the only cues inside the curtained environment were four prominent, distinct 
objects placed near the curtains. When these objects were rotated to a new position, all the 
fields rotate simultaneously, as if all the cells were bound to each other. Furthermore, eight 
cells were then tested with removal of one or two of the cue objects. All cells maintained 
the same fields despite removal of at least one object, and for most cells two objects.  
The conclusion from this study is that the cognitive map is not a collection of 
independent place cells but is instead a stable unit, which responds to a degraded input 
pattern with the entire previously stored output pattern. Specifically, normal place fields 
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from all place cells can be elicited when the animal is exposed to a familiar environment 
but with some usual cues missing. This phenomenon is termed “pattern completion” and is 
in contrast to “pattern separation”, the ability to make the stored representations of two 
similar input patterns more dissimilar in order to decrease the probability of errors in recall, 
which will be discussed later (Marr, 1971; O’Reilly and McClelland, 1994; Guzowski et al, 
2004).  
The CA3 sub-field is known to have a robust recurrent network with pyramidal cells 
receiving synaptic contacts from 2% of other CA3 pyramidal cells (MacVicar and Dudek 
1980) and is often proposed as an anatomical substrate of place cell pattern completion. 
Their extensive network of recurrent collaterals could act as an auto-associative network, 
allowing any cell missing its own particular input for that environment to be fired by others 
active in CA3. Direct support for this proposal has come from a mutant mouse that 
selectively lacked the NR1 subunit of the NMDA receptor in the CA3 area of the 
hippocampus (Nakazawa et al, 2002). The removal of the NMDA receptors prevents the 
selective strengthening of synaptic connections needed to create an auto-associative 
network specific for an environment. CA1 pyramidal cells were recorded while the mice 
where foraging in a cylindrical environment, placed within a curtained enclosure with four 
prominent visual cues. No difference was found in mean firing rate, spike width and place 
field size between control and knock-out (KO) place cells. Thus, spatial information within 
CA1 is relatively preserved despite the loss of CA3 NRs. The main finding of Nakazawa et 
al (2002) is that when place cells were recorded in trials where three of the four visual cues 
were removed, the firing rate, burst frequency and place field size of CA1 place cells in 
KO animals were dramatically reduced, even though the spatial selectivity of the cells 
remained intact. This was in contrast to the control mice, which showed no significant 
changes in place field properties associated with the environmental change. Behaviourally, 
KO animals were normal in the acquisition and retrieval of spatial memory tested in the 
conventional version of the Morris watermaze with four visual cues surrounding the pool. 
However, when a probe trial was run with only one of the four visual cues present, control 
animals’ performance remained intact, while KO animals exhibited a clear deficit of 
memory retrieval. KO animals still showed a selective search strategy in the correct 
quadrant, but the time spent in this quadrant was significantly shorter when compared to 
probe trials with the four visual cues present.  
Thus, electrophysiological results are compatible with the behavioural results, 
suggesting that lack of CA3 drive impairs pattern completion ability and makes it more 
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difficult for mutants to retrieve old spatial memories when only partial cues are available. 
The fact that in the single cue condition the spatial selectivity (both at the behavioural and 
place cell level) is reduced but not completely abolished prompted the authors to suggest 
that this might be sustained by dentate to CA3 NMDA-independent plasticity and by the 
direct entorhinal to CA1 projections. 
Pattern separation 
In addition to pattern completion, CA3 is also involved in pattern separation. Indeed, 
computational models based on hippocampal connectivity have proposed that CA3 is 
uniquely positioned as an autoassociative memory network, capable of performing the 
competing functions of pattern completion and pattern separation (Marr, 1971; O’Reilly 
and McClelland, 1994; Guzowski et al, 2004).   
Leutgeb et al (2004a) simultaneously recorded CA1 and CA3 place cells whilst 
animals were in enclosures with varying geometric similarity in three similar but 
distinguishable rooms. In these rooms, the overlap between active CA1 cell populations 
was much higher than that between CA3 populations. Thus, the CA1 representations 
shared more cells firing in different environments, whereas the CA3 representations were 
based on more distinct active subsets of cells. These results show that overlapping input 
patterns are orthogonalized in ensembles of CA3 neurons whereas CA1 neurons remain 
more faithful to their inputs. Further research from the same group suggested that this 
pattern separation function of the CA3 area was triggered by direct projections from 
entorhinal grid cells to the CA3  (Leutgeb et al, 2007).  
It is interesting to compare this study, which shows pattern separation in CA3, with the 
Lee findings (2004), which shows pattern completion in the same region. The Leutgeb 
study recorded place cells in different rooms while the Lee study did in the same room but 
with altered cues. Thus, a competition exists in CA3 between pattern completion and 
pattern separation processes. When the environmental change is minor, the CA3 subregion 
employs autoassociation via the recurrent collaterals to make the representations more 
similar thus pattern completion predominates, whereas, without this extensive recurrent 
system, CA1 shows less overlap in its spatial representations (Lee et al, 2004). When the 
sensory inputs are changed drastically, CA3 cells produce very different spatial firing 
patterns (pattern separation), whereas CA1 cells maintain more similar place fields 
(Leutgeb et al, 2004).  
One recent study has directly confirmed this hypothesis. Vazdarjanova and Guzowski 
(2004), using time-dependent RNA imaging of immediate-early gene (IEG) activity as a 
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measure of ensemble activity patterns, examined the responses of CA3 and CA1 ensembles 
in rats exposed sequentially to various environmental manipulations. When the animal was 
introduced to two similar environments in which either the proximal or distal cues were 
altered, ensembles in CA3 demonstrated greater overlap between contexts than in CA1, as 
in the Lee et al (2004) paper. In contrast, when the rats were exposed to two dissimilar 
environments in which both proximal and distal cues were varied, the overlap of CA3 
ensembles active in each exposure was at chance levels, whereas that of CA1 ensembles 
was higher, as in the Leutgeb et al. (2004) paper. The obvious caveat to this result, 
however, is that assaying cell firing through gene activity cannot show the spatial nature of 
cell firing. If CA1 cells remapped by shifting field position, the techniques used in this 
study would not detect this.  
Angular cue dissociation 
Another way to investigate the coherent nature of the cognitive map is to put external 
cues in conflict with each other, for example by rotating distal cues in a different direction 
to the local (i.e. intra-maze) cues, and study the response of place cells. A coherent 
representation would be expected to rotate as a whole, following only one set of cues and 
ignoring others. If, on the other hand, different cells rotated with different cues, it would 
suggest that cells responding independently to individual stimuli. 
The first study to address this issue found a complex set of results (Shapiro et al, 1997; 
Tanila et al, 1997). Rats were trained to run on a four-arm plus maze, where the spatial 
reference was defined by both intra-maze (distinct materials on each arm of the maze) and 
extra-maze (four prominent objects surrounding the maze) cues. On some trials, these two 
sets of cues were rotated 90º in opposite directions. The fields of some cells rotated with 
the distal cues, while many other fields rotated with the proximal cues. In another condition, 
the relative positions of distal and proximal cues were scrambled. As with the previous 
result, some fields moved with particular proximal stimuli and some with particular distal 
stimuli, and some cells fired maximally only when the proximal and distal cues were 
oriented in a particular way relative to one another. These findings argue against a coherent 
representation, suggesting, rather, that different cells are ‘tuned’ to different sets of cues. 
Brown and Skaggs (2002) repeated the experiment, recording 4-70 cells simultaneously. 
They found that, initially, cells rotated coherently, all following the intra-maze cues. After 
repeated manipulations, the likelihood of cells remapping increased. When the effects of 
remapping were controlled for, the incidence of cells simultaneously following both cue 
sets was no more than expected by chance. Knierim and McNaughton (2001) came to a 
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similar conclusion, although using a very different experimental protocol (3-dimensional 
rotation of the recording apparatus). In this case, no more cells were bound to the local 
cues than would be expected by chance. 
Later, Knierim et al (2002) substituted a circular track for the plus-maze as the 
recording environment. This study claimed to demonstrate clear split control of place fields. 
This certainly appears true of some of the animals in the study: some fields rotate with 
local cues, some with distal, and some develop double fields, as if rotating with both cue 
sets. The field rotation data, grouped over all animals, shows a corresponding bi-modal 
distribution. However, in most cases, the field rotation data for individual animals does not 
show this. Only 2/8 animals show an obvious bi-modal distribution, in the others, fields 
seem to rotate overwhelmingly with either one cue set or the other. (The study does not 
provide formal analysis of this data). This study therefore showed that split control over 
place fields is possible, but not necessarily that it is the normal response to cue dissociation.  
It remains unclear what kind of mechanism drives place cells to respond to local or 
distal cues. Since different place cells receive different sensory inputs about the 
environment, there might be a competition between this information so that the more 
powerful set controls the activity of the cell (Shapiro et al, 1997). 
All the above studies were conducted in CA1 cells. Lee et al (2004) repeated the 
experimental protocol of Knierim (2002), but simultaneously recorded CA1 and CA3 place 
cells. In probe tests, the cues on the track and those on the walls were rotated 
counterclockwise and clockwise respectively so as to cause a mismatch between the 
sensory input provided by the proximal (track) and distal (wall) cues. When the magnitude 
of the mismatch was small (45°), both CA1 and CA3 ensembles output coherent 
representations that were similar to those of the original, familiar cue configuration. When 
the mismatch amounts were larger than 45°, however, the CA3 and CA1 cells reacted 
differently. The CA3 representation was still coherent, in that approximately half of the 
place fields rotated with the proximal cues and only a minority remapped or displayed 
ambiguous behavior. In contrast, the CA1 representation lost its coherence, as most place 
fields remapped or displayed ambiguous behavior. The finding of increased coherence in 
CA3 place fields is interesting, given the common idea that CA3, with its extensive 
recurrent collaterals, may be able to act as an auto-associative network (chapter 4). An 
alternative explanation, however, may simply be that CA3 receives different inputs to CA1, 
and that these are more controlled by the local cues.  
All studies described so far have used angular dissociation of local and distal cues as 
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their primary experimental technique. Local and distal cues exert control over place fields 
in different ways, however, and their effects may interact in non-obvious ways, making 
prediction or modelling difficult. Fenton et al (2000a; 2000b) also investigated angular cue 
dissociation, but with two similar distal cues (a white card and a black card on a circular 
environment wall). The amount of angular dissociation was also smaller: 25º together or 
apart, compared to 90º or 135º in other studies. Under these conditions, place fields neither 
followed different cues independently, nor remapped. Rather, place representation was 
topologically distorted, such that fields near each cue moved rotationally with the cue, 
while those away from the cues moved radially towards or away from the centre. This 
experiment does show a type of coherent representation, therefore, though a flexible and 
deformable one, rather than a rigid one. 
In conclusion, if there is a coherent place representation in the hippocampus, it is clear 
that it can be ‘broken up’ by a severe manipulation such as placing local and distal cues in 
conflict. All studies using this protocol found that some cells rotate with the cues and 
others remap. However, this does not disprove the existence of a coherent representation 
under more normal conditions. Subjecting animals to a lesser cue manipulation, as in 
Fenton et al (2000a, b), shows a place representation that is coherent, though deformable 
rather than rigid.  
Attractor dynamics of the hippocampal network 
An attractor network has one or several preferred positions or volumes in state space 
such that when the system is started from any other location, it will evolve until it arrives at 
one of the attractors and will then stay there in the absence of new inputs (Marr, 1971; 
Hopfield, 1982; Amit, 1992). In such a network, stored memories can be recalled from 
degraded versions of the original input stimuli (pattern completion), while at the same time 
the retrieved pattern stays separate from other, more different memories in the same 
network (pattern separation). The fact that place cells show both phenomena (previous 
sections) suggests that the hippocampal network may have attractor properties.  
Strong support for this hypothesis comes from Wills et al (2005). In their study, rats 
were first extensively exposed to two very different environments (a wooden circle and a 
square made of morph material). Such exposures resulted in rapid occurrence of remapping, 
which persisted when rats were exposed to circular and square boxes both made of morph 
material. Then Wills et al probed rats to a series of morph boxes, whose shapes took a 
variety of configurations from more circular to more square-like, in a pseudo-random order 
across successive recording sessions. Interestingly, morphing the recording environment 
 93 
from one familiar shape to another led to an abrupt transition in the hippocampal network 
state near the middle of their sequence when the intermediate shapes were presented. Not 
only was the switch point similar for all rats, it was also the same for all simultaneously 
recorded cells within a given rat.  
These results suggest that place cells act in a unitary coherent ensemble fashion, with 
both pattern separation (which permits abrupt switch from circle to square pattern despite a 
small change in the geometry of the boxes) and pattern completion (which allows some 
type of cooperation among different place cells) at work.  
3.7 Place cells and synaptic plasticity 
Place cells are not isolated neurons but receive lots of synaptic input. It has been 
shown that NMDA receptor-dependent synaptic plasticity is not necessary for forming 
place fields, nor for maintaining them between consecutive test sessions in the same 
environment on the same day. However, longer-term stabilization of the place fields is 
seriously dependent on this pathway. Kentros et al (1998) found that NMDA receptor 
blockade by competitive NMDA receptor antagonist CPP neither affected the already 
established place fields in a familiar spatial environment before drug administration, nor 
prevented new place fields emergence (remapping) in a novel environment. The 
representation of the novel environment was stable when re-tested 1 hour later, but 
remapped again when tested the next day: different from that of the first day of exposure. 
Thus, NMDA receptor pathway is important for long-term stability of new, remapped place 
fields. Further research (Shapiro and Eichenbaum 1999) reveals that NMDA receptor 
blockade prevents even the short-term stabilization of place fields. As before, when drug-
treated animals were placed in a novel environment, new place fields were formed. 
However, when the room lights were turned off for 5 min and then turned back on, place 
fields in drug-treated animals moved to new locations. These results are consistent with 
behavioural data that NMDA receptors, although required for some component of spatial 
learning, may not be required for the generation of the spatial representation of a specific 
environment (Bannerman et al, 1995).  
Interestingly, deleting NMDAR1 subunits specifically in CA1 or the CA3 regions 
resulted in different alterations in the properties of place fields. The place fields of the 
NMDAR1-CA1 mutants were roughly one-third larger than fields in wild controls, and 
place cells with overlapping fields showed lower levels of coordinated firing. Not 
surprisingly, these mice exhibited impaired spatial learning (McHugh et al, 1996). In 
contrast, deletion of the NMDAR1 in the CA3 region resulted in a higher sensitivity to 
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partial removal of spatial cues, suggesting that NMDAR1-synaptic plasticity in CA3 
networks is critical for pattern completion of spatial information (Nakazawa et al., 2002).  
3.8 Place cells and spatial behaviour  
If the cognitive map theory is correct, changes in that map should correlate with 
simultaneous changes in the animal’s spatial behaviour. Several lines of transgenic mice 
without stable place fields are also impaired in spatial learning  (McHugh et al, 1996; Tsien 
et al, 1996 a,b; Rotenberg et al, 1996; Cho et al, 1998; Giese et al, 1998).  
An alternative way to test this theory is to examine place cell activities in normal 
animals performing behavioural tasks. O’Keefe and Speakman (1987) trained rats to 
perform a spatial memory task which required them to choose the correct arm of a 4 arm 
plus-shaped maze identified by distal cues to obtain reward. Removal of distal cues from 
the testing environment (with the rat absent) caused an increase in behavioural errors, as 
well as a change in the place-cell firing patterns relative to the trials performed with distal 
cues present. When the same data were realigned according to the rat’s choice of goal arm 
(rather than the actual goal arm), the place fields returned to the same configurations 
obtained in the cues-present trials. In other words, the rat’s choice of goal arm 
corresponded with the information contained in the rat’s hippocampal map. In another 
study (Lenck-Santini et al, 2001), rats were trained in a continuous spatial alternation task 
in which they had to alternate between the two arms of a Y-maze to get a food reward in 
the third (goal) arm. By manipulating the information available to the animals, the 
researchers induced the cells to establish their fields in locations that were out of register 
relative to their standard position, thus making them inconsistent with the learned spatial 
task. When this happened, the rats' performance in the alternation task was markedly 
decreased. In addition, the nature of the behavioral errors during inconsistent field 
placements also changed dramatically in a way that was highly indicative of the rats’ 
spatial disorientation.  
Jeffery et al (2003) took a different approach with different results. They trained rats to 
go to a particular corner of a square-walled box (box A) after the occurrence of a tone. This 
task was shown to be hippocampal dependent. They recorded place cells from these rats in 
box A. When the animals were introduced to the same shaped box with different walls (box 
B), the animals’ place cells remapped. However, the animals’ corner choice performance in 
box B was significantly impaired relative to their performance in box A, but was much 
better than chance (about 63%, chance being 25%). These results appear to show some 
dissociation between place cell firing and behaviour.  
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In summary, although some studies confirmed a functional association between the 
firing patterns of place cells and the spatial behavior of the animal, current indications 
suggest some caution in attributing causal relationships between them.  
3.9 Head-direction cells and grid cells 
In addition to place cells, another two types of cells: head-direction cells (HDCs) and 
grid cells, have been discovered, which are equally important for spatial behaviour.  
Head-direction cells 
HDCs fire maximally when the animal points its head in a given compass direction, 
regardless of its position or behaviour in the environment, therefore signal the allocentric 
direction of the head of the animal in the horizontal plane. These cells have been found in a 
variety of strongly interconnected brain areas, including the presubiculum (Taube et al, 
1990), lateral mammillary nuclei (Blair et al, 1998; Stackman and Taube, 1998), 
anterodorsal thalamic nuclei (AND; Blair and Sharp, 1995) and latero-dorsal thalamic 
nuclei (LDN; Mizumori and Williams, 1993).  
Several studies have recorded the activity of HDCs before and after landmark 
manipulations, in an attempt to define to which environmental features the directional 
system can be tuned. When distal visual cues are rotated the preferred direction of the 
HDCs recorded, like place cells, shifts a near-equal amount as the cues. This has been 
found for all types of HDCs recorded so far, even if the amount of under-rotation varies 
across brain region (Taube, 1998). These results indicate that HDCs can be controlled by 
prominent visual stimulus. In the absence of visual stimuli, the head-direction signal is 
disrupted, but not suppressed (Goodridge et al, 1998). 
So the firing of both place cells and HDCs may be controlled by distal landmarks when 
present. When they are simultaneously recorded in this type of cue-control experiment, 
their signals are strongly coupled (Muller et al, 1987; Knierim et al, 1995; 1998). However, 
this correlation by itself does not tell us if one system controls the other and to which 
extent they are operating in parallel. Current indications are that the head direction system 
controls the hippocampal place system, rather than visa versa. Dorsal presubicular and 
ADN lesions degraded the spatial selectivity of hippocampal place cells, and also made 
their signal more directional (Calton et al, 2003). Mizumori et al (1994) reversibly 
inactivated the LDN, showing a disruption of both hippocampal place fields and 
behavioural accuracy on a spatial memory task (radial arm maze). However, the converse 
is not true. In animals with complete dorsal hippocampal lesions it is still possible to record 
HDCs from the presubiculum and ADN (Golob and Taube, 1997, 1999). The properties of 
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these HDCs are very similar to those recorded from control animals. Thus, the place 
system relies on the HD system to provide it with the direction information for a fixed 
framework.  
Grid cells 
Another important but only recently discovered type of space-related cell is the grid 
cell in the medial entorhinal cortex (Hafting et al, 2005). The entorhinal cortex represents 
the major input structure to the hippocampal formation, therefore the electrophysiological 
studies conducted on this area are of crucial importance for understanding where and how 
spatially selective signals emerge in the hippocampus.  
Early studies reported much lower spatial specificity and selectivity of neurons in 
some areas of the entorhinal cortex compared with that of hippocampal place cells. They 
are also less sensitive to enclosure changes (Quirk et al, 1992; Frank et al, 2000, 2001). 
Now, however, it has become clear that the spatial information carried by neural activity in 
the entorhinal cortex has been underestimated, because the entorhinal cell population was 
undersampled and large variations exist among different parts of this region.  
Spatial representations in the entorhinal cortex follow a two-dimensional anatomical 
topography (Leutgeb et al, 2005). First, the spatial content varies between the lateral and 
the medial entorhinal cortex (Hargreaves et al, 2005). Neurons have stable and sharp 
spatial modulation in the medial subdivision, but not in the lateral subdivision. Second, in 
the medial entorhinal cortex, firing fields become gradually sharper and more concentrated 
along a ventromedial-to-dorsolateral axis (Fyhn et al, 2004). In the ventromedial-to-
intermediate bands, where the early recordings were made (Barnes, 1990; Quirk et al, 1992; 
Frank et al, 2000), firing fields are broad and dispersed. Towards the dorsolateral end, 
however, firing fields get smaller and more confined. A recent study has shown a strong 
spatially selective signal in the superficial layers of the dorsolateral band of the entorhinal 
cortex (Fyhn et al, 2004), which projects to more dorsal areas of the hippocampal 
formation. These cells’ firing maps form a regular gird-like pattern of locations across all 
environments the animal enters. Each grid cell fires in several locations in each 
environment, with the locations forming a regular pattern as though they were nodes on a 
triangular grid. Different cells recorded at the same location have the same grid spacing 
and orientation relative to the environment but differ in the location of the nodes such that 
the firing peaks of one cell are slightly shifted from those of its neighbours in a random 
manner (Hafting et al, 2005). The overall set of fields of several such cells together spans 
the whole surface of the environment. For each cell, the size of the grid appears to be 
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independent of the size or shape of the environment.  
The firing of grid cells can express information about position (grid vertices), direction 
(grid orientation) and distance (number of grid cycles) (Hafting et al, 2005). The grid-like 
firing persists after the removal or displacement of extrinsic sensory input, suggesting that 
path integration is a primary mechanism for generating such a metric representation of the 
environment. In addition, the orientation of the grid is dependent on the location of a 
polarizing visual cue in much the same way as head direction cells and place cells. More 
importantly, it has been shown that the localized firing of these neurons can be maintained 
without a functional hippocampus. Thus, the key features of the map are probably not mere 
reflections of hippocampal output. Instead, the position vector may be computed, at least 
partly, in the medial entorhinal cortex itself. Support for this proposal comes from the 
finding that layers III and V of the entorhinal cortex contain grid cells, head-direction cells 
and conjunctive grid x head-direction cells (Sargolini et al, 2006). These layers are major 
target areas of projections from the presubiculum, which probably convey signals from the 
head-direction cells in this area (Taube et al, 1990). All three cell types are responsive to 
speed of movement of the animal (Sargolini et al, 2006). Thus, the medial entorhinal cortex 
contains the translational and directional input necessary for computing a continuously 
updated metric representation of location.  
The exact relationships between entorhinal grid cells and hippocampal place cells 
require further research. According to some models, the amazingly regular firing pattern of 
grid cells suggests that they may be able to calculate spatial information and act as the 
primary site of path integration, whereas the hippocampus serves to encode episodic 
information (Leutgeb et al, 2005; Fyhn et al, 2007). Moreover, because the multiple fields 
of grids cells make them inappropriate to associate the sensory information to a specific 
location, the hippocampus might also serve as the read-out structure that provides feedback 
information to grids cells to maintain their association to sensory inputs from the 
environment, and to connect grids with different orientations and scales together (O’Keefe 
and Burgess, 2005).  
 
4 Hippocampal physiology in aging 
Aging is accompanied by a decline in cognitive abilities, particularly in spatial learning 
and memory. When young and old rats are compared on spatial navigational tasks, such as 
the Morris water maze task, the clear and consistent finding between laboratories is that old 
rats do not remember the spatial location of the escape platform as well as do young rats 
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(Barnes et al, 1997). Aging also causes deterioration of hippocampal circuitry and 
plasticity, which may explain the cognitive impairment seen in the same subjects.  
4.1 Changes of hippocampal anatomy in aging 
In the past it was considered that substantial neuronal loss might be associated with 
aging and thus responsible for the cognitive decline. Though early studies noted a loss of 
hippocampal principal cells with age (Coleman and Flood, 1987), careful anatomical 
studies have shown that there is no loss of neurons in the primary CA fields of the 
hippocampus, nor do granule cell numbers change during normal aging in humans (West et 
al, 1994), rats (Rapp and Gallagher, 1996; Rasmussen et al, 1996), or mice (Calhoun et al, 
1998). Thus, widespread hippocampal cell loss is not required for the appearance of age-
related cognitive deficits. 
As for synapses, there is no evidence of gross synaptic changes in aging. Instead, 
synaptic loss is highly region-specific and mainly affects cortical inputs to the 
hippocampus. Geinisman et al (1992) used an unbiased stereological method to count 
synapses in memory-impaired aged rats and reported a decrease in the number of 
axospinous synapses in the mid-molecular layer of the dentate gyrus. More recent work 
examined synapse-associated protein levels in the hippocampus (Smith et al, 2000) and 
found significant losses of synaptophysin in aged, memory-impaired rats, but only in 
stratum lacunosum moleculare of CA3. Moreover, when all aged rats, regardless of spatial 
learning ability, were considered together, synaptophysin levels (in CA3 lacunosum 
moleculare and the outer and middle portions of the molecular layer of the dentate gyrus) 
were significantly correlated with performance in the Morris water maze. Similar results 
have been reported in humans (Scheff et al, 1996).  
4.2 Changes of hippocampal synaptic transmission in aging 
Electrophysiological data support the anatomical observation that there is a reduction 
in synapse number in the dentate gyrus of aged animals. In the aged rat, the field EPSP 
recorded in the dentate gyrus is reduced (Barnes, 1979; Barnes and McNaughton, 1980). 
There is general agreement that synaptic plasticity is also impaired in aging. However, the 
changes are complex, protocol-dependent and region-specific (reviewed by Burke and 
Barnes, 2006). Aged rats have deficits in both LTP induction and maintenance, which may 
contribute to the observed cognitive deficits.  
Aged animals appear to have intact hippocampal LTP induction when robust, high-
intensity stimulation protocols are used. However, when peri-threshold stimulation 
parameters are used, LTP induction deficits can be observed in both the dentate gyrus and 
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CA1, but in different manners. In the dentate gyrus, larger amplitude current injection is 
required to elicit LTP at the perforant path–granule cell synapse of aged rats compared with 
young rats, indicating an increased threshold for LTP induction in these synapses (Barnes 
et al, 2000). Aged neurons in area CA1 do not have an increased threshold for LTP, but 
when peri-threshold stimulation parameters are used, the level of LTP induction in aged 
rats is less than in young rats (Rosenzweig et al, 1997). In addition, at CA1 synapses, there 
is also a reduction in the magnitude of LTP, which may be explained by less depolarization 
during induction and consequently less activation of NMDA receptors (Rosenzweig et al, 
1997).  
As for LTP maintenance, there appears to be no difference in LTP decay rates over the 
course of 1 h in aged and adult rats, assuming high-intensity stimulation parameters are 
used so that induction is equivalent across age groups. Over a much longer time scale, 
however, age-related maintenance deficits appear in both dentate gyrus (Barnes, 1979; 
Barnes and McNaughton, 1980) and CA3 (Dieguez and Barea-Rodriguez, 2004).  
4.3 Place cell physiology in aging 
Much work has been done in place cell physiology in aged rats, with different studies 
focusing on different aspects. Consistent with known age-related changes in hippocampal 
plasticity, there is a loss of rapid experience-dependent place field expansion in aged 
hippocampal CA1 paramidal cells (Shen et al, 1997). The lack of field broadening in old 
rats might therefore be expected to lead to a failure to link together the spatial components 
of a route. Deficits in this form of plasticity may contribute to the differences between age 
groups in the stability of map formation.  
As for spatial encoding, different studies have generated divergent views on the nature 
of age-related changes in spatial representation in the rat. In the first study, it was reported 
that the older animals had larger firing fields (Barnes et al, 1983). Subsequent studies, 
however, have not been able to replicate this change but have found that the field sizes of 
the aged animals were comparable or even more compact than those of the adult controls 
(e.g. Mizumori et al, 1996; Tanila et al, 1997). In contrast, all these studies report age-
related changes when hippocampal network (composed of place cells) properties are 
examined.  
For example, Wilson et al (2003) and Oler and Markus (1995) described place cells in 
aged rats as "rigid," in that they maintain the same spatial representation abnormally across 
multiple environments that share some cues. Barnes et al (1997) characterized place cells 
in aged rats as "multi-stable," that is, unpredictably switching among multiple spatial firing 
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patterns on repeated explorations of the same environment. Alternatively, Rosenzweig et al 
(2003) have characterized place cells in aged rats as delayed in anchoring spatial 
representations to salient external cues.  
Though contradictory at the first glance, all these descriptions can be explained by 
weakened control of external visual cues over hippocampal spatial representations in aged 
rats. Place fields in these rats may present as overly stable, unstable, or delayed in 
stabilizing to external stimuli under different experimental protocols. In a recent study, 
Wilson et al (2004) recorded place cell activity from aged and young rats as they 
repeatedly explored one familiar and one novel environment that differed in both geometry 
and visual landmarks. To test whether the place fields in the new environment were 
anchored to external visual cues, the authors occasionally rotated the arena frame and 
observed a course of place cell firing patterns that sequentially reflected each of the 
previous descriptions of age-associated abnormalities in spatial representation. They 
showed that while hippocampal neurons of young rats rapidly remapped in a novel 
environment, hippocampal spatial representations in aged rats abnormally maintained the 
spatial representation in the familiar environment, as reported by Tanila et al (1997), Oler 
and Markus (2000), and Wilson et al (2003). However, the rigidity between two distinct 
environments is temporary. Also, consistent with Rosenzweig et al (2003), place fields of 
aged rats were not initially controlled by the external cues. With additional experience, 
place fields of aged rats did rotate with the landmarks, demonstrating that the hippocampal 
spatial representations in aged rats were eventually bound to external cues. However, even 
after numerous repeated exposures, the hippocampal spatial representations of aged 
memory-impaired rats rotated with the landmarks on some but not all occasions and 
differed across experiences within the same environment, reflecting the characteristics of 
"multi-stability" described by Barnes et al (1997). 
Most of the studies mentioned above did not discriminate between CA3 and CA1 place 
cells. As discussed earlier, CA1 and CA3 place cells show distinct characteristics of 
information coding (Guzowski et al, 2004). This raises the question if aging specifically 
influences a particular subregion of the hippocampus. To answer this question, Wilson et al 
(2005) compared the spatial firing patterns of CA1 and CA3 neurons in aged memory-
impaired rats with those of young rats as they explored familiar and novel environments. 
They found that CA1 place cells in aged and young rats had similar firing characteristics in 
the familiar and novel environments. In contrast, aged CA3 place cells had higher firing 
rates and larger field size in general, and failed to change their firing rates and place fields 
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as much as CA3 cells of young rats when the rats were introduced to a novel environment. 
Thus, aged CA3 cells failed to distinguish change when new information was provided, 
which may underlie the age-associated behavioral impairment observed in spatial learning. 
The dissociation between CA3 and CA1 responses strongly implies that the aging effects 
on hippocampal physiology are not secondary to any more general deficit, such as sensory 
or perceptual impairments. Instead, they may stem from intrinsic properties of hippocampal 
subregions. Whether similar subregional specificity is also present in age-related diseases, 
such as Alzheimer’s disease, remains unclear.  
There is only one study investigating place cell physiology in aged mice. Unlike data 
from rats, Yan et al (2003) reported reduced spatial tuning and stability of hippocampal 
place cells in aged mice, which mainly resulted from significantly higher firing of place 
cells out of their place fields.  
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Chapter 6   Theories of Hippocampal Function 
 
 
“What does the hippocampus do?” has been a highly debated question in neuroscience. 
It is generally accepted that the hippocampus is important for spatial cognition in animals. 
Similarly, there is little doubt that the hippocampus is crucial for memory in humans. But 
what is the exact role of the hippocampus in these cognitive processes remains 
controversial. In this chapter, I will discuss some of the most influential theories on 
hippocampal function.  
 
1 The cognitive map theory 
As the first of several spatial theories of hippocampal function, the cognitive map 
theory stemed from the discovery of place cells by O’Keefe and Dostrovsky (1971). In this 
theory, O’Keefe and Nadel (1978) proposed that the hippocampus acted as a neural system 
that organized the encoding and representation of perceived stimuli with respect to an 
allocentric framework of absolute, unitary space, or a cognitive map. This framework is 
thought of as innate, and the underlying geometry of the system is Euclidean.  
O’Keefe and Nadel spelt out the differences between two major systems they believed 
could support spatial information and processing: a taxon and a locale system. Only the 
latter was instantiated by and depended upon the proper functioning of the hippocampus. 
The locale system automatically produces a map of an environment as soon as it is 
explored, and stores it indefinitely. The creation of the map is all-or-none, meaning that 
once a map for an environment exists, it is not modified. (References to changes in the 
environment could be added, but these do not affect the spatial structure of the map). The 
locale can ‘act at a distance’ allowing animals to move with reference to places they cannot 
perceive, for instance, taking shortcuts. By contrast, the non-hippocampal taxon navigation 
system is comprised of guidance and orientation strategies, and learns, incrementally, only 
those particular routes relevant to a given behavioural task. 
According to the theory, the hippocampus of rodents and other animals generates 
cognitive maps of all environments the organism encounters during its life. The map of 
each environment is composed of a set of place representations (entailed by the place fields 
of hippocampal pyramidal cells) connected together by rules that represent the distance and 
directions among them. Such maps are stored in the hippocampus and are used for spatial 
navigation. Moving from the animal sphere, O’Keefe and Nadel proposed that in humans 
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the hippocampus has come to provide the basis of episodic memory. A possible link 
between topographic and episodic memory is the existence of an allocentric cognitive map 
with the addition of verbal and temporal inputs. O’Keefe and Nadel have postulated that 
while the right hippocampus maintains a primarily spatial function, the left hippocampus 
might incorporatate a temporal sense and linguistic functions that together provide the 
basis for episodic memory and narratives.  
The theory was supported by features of hippocampal anatomy, correlates of the 
hippocampal EEG, behavioural studies of hippocampal lesioned animals and, primarily, by 
spatial correlates of single unit firing in the hippocampus. These cells were proposed to 
form the neural substrate of the cognitive map. Though the place cell literature described in 
a previous section seems to broadly support the cognitive map theory, some of the 
properties of the place cell system cannot be adequately explained on the basis of this 
theory alone. For example, the results of Lever et al (2002) cannot be easily accommodated 
by the cognitive map theory. This study showed that the changes that occurred in the 
hippocampal place representations of two geometrically distinct environments were 
incremental, not all or none and thus were unlike those predicted for the locale system by 
O’Keefe and Nadel. Moreover, the changes were observed at different times in different 
place cells, showing that the hippocampal cognitive map is not as unitary as originally 
thought (and see also the results by O’Keefe and Burgess, 1996). Another set of difficulties 
for the theory is that subjects, both rodents and humans, with hippocampal damage can 
sometimes acquire allocentric spatial information, though at a slower rate (Wise and 
Murray, 1999; Gaffan et al, 2000). However, this is not fatal to the theory because recent 
studies have established that effective spatial navigation can be achieved in many other 
ways (see below).  
 
2 The declarative theory 
This theory emphasizes the distinction between declarative memory and procedural 
memory (Cohen and Squire, 1980). The declarative theory claims that the primary function 
of the hippocampal formation is memory. Moreover, the hippocampal formation selectively 
mediates declarative memory and shows rapidity, flexibility, richness, and conscious 
accessibility. This account was based more on the human and clinical literature on amnesia, 
but virtually all hippocampal theorists predict continuity between animals and humans.  
One successful feature of this theory is its prediction about consolidation. Squire’s 
theory, based on the clinical literature on retrograde amnesia, has emphasized the idea that 
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hippocampal storage is time-limited and that neocortical areas gradually acquire memory 
traces stored in hippocampus. In essence, memories that used to depend on the 
hippocampal formation can become neocortical-dependent and hippocampal-independent. 
Two one-subject studies have shown intact remote spatial memory in patients with 
profound hippocampal damage (Teng and Squire, 1999; Rosenbaum et al, 2000). These 
two papers undermine the view that the hippocampus is required at all times to store and 
retrieve spatial memories. The current view is that the hippocampus initially binds together 
the distributed sites in neocortex that together represent the memory of a whole event 
(Zola-Morgan and Squire, 1990). This low-capacity, fast system permits the acquisition and 
storage of representations involving arbitrarily different elements, and for a period it 
provides a basis for retrieving the full representation, even when a partial cue is presented. 
As time passes, the burden of long-term memory storage is assumed fully by neocortex 
(however, see next section for slightly different views).  
As mentioned earlier, declarative memory can be sub-divided into episodic and 
semantic components. The declarative theory predicts that the medial temporal lobes are 
involved in both types of memory and that the extent of the memory impairment varies 
directly with the amount of tissue damaged. However, while it is generally accepted that 
episodic memory is severely impaired in amnesic patients and is dependent on the 
hippocampus in humans, the relationship between semantic memory and this brain region 
remains debated. Amnestic patients do have difficulty acquiring semantic knowledge but 
they can typically succeed to some extent after much repetition (Tulving et al, 1991). There 
has been considerable recent interest in the idea that the hippocampal formation is essential 
for episodic rather than all forms of declarative memory in humans. Recent work on three 
patients who sustained bilateral damage limited to the hippocampus early in life (Vargha-
Khadem et al. 1997) suggests that such damage results in memory deficits for episodes and 
events but not for semantic or other factual material. 
In the animal literature, the most used task to test declarative memory is the non-match 
to sample task with various delays. Other recognition memory tasks are also used. The vast 
majority of studies using restricted ibotenic acid lesions of hippocampus have failed to 
support a role for the hippocampus in non-match to sample tasks and recognition memory 
tasks (e.g. Jarrard, 1993; Mumby et al, 1996). Furthermore, Mumby et al, (1996) helped to 
explain previous recognition deficits associated with ischaemic hippocampal lesions (Zola-
Morgan and Squire, 1986; Zola-Morgan et al, 1992) by showing that ischaemic-induced 
hippocampal rats showed recognition memory deficits but when their hippocampi were 
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removed after ischaemia, their performance was unimpaired.   
 
3 Multiple trace theory  
In contrast to the declarative theory, Nadel and Moscovitch (1997) drew evidence from 
the animal literature, amnesic patients studies and neuroimaging studies in healthy subjects 
to support the opposite view that certain types of memories are encoded and permanently 
stored within the hippocampus. 
According to this theory, the hippocampus automatically encodes memories, acting as 
an index to the neocortex that represents the sensory cues and other features of the attended 
event (Teyler and DiScenna, 1986). Thus, in order to reactivate a memory one requires an 
intact hippocampus. When a memory is replayed, in a different temporo-spatial and neural 
context a new trace is laid down in the hippocampus. This means that over time, some 
memories get strengthened through rehearsal and are represented by several traces in the 
hippocampus, while some others are lost. Thus, the evidence of a graded retrograde 
amnesia that the consolidation theory holds onto to demonstrate that memories, once 
“mature”, are shuttled to the cortex, could be reinterpreted on the basis that partial 
hippocampal lesions could selectively spare well-rehearsed memories as opposed to more 
recent memories which are encoded in fewer hippocampal traces. 
Another important feature of the multiple trace theory is that the hippocampus is 
thought to be involved in the processing of only a subset of mnemonic material. For Nadel 
and Moscovitch the hippocampus is the seat of episodic memories and in particular of 
autobiographical episodic material, whereas more semantic materials, like factual 
knowledge about the world and the self might become, over time, hippocampally-
independent.  
In support of Nadel and Moscovitch’s views, several neuroimaging studies in healthy 
subjects have showed that activation of the hippocampus is as robust when remote 
memories are being retrieved as when recent memories are retrieved (Ryan et al 2001; 
Maguire, 2001). These findings speak in favour of a permanent hippocampal role in 
memory retrieval. Studies on amnesic patients and animals also support this theory, given 
that the retrograde amnesia for autobiographical events (or spatial tasks in animals), when 
tested, extends over very long periods of the subjects’ life (30 years or over), and it shows, 
in general, a rather flat gradient (the deficit being similar in intensity at all time periods 
considered), while semantic information (or non-spatial tasks in animals) is generally more 
mildly affected and shows a more graded retrograde amnesia (Salmon et al, 1985; Zola-
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Morgan and Squire, 1990; Clark et al, 2005).  
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Chapter 7   Aims and Design of the Present Study 
 
 
After a detailed review of the background information, this chapter outlines the aims, 
design and predictions of results of the present study.  
 
1 Rationale and aims of the present study 
In summary, the unique anatomical and physiological position of the hippocampus in 
the brain endows this brain region with higher susceptibility to diseases characterized of 
neuroplasticity failure and cognitive impairments, such as AD. Accumulating evidence 
suggests that AD represents an Aβ-induced synaptic failure. Yet how these molecular and 
cellular changes induce cognitive impairments at the behavioural level remains largely 
unknown. The hippocampal place cell is a well understood model for studying spatial 
cognition in animals. It has been repeatedly shown that pharmacological and genetical 
manipulations that disrupt hippocampal neuroplasticity are always accompanied by place 
cell and behavioural deficits (chapter 5). However, there have been no reports of place cell 
physiology in AD. 
Based on the evidence presented in previous chapters, I hypothesize that place cells in 
aged transgenic mice of AD could not encode and process spatial information as well as 
those in control animals. In other words, these animals showed degraded neuronal 
representations of the environment. Such deficits may result from synaptic dysfunction 
caused by soluble Aβ or amyloid plaques in the brains of the subjects. As a result, a normal 
“cognitive map” cannot be formed in these animals, which underlies the neural basis of 
spatial cognition deficits in this disorder. In this way, the hippocampal network deficit 
provides the linkage between molecular and behavioural changes in AD.  
The aim of the present project is to test this hypothesis.  
 
2 Design of the present study 
2.1 General design 
To test this hypothesis, I train young and aged AD mice and their littermate controls in 
the forced T-maze alternation task, to examine their spatial working memory ability. After 
they acquired the task, these subjects are implanted for place cell recording. Once place 
cell activities are detected, behavioural training resumes with various delays to provide a 
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better test for their memory. Meanwhile, place cells are recorded in the same subjects, to 
examine their place cell representation of the space. During this period, a simple 
environmental manipulation – a 180
o
 maze rotation – is introduced between sample and 
test trials of the task, to examine place cells’ physiological as well as the animals’ 
behavioural responses to this change. Finally, after all experiments are finished, the animals 
are sacrificed to examine the pathology of their brains. When all these data are obtained, 
statistical analysis is performed among behaviour (spatial memory task performance), 
physiology (place cell ability to encode spatial information), and pathology (cortical and 
hippocampal load of amyloid plaques or soluble Aβ) for possible correlations.  
2.2 Choice of subjects 
The tg2576 model is selected to be the subject of the present study, because it is one of 
the first successful models of AD and has been well characterized behaviourally, 
physiologically and pathologically in the past ten years. These animals develop age-
dependent amyloid pathology, synaptic dysfunction and cognitive impairments (chapter 3). 
One disadvantage of this model is that these animals do not show all the pathological 
changes in AD, eg, they do not have NFTs or neuronal death in their brains (chapter 3). 
However, this drawback makes it easier to analyze the molecular correlates, if any, of the 
potential physiological changes in these subjects. By the time this thesis is submitted, 
several double or triple models of AD have been developed, which show NFTs and 
neuronal death as in AD patients. These models may serve as appropriate subjects for 
further research in this area.  
In the present study, two age ranges of the animals are selected: 3-5 months and >13 
months. It may be argued that investigation on middle-aged animals provides more 
important information about the pathogenesis of AD, especially at its earliest stages. 
However, since no place cell recording has ever been performed in AD models, I am not 
sure whether there are any changes in place cell properties in these animals. For this reason, 
more aged animals that show more severe pathological and behavioural deficits are 
selected for the present study.  
2.3 Choice of behavioural task 
The forced T-maze alternation task is selected for the present study because it has 
several advantages over other tasks. Firstly, this task has been shown to be very sensitive to 
hippocampal damages in the rodent (Burton et al, 2000). At the same time, performance 
deficits of aged tg2576 mice in this task have already been reported by several groups 
(Chapman et al, 1999; Corcoran et al, 2002; Barnes et al, 2004). Secondly, delays, long or 
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short, can be easily introduced into the task to increase its difficulty, enabling a better 
evaluation of memory in these animals. Thirdly, one advantage of spatial working memory 
tasks over reference tasks is that the same task can be used over weeks or months, to 
monitor the longitudinal changes of cognitive abilities in the same subject. Finally, this dry-
land task enables simultaneous place cell recording.  
2.4 Procedures considered but not performed 
Given that this is the first attempt to study place cell physiology in a transgenic model 
of AD, a number of other potentially interesting experiments have been considered. 
However, these procedures have not been carried out, due to (1) shortness of space and 
manpower: all the experiments have to be performed in the same environment in the same 
room, whereas training and recording trials with long delays are extremely time-consuming; 
and (2) technical difficulties: long-term place cell recording in mice is quite difficult 
compared with rats. According to experience in our laboratory, mouse place cells tend to 
decrease or even stop firing after 4-5 hours’ continuous recording within a day. Moreover, 
it is very difficult to perform long-term place cell recording from one mouse for more than 
5-6 days, because of tetrode movements or cell death. Even across days, the clusters might 
change dramatically. These problems could result from the relatively unstable construction 
of mouse microdrives and the small size of mouse brains.  
More training in longer-delay trials 
It has been suggested that performance in long-delay trials of spatial working memory 
tasks provides more specific evaluation of hippocampal function than short-delay trials 
(Lee and Kesner, 2003). However, as mentioned earlier, training of long-delay trials was 
extremely time-consuming and such a design was not practicable.  
Recording in the T-maze 
Wood et al (2000) suggests that rat place cells may remap depending on the subject’s 
future actions even at the same spatial location. An intriguing inference from this study is 
that by recording place cells at the stem arm of the T-maze, one may be able to predict the 
subject’s intended arm choice. However, such a proposal could not be tested, because 
single runs in the T-maze would not provide enough sampling for clear identification of 
place fields.  
Other environmental manipulations 
Environmental manipulations are the best way to study place cell activities in animals. 
In the present study, a simple maze rotation has been applied. Many other procedures, such 
as those discussed in section 3.6, chapter 5, would undoubtedly provide more information 
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about hippocampal network dynamics in transgenic animals. However, for time and 
technical difficulties, these interesting manipulations could not be performed in the present 
study, but represent intriguing ideas for future work.  
Long-term place cell stability 
It has been shown that aging affects long-term stability of place fields, eg over days 
(Yan et al, 2003). Such analysis was not performed due to technical difficulties (unstable 
clusters in mice across days).  
 
3 Predictions of results 
If the above hypothesis were correct, the following results would be expected.  
Behaviourally, transgenic animals should show an age-dependent impairment in the T-
maze alternation task, as repeatedly shown from previous studies (Chapman et al, 1999; 
Corcoran et al, 2002; Barnes et al, 2004). In addition, longer delays introduced between 
sample and test trials should equally affect performance of transgenic and control animals 
(Barnes et al, 2004).   
Pathologically, transgenic animals should develop age-dependent changes in their 
brains, especially in the hippocampus, including amyloid plaques and soluble Aβ, as 
repeated shown from previous studies (Hsiao et al, 1996; Irizarry et al, 1997; Chapman et 
al, 1999; Corcoran et al, 2002; Westerman et al, 2002).  
Physiologically, place cells in aged but not young transgenic animals should show 
deficits in encoding spatial information about the environment, as the result of severe brain 
pathology and synaptic dysfunction. For example, field sizes of these cells should be bigger 
than those of control animals, whereas spatial information content lower, suggesting 
degraded place cell representation of space in these animals. When the 180
o
 maze rotation 
was introduced, place cells in transgenic mice might also respond differently compared 
with controls. External cues might exert weakened control over place cells in aged 
transgenic animals, as inferred from previous studies on aged rats, though the exact change 
would be difficult to predict. But the behavioural response should be consistent with the 
physiological response, which could be deducted from the animal’s performance change in 
the task.  
Finally, when behavioural, physiological and pathological data were combined, 
correlations were expected between each pair of them.  
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Methods 
 
Chapter 8   Materials and Methods 
 
 
This chapter describes the materials and experiment procedures in the present study. 
The experimenter was blind to all experiment procedures, including animal training, 
surgery, place cell recording, cluster cutting, quantitative analysis of place cell properties, 
and histology.  
 
1 Subjects 
The subjects studied were APP695SWE transgenic (tg2576) mice in a SJL background 
backcrossed to C57/BL6, obtained from Merck Sharp and Dohme (Harlow). The founder 
of the tg2576 line was a C57Bl/6jxSJL F3, which was subsequently crossed twice into 
C57Bl/6j. Subsequent generations were then crossed to C57Bl/6jxSJL F1. Thus, in all 
cases, the average contribution of C57Bl/6j ranged from 59% to 88%, with the remainder 
from SJL (Chapman et al, 1999). On each individual test, transgenic mice were always 
compared to age- and background-matched littermate controls. Four groups were included: 
young (3-5 months) control and transgenic groups, and aged (15-17 months) control and 
transgenic groups.  
All subjects were singly housed in Perspex cages, and maintained on a 12/12 hour 
light/dark schedule, with lights off at 6 pm. Mice were weighed daily, and maintained at 
about 90% and no lower than 85% of their free feeding weight during training and 
recording. All experiments were carried out blind to genotype and in accordance with the 
UK Animals (Scientific Procedures) Act 1986.  
 
2 Apparatus and laboratory layout 
The start box (30 * 30 * 30 cm) with a removable door (6 cm wide) in one side of its 
walls, and two identical T-mazes (length of stem and choice arms = 45 and 35 cm 
respectively, width = 7 cm, height = 10 cm) were all built from wood and painted grey.  
All the experiments were conducted in the same environment enclosed by black 
curtains (diameter = 2 m) with 4 distinct cardboards as distal visual cues, as shown in 
Figure 8.1.  
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Figure 8.1  Plan view of laboratory, showing general setup of the recording environment. All 
training and recording sessions take place within the curtained environment with four distinct 
cue cards. At other times, the mouse is placed on the holding platform. A light is hung above 
the cue card in the west side to illuminate the environment. 
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3 Experiment 1: T-maze alternation task acquisition 
A total of 62 animals were trained on the T-maze forced alternation task. Animals were 
assigned to 4 groups on the basis of age and genotype: young control (n = 15; mean age = 
2.5 months, range 1.9-3.2 months), young tg2576 (n = 16; mean age = 2.7 months, range 
1.9-3.2 months), aged control (n = 13; mean age = 15.4 months, range 13.4-16.4 months) 
and aged tg2576 (n = 18; mean age = 15.4 months, range 13.5-16.8 months).  
For behavioural testing, mice ran from a start box for reward (condensed milk) on a 
forced alternation task in a T-maze as previously described (Chapman et al, 1999; 
Corcoran et al, 2002; Figure 8.2). After 5 days of habituation to the apparatus (for each 
day, 2 min in the starting box, 3 min in the maze and another 5 min in the whole apparatus) 
and food, each mouse was given 6 pairs of training trials per day for 12 days. On the first 
(sample) trial of each pair, the animal was forced to choose one of the choice arms of the 
T-maze (the other was blocked by a removable door) and received food reward at the end. 
10-15 seconds after consuming the reward, the mouse was returned by the experimenter to 
the start box and confined there for 15 seconds, while the T-maze was replaced with 
another identical one to eliminate intramaze cues. The animal was then given a free choice 
between both T arms and only rewarded for choosing the ‘novel’ arm not entered on the 
first trial. The choice was made when the whole body of the mouse passed 1/3 of the length 
of either choice arm. The location of the sample arm (left or right) was varied 
pseudorandomly across trials so that mice received equal numbers of left and right 
presentations on each day, but no more than two consecutive trials with the same sample 
location. Mice were run in squads of 5-7 to minimize variation in intertrial interval, which 
was about 12 minutes for all animals.  
 
4 Microdrive construction, surgery and screening 
2-3 days after task acquisition, a subset of animals (due to environmental and 
manpower restrictions) underwent implantation of microelectrodes for chronic 
hippocampal recording (young control, n=6; young tg2576, n=7; aged control, n=10; aged 
tg2576, n=15). Dr Francesca Cacucci helped perform about half of the surgery and 
screening work.  
Figure 8.2
Figure 8.2  The T-maze alternation task. On the first trial (sample trial, phase 2), a mouse is 
forced to choose one of the choice arms of the T-maze and receives food reward at the end. 
After consuming the reward, the mouse is returned by the experimenter to the start box. After  
a delay (phase 3), the animal is then given a free choice (test trial, phase 4) between both T 
arms and only rewarded for choosing the ‘novel’ arm not entered on the first trial. Place cell 
recording takes place in phases 1 and 3. 
Pre-Sample
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4.1 Electrodes and microdrives 
The electrodes were made from microwire (90% platinum, 10% iridium, HM-L 
insulated), 17µm in diameter (California Fine Wire). All electrodes used were tetrodes, 
constructed by twisting four individual pieces of wire together.  
Electrodes were loaded into a moveable 16-channel microdrive (4 tetrodes).  Figure 8.3 
shows a diagram of the standard microdrive. Part of the microdrive, consisting of the two 
metal posts, is stationary with respect to the brain of the animal. This structure is attached 
to the head of the animal using dental cement. One of the posts (right hand side in Figure 
8.3) carries a fine-threaded screw. Fitted over this screw is a nut (consisting of heat shrink 
plastic), attached to which, via dental cement, is the electrode cannula. When the screw 
turner (right top, Figure 8.3) is used to rotate the threaded post, the portion of the 
microdrive attached to the nut, including the electrodes, moves up or down. One 360º turn 
moves the electrodes 250 µm.  
The ends of the tetrode wires were stripped of insulation (exposure to naked flame), 
wrapped around microdrive wires, and the junction sealed with conductive silver paint.  
4.2 Surgery 
In surgery, a mouse was first anaesthetised as follows: oxygen at 3 litres per minute, 
with isoflurane at 3% of the gas volume. The animal’s head was then shaved using electric 
clippers. Before the animal was fitted with the ear bars, nitrous oxide was introduced at 3 
litres per minute, and the oxygen flow was reduced to 1.5 litres per minute. At this point, 
analgesic [Buprenorphine (Vetergesic), 45 µg, i.m.] and prophylactic antibiotic 
[Enrofloxacin (Baytril), 2.5mg, s.c.] were administered. The percentage of isofluorane was 
gradually decreased throughout surgery, stabilising at 0.5 to 1.2 %. Once the animal was 
stably anaesthetised, it was fitted with ear bars and mounted in the stereotaxic frame.  
The skull was exposed and the mouse’s head adjusted so that the upper surface of the 
skull was parallel to the base plate of the stereotaxic frame. Six holes for screws were 
drilled using a 0.9 mm burr drill. Two holes were drilled over the occipital, two over the 
frontal bone, and two over the parietal bone contra-laterally to the implant side. Stainless 
steel screws were screwed into each hole for structural support. One screw served as the 
ground attachment for unit recording.  
A hole 1.5 mm in diameter was made over the left hemisphere (2.0 mm posterior and 
2.0 mm lateral to bregma, targeting the CA1 area). The microdrive-tetrode assembly was 
then stereotaxically positioned with the electrode tip at the target coordinates, and then 
lowered so that the electrodes were placed at the initial depth below the pial surface of the 
Figure 8.3
Figure 8.3  Microdrive construction. Diagram showing the main features of the microdrive. 
Microdrive is fixed with respect to the skull surface, using dental cement (not shown). 
Turning the screw-turner causes the cannula to move up and down relative to the main screw. 
The cannula was loaded with up to four tetrodes. 0.5 mm solid-core steel wire, mounted in 
dental cement, carried the signal between the tetrodes and the headstage connection (not 
shown). 
Original version of this drawing by John Huxter. 
FRAME
DENTAL 
CEMENT
SCREW-TURNER
CANNULA
MAIN SCREW
SLEEVE
SKULL SURFACE
ELECTRODES
HEAT SHRINK NUT
ELECTRODES
 114
brain (0.4-0.6 mm) . The sleeve around the electrode cannula was then lowered so that its 
lower surface rested on the brain surface. The exposed brain around the sleeve was covered 
with sterile vaseline. The tetrode-microdrive assembly was then fixed to the skull by 
applying dental cement around the sleeve, the feet of the microdrive, the screws and the 
skull.  
4.3 Screening 
5-7 days after surgery, screening for cell activity began. Screening took place while the 
mouse was on the holding platform (Figure 8.1). The main physiological marker used for 
the hippocampus was the high-frequency “ripples” state, seen when the animal is still and 
at low arousal levels (see chapter 5). The electrodes were slowly moved down towards CA 
in multiples of 62.5 µm steps until signs of low amplitude ripples were seen. When ripples 
were seen, the electrodes were moved down in 32 µm steps, until complex spike activity 
was detected.  
 
5 Experiment 2: Delayed T-maze alternation task and place cell 
recording 
Given environmental, time and manpower restrictions of the laboratory, no more than 
two animals were trained and recorded simultaneously at this stage. In total, 42 subjects 
have been included in this phase of experiment (9 young control, 6 young tg2576, 13 aged 
control and 14 aged tg2576 animals). 
5.1 Standard trials and recording 
Once place cell activity was detected, the mouse was further trained in the T-maze 
alternation task. On each training day, there were 4 pairs of trials with 15 sec delay 
(identical to the task acquisition phase), followed by 6 pairs of longer-delay trials (2min for 
the first 2 days and 6min for the next 3 days). Place cell activities were recorded during 
these longer-delay trials, prior to the sample trials (6 min) while animals navigated in the 
start box. Small chocolate flakes were used to encourage exploration of the box when 
necessary.  
5.2 Probe trials and recording 
In the next 3 days, animals were trained in both standard trials as above, and probe 
trials when the start box and the T-maze were rotated 180
o
 between sample and test trials 
(Figure 8.4), to examine the hippocampal network dynamics in response to environmental 
changes. The animal first received the sample trial and returned to the start box as normal. 
Then the whole apparatus (the start box and the T-maze) was rotated manually 180
o
 on a 
NFigure 8.4  Plan view of the experimental environment in probe trials. In standard trials, the 
start box and the T-maze remain fixed through the whole trial (A). In probe trials, the start box 
and the T-maze are rotated 180 degree after the sample run, whereas the distal cue cards remain 
unchanged (B). The experimenter always sits in the east side of the environment. 
Figure 8.4
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swivel platform. The whole rotation procedure took around 3 seconds (the animal was able 
to perceive this manipulation). Then came the delay period of 2 min and the test trial. Place 
cell recording was performed both before sample trials (6min) and before test trials during 
the delay period (2min). Within these 3 days, each animal received 10 trials under standard 
condition and 10 with maze rotation. These two types of trials were pseudorandomly mixed 
up so that no more than 2 consecutive trials were the same type. In probe trials, the 
opposite arm in the environment (that was, the same arm in the maze) was taken as the 
correct choice.  
5.3 Distal cue rotation recording 
By the end of all training and recording procedures, a small proportion of subjects were 
tested for their visual ability (young control: n=3; young tg2576: n=1; aged control: n=4; 
aged tg2576: n=3). Each animal received three 10 min recording session in a white 
cylinder (d = 50cm; h = 50cm) with black floor. In the first and last sessions, the distal cues 
in the curtain-enclosed environment remained the same as before. In the second session, 
however, these cues were rotated 180
o
 consistently. These sessions were separated by 20 
min intervals, when the floor was cleaned with soap to eliminate local odour cues.   
5.4 Unit recording and data acquisition 
Unit recording apparatus 
During recording sessions, each mouse was connected to the recording equipment via a 
headstage amplifier fitted onto the plug of the microdrive. These amplifiers and cables 
were light in weight and animals could move around freely with them without showing any 
aversive activities. These headstage amplifiers were unity-gain buffers, which served to 
isolate the electrodes from the wires carrying their signals to the recording system. The 
implanted electrodes were AC-coupled to these amplifiers. Lightweight hearing-aid wires 2 
to 3 metres in length connected the headstage to a preamplifier (gain 1000).  
Signals were amplified (15-50 thousand times) and bandpass filtered (500 Hz-7 kHz). 
The signals were recorded differentially, meaning that a reference signal (a channel on a 
different tetrode) was subtracted from the target signal. This technique is designed to 
remove noise and artifact from the signal. Each channel was continuously monitored at 20-
µs intervals and potentials were captured using 50 time sample points (200 µs pre-threshold 
and 800 µs post-threshold) whenever the signal from any of the pre-specified recording 
channels exceeded a given threshold set by the experimenter. 
 Two infrared light-emitting diodes (LEDs) were attached to the mouse, in order to 
track head position and orientation with a video camera (position sampling rate 46.875 Hz). 
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The two LEDs were separated by 4 cm and identified on the basis of their differential 
brightness. All unit recording apparatus was custom built (O’Keefe lab, Axona). 
Cluster cutting 
Isolation of single units from multi-unit data (cluster cutting) is based on the premise 
that an action potential from an individual cell will be recorded on more than one wire of 
the tetrode. As the amplitude of the signal decreases in proportion with 1/(distance from 
neuron)
2
, the amplitudes of the action potential on the four wires of the tetrode depend on 
their position with respect to the cell. A set of action potentials with the same set of 
amplitudes is assumed to originate from one neuron. 
For all the data used in this thesis cluster cutting was performed manually, blind to 
genotype, using custom software (TINT, Neil Burgess). A series of scatter plots are 
created, plotting peak-to-trough amplitudes for all action potentials. The series contains all 
possible combinations of comparison. (Six scatter plots for four amplitude values). A set of 
action potentials that share the same amplitude profile should form a coherent “cluster” on 
every one of the scatter plots. In order to reduce error, only clusters well separated from 
other action potentials in 4-D amplitude space are considered. Although cluster cutting is 
conducted mainly on the basis of Peak-to-Trough amplitude, other parameters used include 
voltage at an arbitrary time, time-of-peak and time-of-trough.  
5.5 Quantitative analysis of place fields 
Cell inclusion criteria 
Only CA1 place cells (confirmed by histology) were included in the present study. 
Cells were included in the analysis if they had: a) spike width > 300 µs and b) peak firing 
rate > 1 Hz (Cacucci et al, 2007).  
Each subject received place cell recording for a maximum of 8 days. On each day, each 
place cell was included for property analysis in the last trial that it reached the above 
criteria. Some cells fired in more than 1 day during recording. These cells were double 
counted across days in the analysis.  
Derivation of place fields 
There is no standard protocol used to construct and present place fields. The procedures 
used in this thesis and described below follow, very closely, the protocols used recently in 
the O’Keefe laboratory (O’Keefe and Burgess, 1996; Lever et al, 2002). The software used 
is the previously mentioned TINT program (written by Neil Burgess).  
Within the viewing area of the camera, it is possible to create an experimenter-defined 
co-ordinate frame, which was always set to 500 x 500 pixels. The environment was always 
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placed in a standard position with respect to this frame. One pixel in the firing rate maps 
therefore always represented 2.5 mm
2
 of space on the floor of the recording environment. 
In order to construct firing rate maps, the raw pixel data were first binned. For a given 
bin, the number of spikes of each cell in that bin is divided by the rat’s dwell time in that 
bin, to give a firing rate for each cell in that bin. However, following previous work 
(O’Keefe and Burgess, 1996), rather than display the data bin-by-bin, a box-car averaging, 
or ‘smoothing’, is applied to the map. This is in order to compensate for the poor sampling 
of places that sometimes occurs during recording. When smoothing is applied, the rate of a 
particular bin is derived from the total number of spikes fired in that bin and surrounding 
bins, divided by the total dwell time in that bin and the same surrounding bins. The number 
of surrounding bins used is determined by the ‘level’ of smoothing. The level used in this 
thesis is 5 in the TINT program. Smoothing level 5 means that for each bin, a larger square 
with 5-bin-long sides, whose center is the current bin, is used to smooth the rate of that bin. 
This smoothing is applied to every bin in the environment, ie. the larger, 25-bin-in-area, 
smoothing squares are overlapping. Only visited bins are considered during smoothing, 
therefore at the edge of the environment, less than 25 bins would be used. 
The firing rate in each bin was mapped as a colour or grey-scale plot. The 5 colours or 
shades were autoscaled so that each represented 20% of the peak rate. In descending order, 
bins with the highest rates were shown in red, then yellow, then green, then light blue, then 
dark blue for the lowest rates. A white bin represented an area that is unvisited. Place field 
size represented the percentage of sampled environment in which the cell’s firing rate was 
greater than the overall mean firing rate during that trial.  
Autocorrelograms 
The auto-correlation function of a spike train gives the frequency of occurrence of a 
pair of spikes separated by a time τ. 
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The autocorrelogram is a histogram formed by dividing the range of τ into equal bins 
centred on τi and counting the number of spikes whose temporal separation falls into each 
bin, and it can be thought of as an approximation of φ(t). The autocorrelogram is then 
normalised by the number of pairs of spikes observed during the trial to give the 
probability density function for the time between the spikes.  
Waveform analysis 
During recording, whenever the voltage exceeds an experimenter-set threshold value, a 
1-ms long signal trace is recorded. This 1-ms long trace encompasses 200 µs before and 
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800 µs after the time the threshold was crossed. For each cell isolated (see cluster cutting) a 
representative waveform is constructed by averaging the traces of all the spikes collected 
for that given cell. For this averaged waveform, two parameters are measured: (1) spike 
width: measured as the time interval between the peak and trough of the 1ms-long 
waveform; and (2) spike amplitude: measured as the voltage difference between the peak 
and trough of the waveform. 
Information measures 
Spatial information was a measure of the extent to which the cell’s firing could be used 
to predict the position of the animal (Skaggs et al., 1993). It was computed using the spatial 
information measure introduced by Skaggs et al (1993). They measured the amount of 
spatial information carried by each spike the cell fired, expressing it in bits per spike. 
Briefly the estimate of the rate of information I(R|X) between firing rate R and location 
X proposed by Skaggs et al (1993) is: 
   ∑ 




≈
i
i
ii
F
xf
xfxpXRI
)(
log)()()|( 2
r
rr
  
where 
)( ixp
r
 is the probability for the rat being at location i
x
r
 , 
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is the firing rate 
observed at i
x
r
, and F is the overall firing rate of the cell.  
There is an intrinsic problem with the estimation of the spatial information carried by 
each spike the cell fires: the data acquired is strongly under-sampled, and we generally can 
only produce an estimate of the firing rate of the cell in any given bin (estimated here 
as
)( ixf
r
, the mean firing rate observed at bin i
x
r
). There is not enough data to properly 
estimate the reliability of the observed
)( ixf
r
.  The Burgess information measure is an 
attempt at tackling this problem, by assuming that the probability distribution of firing rate 
in bin i
x
r
 follows a Poisson distribution with its mean equal to the observed rate 
)( ixf
r
. 
Field stability and correlation analysis 
To study place field stability between pre-sample and delay recording sessions in 
standard probe trials, a smoothed locational firing rate map was generated for each session. 
Maps from these two sessions were compared using a bin-by-bin correlation. Bins in which 
the rate was zero in both maps were discarded, to avoid artifactually inflating the 
correlation values resulting from many zero-zero bin correlations. The resulting correlation 
coefficient (Pearson’s r) served as a measure of the similarity of the maps. 
To examine place cells’ responses in rotation trials, two methods had been tried. First, 
for each pair of recording sessions, bin-by-bin correlations were obtained between the pre-
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sample map and the delay map unchanged (0
o
) or 180
o
 rotated. If the place field followed 
local cues (the box), the 180
o
 rotated map should show a high correlation with the pre-
sample map. If the field followed distal cues, a high correlation was expected for the 0
o
 
map. However, since this method did not work well (for details see next chapter), a second 
method was used. For each pair of recording sessions, the rate map of the delay session 
was rotated every 5
o
 to find the angle that showed the highest bin-to-bin correlation with 
that of the pre-sample session. Under standard condition, this angle would be close to 0
o
, 
given that place fields remained stable in the same environment. In rotation trials, however, 
the angle would be close to 0
o
 if the map fixed to the environment, close to 180
o
 if the map 
fixed to the start box, and random (0-180
o
) if all cells remapped.  
 
6 Histology 
After the completion of all experiments, each mouse was killed with an overdose of 
sodium pentobarbital (Euthatal; 50 mg). The brain was extracted and hemisected sagitally. 
The implanted hemisphere (left) was stored in 4% paraformaldehyde (PFA) with 0.1 M 
phosphate-buffered saline (PBS, pH 7.6) at 4
o
C, whereas the other hemisphere (right) was 
quickly frozen in dry ice and stored at -80
o
C.  
The following histological procedures were performed by our cooperators from Merck 
Sharp and Dohme (Harlow). Some analysis was performed with the aid of Dr Francesca 
Cacucci.  
6.1 Measuring amyloid plaque deposition 
The implanted hemi-brains were embedded in paraffin, sliced coronally on a 
microtome at 7µm, and mounted on gelatin-coated slides. Some of the slides were stained 
with cresyl violet, for tetrode localisation, whereas the others were used to measure 
amyloid plaque deposition.  
Plaques were identified with Congo red staining. For each hemi-brain, amyloid plaque 
quantification was assessed using a total of 10 coronal sections through the hippocampus 
(sections were spaced 280µm apart). Brain sections were routinely deparaffinized, 
incubated in alkaline sodium chloride solution (2.5 mM NaOH in 80% ethanol) for 20 min 
and then stained with alkaline Congo red solution (0.2% in 80% ethanol saturated with 
sodium chloride; Sigma), washed three times in absolute ethanol and coverslipped with 
DPX. Congo red positive Aβ plaques were visualised with a Leica DMLB microscope 
(with a total x100 magnification factor), and images captured using a DC300F Leica 
camera. Quantitative image analysis was performed using Image J as the image analysis 
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system. The software uses red, green and blue (RGB) levels to segment objects in the 
image field. Segmentation thresholds were established using a series of standard slides that 
have extremes of intensity and remained constant throughout the analysis. Hippocampal 
and cortical measurements were performed by manually circumscribing the areas of 
interest. Hippocampal measurements refer to an area encompassing all hippocampal fields 
(CA1, CA3 and dentate gyrus), while cortical measurements refer to the neocortical areas 
overlying the hippocampus, including the retrosplenial cortex, the frontal cortex, the 
hindlimb area of cortex, the parietal cortex, the temporal cortex and the occipital cortex. 
6.2 β-amyloid concentration assessment 
Hemibrains contralateral to electrode implantation were immediately frozen on dry iced 
and stored at -80
o
C until use. The concentrations of soluble and total amyloid in the brain 
were assessed using a standard sandwich enzyme-linked immunosorbent assay (ELISA). 
Soluble β-amyloid concentration  
The frozen hemibrains were homogenized in 10 volumes (wt/v) of 0.2% DEA 
containing 50 mM NaCl, pH 10, and protease inhibitors (Complete; Roche Diagnostics, 
Mannheim, Germany) and then centrifuged at 355,000g at 4°C for 30 min (Optima MAX 
ultracentrifuge; Beckman Coulter Fullerton, CA). The resulting supernatant was retained as 
the soluble fraction and neutralized by addition of 10% 0.5 M Tris-HCl, pH 6.8. Samples 
were frozen at -80°C awaiting analysis by immunoassay. 
Total β-amyloid concentration 
The protocol used for extraction of total amyloid from the brain sections is based on the 
GnHCl extraction method described previously (based on Johnson-Wood et al, 1997). The 
hemibrains were homogenized in 10 volumes of 5 M GnHCl, 50 mM HEPES, pH 7.3, 5 
mM EDTA plus 1X EDTA-free protease inhibitor cocktail (Complete). After mixing at 
room temperature for 3 h, the homogenate was diluted 10-fold into ice-cold 25 mM 
HEPES, pH 7.3, 1 mM EDTA, 0.1% bovine serum albumin plus 1X protease inhibitor 
cocktail and centrifuged at 16,000g for 20 min at 4°C. Aliquots of supernatant were stored 
at -80°C to prevent degradation.  
Immunoassay analysis 
The biotinylated antibody 4G8 was used in combination with the monoclonal 
antibodies G2-10 or G2-11 for detection of A  (40) or A  (42), respectively. These  
species reflect subpopulations of peptides with heterogeneous N termini encompassing at 
least the 4G8 epitope at residues 17 to 24. Analysis of the samples was performed using the 
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SECTOR Imager 6000 (Meso Scale Discovery, Gaithersburg, MD), as described 
previously (Best et al, 2005).  
( * According to the discussion in chapter 3, hippocampal soluble Aβ, especially Aβ 
oligomers, is the most promising candidate for the physiological changes in the tg2576 
mice. But this analysis was not performed because (1) the importance of soluble Aβ had 
not been fully recognized by the time the present project started; and (2) Merck Sharp & 
Dohme, who helped perform histology, experienced some difficulty in isolating the 
hippocampus from the first group of brain samples. ) 
 
7 Data analysis 
All statistical analysis was performed using SPSS version 11.5.  
  
 122
Results 
 
Chapter 9   Results 
 
 
This chapter shows the findings from the experiments described in the previous chapter.  
 
1 General characterization 
Transgenic mice were comparable with their littermate controls regarding general 
appearance, body weight and survival rate (data not shown). However, it was noticed that 
tg2576 mice showed greater homecage activities than wild-type mice, especially in aged 
animals. This was consistent with earlier report that tg2576 mice exhibited disinhibitory 
tendencies, which possibly resulted from the disruption of normal cholinergic function and 
plaque loads (Ognibene et al, 2005). 
 
2 Behavioural testing 
2.1 T-maze alternation task acquisition 
A total of 62 subjects have been included in this experiment (15 young control, 16 
young tg2576, 13 aged control and 18 aged tg2576 animals). After 12 days of training, 
every 3 days’ data were grouped into 1 training block (4 training blocks all together; Figure 
9.1A). A mixed design ANOVA revealed significant effects of training blocks [F(3, 174) = 
32.47, p < 0.001], indicating overall improvement after training, genotype [F(1, 58) = 
16.26, p < 0.001] and age [F(1, 58) = 5.32, p = 0.025], indicating performance impairments 
caused by the transgene and aging. There was also a significant effect of blocks by 
genotype by age [F(3, 174) = 3.23, p = 0.024]. Further analysis indicated a performance 
difference between aged tg and aged control animals [F(1, 29) = 11.60, p = 0.002], and 
significantly worse performance of aged tg animals on the third [F(1, 29) = 8.37, p = 0.007] 
and final [F(1, 29) = 11.71, p = 0.002] blocks, indicating that aged transgenic mice 
performed much worse than aged control animals after training. This performance deficit 
was underscored by the observation that only 39% of aged transgenic mice reached the 
learning criterion in 12 days of training (>80% alternation rate for 3 or more consecutive 
days), compared with more than 69% of the other three groups [χ2(3) = 10.67, p = 0.014, 
Figure 9.1B]. In addition, there was a performance difference between young tg and young 
Figure 9.1
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Figure 9.1  Performance in the T-maze alternation task. (A) Acquisition of the T-maze alternation 
task (15-secs delay version) was selectively impaired in aged transgenic animals [training blocks 
x age x genotype: F(3,174) = 3.23, p = 0.024]. Each block consisted of 3 training days (6 
trials/day).  (B) Only 37% of aged transgenic mice reached the learning criterion in 12 days of 
training (>80% alternation rate for 3 or more consecutive days), in contrast to > 70% of aged 
non-transgenic littermates and both transgenic and non-transgenic young mice [ (3) = 10.67, p 
= 0.014]. (C) Overall performance on the T-maze task decreased with increasing delay [effect of 
delay: F(2,76) = 9.70, p = 0.003]. Aged mice performed significantly worse than young mice 
upon introduction of delays but there was no additional deficit in the aged tg group [delay x geno-
type x age: F(2,76) = 0.08, p = 0.782]. Error bars showed S.E.M.s. 
χ2 
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control animals as well [F(1, 29) = 5.59, p = 0.025]. However, this difference lied in the 
worse performance of young tg animals on the first [F(1, 29) = 5.12, p = 0.031] and second 
[F(1, 29) = 9.95, p = 0.004] but not the third [F(1, 29) = 0.75, p = 0.393] or fourth [F(1, 29) 
= 1.02, p = 0.322] blocks, indicating that young transgenic mice performed worse than 
control animals at the beginning, but equally well by the end of the training. Such an age-
independent learning deficit has been reported earlier in tg2576 (Westerman et al, 2001) 
and other AD models (eg, Chen et al, 2000), and could result from the APP overexpression 
in these animals (Westerman et al, 2001).  
2.2 Delayed T-maze alternation task 
In total, 42 subjects have been included in this phase of experiment (9 young control, 6 
young tg2576, 13 aged control and 14 aged tg2576 animals; the other animals from the 
previous phase of experiment were disgraded because of death or lack of manpower in 
training and recording). When longer delays were introduced, all 4 groups showed poorer 
performance with increasing delay time (Figure 9.1C). A mixed design ANOVA revealed 
significant main effects of delay [F(2, 76) = 9.07, p < 0.001], genotype [F(1, 38) = 7.36, p 
= 0.010], and age [F(1, 38) = 18.02, p < 0.001]. There was also a significant effect of age 
by genotype [F(1, 38) = 5.08, p = 0.030], suggesting that aged transgenic mice performed 
worse than other groups in the delayed alternation task. However, there were no effects of 
delay by genotype by age [F(2,76) = 0.08, p = 0.93], suggesting that introducing a delay 
equally affected these four groups. Thus, in further analysis, performance of all delays was 
pooled together for each group.  
2.3 Probe trials 
There were two broad strategies for the subject to solve the T-maze task, which could 
be easily differentiated by a 180
o
 maze rotation between sample and test trials. If the 
animals were using the extramaze cues to guide their behaviour (extramaze strategy), they 
would go to the opposite location in the environment yet the same arm in the maze, 
whereas if they were using intramaze cues, body turn or path integration (all named 
intramaze strategy in contrast to the extramaze strategy), the same location in the 
environment yet the opposite arm in the maze (for more detailed discussion see the next 
chapter). Factors influencing the subject’s choice of strategies would be discussed in the 
next chapter.  
In total, 41 subjects have been included in this phase of experiment (9 young control, 6 
young tg2576, 13 aged control and 13 aged tg2576 animals). Most tested subjects, 
regardless of genotype and age, have adopted the intramaze strategy. However, some 
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animals have performed in a random manner after maze rotation whereas a few others have 
clearly chosen the extramaze strategy. The adoption of various strategies by different 
subjects made it unreasonable to analyze these data at the group level. However, some 
details of these behavioural results will be discussed in the next section, together with 
electrophysiological data.  
 
Overall, these behavioural results were comparable with earlier studies from other 
groups (Chapman et al, 1999; Corcoran et al, 2002; Barnes et al, 2004) and confirmed an 
age-dependent cognitive impairment in tg2576 mice.  
 
3 Place cell physiology 
Only CA1 place cells were included, based on histological confirmation after all the 
experiment. A typical tetrode track was shown in Figure 9.2A.  
Table 9.1  Summary of place cells included in the analysis in the present study 
 
 Mouse code Total No. of cells 
Total No. of 
recording days 
Averaged No. 
of cells/day 
Young control 
1 
2 
3 
4 
38 
22 
49 
12 
7 
6 
8 
5 
5.4 
3.7 
6.1 
2.4 
Young tg2576 
1 
2 
3 
50 
61 
6 
7 
7 
2 
7.1 
8.7 
3 
Aged control 
1 
2 
3 
4 
5 
83 
42 
37 
42 
36 
8 
6 
4 
7 
4 
10.4 
7 
9.3 
6 
9 
Aged tg2576 
1 
2 
3 
4 
5 
6 
7 
8 
9 
55 
66 
37 
51 
47 
70 
10 
10 
27 
5 
8 
6 
6 
7 
8 
5 
3 
5 
11 
8.3 
6.2 
8.5 
6.7 
8.8 
2 
3.3 
5.4 
 
Figure 9.2
Figure 9.2   Histology. (A) A photograph showing the typical tetrode track in the hippocampus of 
an implanted mouse (cresyl violet staining). Only CA1 place cells were included in the present 
study. (B) Extensive amyloid plaques were detected in brains of aged tg2576 mice with Congo red 
staining. (C) Figure (B) viewed under blue fluoresent light. (D) A higher resolution photograph 
showing amyloid plaques. 
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3.1 Properties of single neurons 
These property measures were obtained in the start box from standard trials.  
Altogether, 121 place cells from young control mice (n=4), 115 from young tg2576 
mice (n=3), 240 from aged control mice (n=5) and 373 from aged tg2576 mice (n=9) were 
included in the analysis of properties (Table 9.1). There were no differences across groups 
regarding the total number of cells [F(3, 17) = 0.50, p = 0.685] or the averaged number of 
cells recorded/day [F(3, 17) = 1.83, p = 0.180].  
A first glance at field maps from different groups of animals suggested that some, but 
not all, aged transgenic animals showed larger and fuzzier place fields than animals of the 
other groups (Figure 9.3A and B). Such an impression was supported by statistical analysis. 
There were significant effects of age on place field size [F(1, 17) = 15.06, p = 0.001], 
spatial information content [F(1, 17) = 17.30, p = 0.001], and peak firing rate [F(1, 17) = 
6.80, p = 0.018], but not on measures of basic neuronal properties, including mean firing 
rate [F(1, 17) = 0.79, p = 0.385], spike width [F(1, 17) = 4.29, p = 0.054] and spike 
amplitude [F(1, 17) = 2.70, p = 0.119], were comparable. However, when aged control 
animals were compared with young controls, no effects were seen in the above measures 
[place field size: F(1, 7) = 3.11, p = 0.121; spatial information content: F(1, 7) = 3.04, p = 
0.125; peak firing rate: F(1, 7) = 0.11, p = 0.756; mean firing rate: F(1, 7) = 0.08, p = 
0.783; spike width: F(1, 7) = 2.77, p = 0.140; spike amplitude: F(1, 7) = 0.004, p = 0.951], 
suggesting that place cells in young and aged control mice were indistinguishable.  
Moreover, age and genotype interactions were found among groups regarding spatial 
information content [F(1, 17) = 4.89, p = 0.041, Figure 9.3C], place field size [F(1, 17) = 
6.10, p = 0.024, Figure 9.3D], and peak firing rate [F(1, 17) = 4.84, p = 0.042, Figure 
9.4B], while mean firing rate [F(1, 17) = 0.28, p = 0.602], spike width [F(1, 17) = 0.33, p = 
0.574], and spike amplitude [F(1, 17) = 2.49, p = 0.133] did not differ amongst the groups 
(Figure 9.4A, C and D). A test of simple effects confirmed that place cell quality did not 
differ across genotypes in young animals [spatial information: F(1,17) = 0.46, p = 0.50; 
place field size: F(1,17) = 0.33, p = 0.57] but did significantly differ in aged animals 
[spatial information: F(1,17) = 8.46, p = 0.01; place field size: F(1,17) = 12.22, p = 0.003], 
suggesting that place cells in aged tg2576 mice showed deficits in representing locations, 
indicated by larger place field size and lower spatial information content. Sample clusters, 
waveforms and autocorrelograms of place cells from an aged control mouse and an aged 
transgenic mouse were shown in Figure 9.5.  
Figure 9.3
Figure 9.3  Degraded place fields in aged tg2576 mice. (A) Four representative place cells 
recorded from one young control mouse (left) and one young tg2576 mouse (right). (B) Four 
representative place cells recorded from one aged control mouse (left) and 4 different aged tg2576 
mice (right 4 columns). Mouse 1 place cells showed the highest mean spatial information across 
aged Tg2576 mice, Mouse 4 the lowest, Mouse 2 and 3 reflected average values. (C) Place cells 
in the aged tg mice had lower spatial information content than aged controls and young animals 
[effect of age: F(1,17) = 17.29, p = 0.001; age x genotype: F(1,17) = 4.89, p = 0.041] (D) Place 
fields were markedly larger in aged transgenic animals [effect of age: F(1,17) = 15.06, p =0.001; 
age x genotype: F(1,17) =  6.10, p = 0.024]. Numbers to the upper left of rate maps in (A) and (B) 
indicated peak firing rates.
A B
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Figure 9.4
Figure 9.4  Basic properties of place cells in four groups of subjects. Aged transgenic mice 
showed lower peak firing rate than other groups [F(1, 17)=4.84, p=0.042, B], whereas mean firing 
rate [F(1, 17)=0.28, p=0.602, A], spike amplitude [F(1, 17)=2.49, p=0.133, C], and spike width 
[F(1, 17)=0.33, p=0.574, D]  were not different across groups. 
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Figure 9.5  Sample clusters and waveforms of place cells. (A) An exemplar cluster plot from an aged 
control mouse. Action potentials were recorded extra-cellularly using tetrodes. Waveform param-
eters (here, peak-to-trough amplitude) for each recorded spike on each wire of the tetrode were then 
plotted against each other. Spikes that formed clearly isolated clusters were defined as being from 
different units (plotted in different colours). (B) Waveforms of two sample place cells from the trial 
in (A). Each waveform plot shows the waveforms on all four tetrode wires (top to bottom), for both 
the mean waveform (right-hand panel) and the overlaid plots of all recorded waveforms (left-hand 
panel). (C) Place fields and temporal autocorrelograms of 500ms for the cells in (A) and (B). (D) An 
exemplar cluster plot from an aged tg2576 mouse. (E) Waveforms of two sample place cells from the 
trial in (C).  (F) Place fields and temporal autocorrelograms of 500ms for the cells in (D) and (E).
Part of this figure was constructed with the aid of Dr Tom Wills. 
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It was interesting and important to note, that the decrease in the accuracy of spatial 
representation was not uniform across the aged tg2576 mice (see Figure 9.2B). Some 
animals showed severely degraded place fields (mouse 4) while the place fields of others 
appeared normal (mouse 1), suggesting a large individual difference within the group.  
Another interesting finding was a strong correlation between the place cell quality and 
the number of place cells detected in the aged tg2576 group. Given that different animals 
received place cell recording for different number of days, the average number of place 
cells recorded per day was calculated for each subject. There were strong correlations 
between the number of cells recorded and the average spatial information content (r = 
0.911, p = 0.001; Figure 9.6A) and between the number of cells recorded and the average 
place field size (r = - 0.891, p = 0.001; Figure 9.6B), suggesting that some aged tg2576 
animals no only had poorer quality place cells, but also had fewer place cells to fire in an 
environment.  
3.2 Place field stability 
Place field stability was examined in standard trials where the start box remained at the 
same place between sample and delay sessions. All four groups showed a high bin-to-bin 
place field stability without age [F(1, 15) = 1.67, p = 0.216], genotype [F(1, 15) = 0.26, p = 
0.618], or genotype by age [F(1, 15) = 0.716, p = 0.411] differences, suggesting that place 
cells from all groups of animals showed similar field stability in a highly familiar 
environment (Figure 9.7).  
Longer-term (eg across-day) place cell stability analysis has not been performed 
because of technical difficulties.  
3.3 7etwork properties 
The high place field stability allowed the examination of hippocampal network 
properties in probe trials, when the start box was rotated 180
o
 between sample and test 
trials. Altogether, 51 place cells from young control mice (n=4), 57 from young tg2576 
mice (n=3), 102 from aged control mice (n=5) and 184 from aged tg2576 mice (n=7, 2 had 
been eliminated from the previous phase because place cells could no longer be recorded 
from them at this stage) were included in the analysis of properties.  
For each pair of recording sessions, bin-by-bin correlations were obtained between the 
pre-sample map and the delay map unchanged (0
o
) or 180
o
 rotated. If the place field 
followed local cues (the box), the 180
o
 rotated map should show a high correlation with the 
pre-sample map. If the field followed distal cues, a high correlation was expected for the 0
o
 
map. However, although place fields showed high correlations (in average >0.5) under 
Figure 9.6
Figure 9.6  Correlations between place cell numbers and place cell quality in aged tg2576 mice. 
The number of place cells recorded from each animals/day was strongly correlated with the 
spatial information content (r=0.911, p=0.001) (A) and place field size (r=-0.891, p=0.001) (B) of 
place cells from the same subject.   
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Figure 9.7
Figure 9.7  Place field stability in a familiar environment. (A) Place cells from four groups of 
subjects had similar field stability in a faminilar environment, as measured by the bin-to-bin 
correlation between pre-sample (6 min) and delay (2 min) recording sessions. Effect of age: F(1, 
15)=1.67, p=0.216; effect of group by age: F(1, 15)=0.716, p=0.411. (B), (C), (D) and (E) Sample 
place fields from animals of each group. 
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standard conditions when the start box remained at the same place (Figure 9.7), these 
values dropped to ~0.2 after either 0
o
 or 180
o
 map rotation. This low level correlation made 
it very difficult to draw convincing conclusions quantitatively about place cell responses to 
maze rotation, even if one could easily tell these cells’ responses (following the box or the 
environment) by checking the field maps.  
This technical failure could result from the following reasons: (1) The delay session 
was 2 min and in a novel location of the environment. Some animals were more cautious in 
exploration under this condition, making it difficult to get enough sampling for field 
analysis; (2) During the rotation process, the whole apparatus (the start box, its floor and 
the T-maze) was on a piece of wood which was a bit slippery, making it difficult to get 
accurate 180
o
 rotations every time; (3) This procedure brought about a conflict between 
local and distal cues, making it unlikely that place cells responded purely to one set of cues 
with complete ignorance of the other; and (4) Some place fields were so small that even a 
tiny shift in the location would produce significantly low correlation values. 
Since this method failed to provide convincing results, a second method was applied. 
For each pair of trials, the rate map of the delay session was rotated every 5
o
 to find the 
angle with the highest bin-to-bin correlation with that of the sample session, and place cell 
responses to the 180
o
 rotation of the apparatus between sample and test trials were 
classified into one of three categories:  
(1) Box-centered: the location of the place field remained stable and always followed 
the box, defined by a >135
o
 angle that showed the highest correlation;  
(2) Environment-centered: the location of the place field remained stable and always 
followed the curtain-enclosed environment (distal cues), regardless of the movement of the 
maze, defined by a <45
o
 angle that showed the highest correlation;  
(3) Remapping: the location of the place field changed in a random manner, defined by 
a >45
o
 yet <135
o
 angle that showed highest correlation.  
It must be noted that these definitions were arbitrary and not totally accurate. For 
example, remapping happened in a totally random manner so some remapping cells could 
be mis-categorized into box-centered or environment-centered groups.  
Next, data were analysed in two ways: subject-based and cell-based, with behavioural 
data discussed as well.  
Subject-based analysis 
In this way, each group’s response to maze rotation was analysed on the basis of 
individual subjects. For each subject, all place cells’ field responses to maze rotation were 
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calculated and the subject’s response to maze rotation was defined as box-centered if more 
than 50% cell fields followed the box, environment-centered if more than 50% cell fields 
followed the environment, and remapping if neither criteria applied.  
(1) Young control: All 4 young control animals followed the box (Figure 9.9A, B). 
Sample place fields were shown in Figure 9.8A and B. Consistently, all of them used 
intramaze strategy to solve the task after maze rotation.   
(2) Aged control: 3 out of 5 subjects in this group followed the box like young controls, 
and the other 2 followed the environment (Figure 9.8C and D, Figure 9.9A, B). Despite this 
dissociation, all subjects showed comparable performance between standard and rotation 
trials, and used box-centered strategy. However, it must be noted that the 2 environment-
centered subjects performed more poorly than the other 3 (Figure 9.9A). These data were 
consistent with data from a rat study, which reported more powerful control of distal cues 
on place cells in aged cognitively impaired rats (Tanila et al, 1997).  
(3) Young tg2576: Among the 3 subjects in this group, 1 mouse, like young wt, 
followed the box and used the same strategy in probe trials. However the other 2 subjects 
remapped and performed in a random manner after rotation (Figure 9.8E and F, Figure 
9.9A, B). This result was particularly interesting, because one of them performed very well 
in standard trials, suggesting, though not proving, that place cell remapping might have 
impaired his performance in probe trials.  
(4) Aged tg2576: 2 animals followed the environment and all the rest in this group 
remapped after maze rotation (Figure 9.8G and H, Figure 9.9A, B). Nearly all subjects 
performed randomly in probe trials, although some were not impaired in standard trials 
(Figure 9.9A).  
(5) Statistical analysis 
Statistics revealed a significant effect of groups [χ2(6) = 15.39, p = 0.017, Figure 9.8A], 
indicating different responses of the four groups to the maze rotation. Further analysis 
showed a difference between aged control and aged tg2576 [χ2(2) = 7.89, p = 0.019], and a 
nearly significant difference between young control and young tg2576 [χ2(1) = 3.73, p = 
0.053]. These data suggest different hippocampal network dynamics between wild-type 
and transgenic animals in response to environmental manipulations, which could be present 
as early as 4-5 months of age. However, a clear conclusion could not be drawn given the 
relatively few number of subjects.  
(6) Behaviour-physiology analysis 
1.0 4.2
1.7
2.9 2.5
2.3
Figure 9.8
Figure 9.8  Sample place cell responses to maze rotation in probe trials. All young control 
animals followed the box (A) and (B). Some aged control animals followed the box (C) while 
others followed the environment (D). As for the young tg2576 group, some animals followed the 
box (E) whereas others remapped (F). Most aged tg2576 anmials remapped (G) but two of them 
followed the environment (H). When the cell followed the box, its place field should be 180 
degree opposite between pre-sample and delay sessions. When followed the environment, nearly 
identical. When remapped, the place field changed its location in a random way. 
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Figure 9.9  Subject-based analysis of electrophysiological and behavioural responses to maze 
rotation in probe trials. (A) Proportions of cell response to maze rotation in all subjects. All young 
control animals followed the box. Some young tg2576 animals followed the box whereas others 
remapped. As for the aged control group, some followed the box while some followed the envi-
ronment. All but two aged tg anmials remapped. Each subject’s performance in the standard and 
probe trials was shown underneath its own column. (B) Different groups of animals responded to 
maze rotation in different ways [   (6) = 15.39, p = 0.017]. (C) Performance in standard and probe 
trials categorized by cell responses. The environment-centered and remapping groups were 
cognitively impaired compared with the box-centered group [F(2, 16)=5.84, p=0.012]. 
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All subjects, regardless of their age and genotype, were divided into three groups based 
on their place cell responses to maze rotation, and their performance in standard and probe 
trials was compared (Figure 9.9C). Statistics indicated an effect of groups [F(2, 16)=5.84, 
p=0.012], indicating performance differences among groups, and an effect of training 
condition [F(1, 16)=12.73, p=0.003], suggesting that animals performed better in standard 
trials than in probe trials, but no effects of interactions [F(2, 16)=1.28, p=0.304]. Further 
analysis indicated a difference between box-centered and environment-centered groups 
[F(1, 10)=6.12, p=0.033], a difference between box-centered and remapping groups [F(1, 
13)=11.65, p=0.005], but no differences between environment-centered and remapping 
groups [F(1, 9)=0.011, p=0.909], suggesting that environment-centered and remapping 
animals were cognitively impaired compared with box-centered animals.  
Cell-based analysis 
An alternative strategy to analyze these data was to pool all the cells of the same group 
of animals together. In this way, instead of getting a categorization for each individual 
subject, a categorization for the whole group was obtained.  
(1) Young control: Consistent with subject-based analysis, fields of most cells from 
this group followed the box (Figure 9.10A).   
(2) Aged control: Consistent with subject-based analysis, fields of most cells from this 
group followed the box (Figure 9.10A).  
(3) Young tg2576: Inconsistent with subject-based analysis, fields of most cells from 
this group followed the box (Figure 9.10A). This was mainly because we had far more 
number of cells from the subject following the box than the other two remapping subjects.  
(4) Aged tg2576: Fields of most cells either followed the environment or remapped 
whereas only a minority of cell fields followed the box (Figure 9.10A). This result was 
slightly different from the subject-based analysis but the consistent point was that place 
fields from this group did not tend to follow the box as control mice, young and aged.  
(5) Statistical analysis 
Statistics revealed a significant effect of groups [χ2(6) = 87.47, p < 0.001], indicating 
different responses of the four groups to the maze rotation. Further analysis showed a 
difference between aged control and aged tg2576 [χ2(2) = 37.65, p < 0.001], and a 
significant difference between young control and young tg2576 [χ2(2) = 12.16, p = 0.002]. 
These statistical data were consistent with subject-based analysis and suggested different 
hippocampal network dynamics between wide-type and transgenic, even at a young age.  
(6) Behaviour-physiology analysis 
Figure 9.10  Cell-based analysis of electrophysiological and behavioural responses to maze rota-
tion in probe trials. (A) Proportions of cell response to maze rotation in each group. Responses 
from transgenic groups differed from control groups at both young [    (2) = 12.16, p = 0.002] and 
aged [    (2) = 37.65, p < 0.001] stages. (B) Performance in standard and probe trials of the four 
groups. Maze rotation caused a significant performance drop for all groups [F(1, 30)=10.36, p = 
0.003], but not interactions were detected, suggesting that this manipulation affected four groups 
equally. 
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Statistics revealed a significant effect of maze rotation [F(1, 30)=10.36, p = 0.003], 
suggesting that this manipulation induced a performance drop (Figure 9.10B). However, 
this procedure affects different groups to the same level, since no interactions of rotation by 
age [F(1, 30) = 0.51, p = 0.481], or rotation by genotype [F(1, 30) = 0.91, p = 0.347], or 
rotation by age by genotype [F(1, 30) = 0.16, p = 0.697] were detected.  
 
The small discrepancy between subject-based and cell-based analysis, especially in the 
young transgenic group, mainly resulted from the relatively small number of subjects and 
varied numbers of cells from each subject. However, given that this was only the pilot 
work in this field, further research needs to be performed to clarify this potential 
hippocampal network difference.  
3.4 Distal cue rotation 
An academically uninteresting explanation for the above behavioural and physiological 
changes in tg2576 mice was that these animals, instead of having spatial cognition deficits, 
experienced visual disabilities and could not see clearly. However, this possibility was 
unlikely, since this model had been well characterized previously and no such problems 
had been reported, even in experiments specifically designed to test their visual abilities 
(eg, Hsiao et al, 1996; Westerman et al, 2001; Barnes et al, 2004). In the present study, a 
small subset of subjects underwent a series of distal cue rotation recording sessions by the 
end of the whole experiment. No all the subjects received this procedure either because 
place cells could no longer be recorded from them by this stage, or because their place 
fields were too disrupted or unstable to draw any clear conclusions. However, place cells 
from all tested animals consistently followed the distal cues in these sessions, further 
arguing against the possibility that these animals had visual problems. Sample place fields 
were shown in Figure 9.11.  
 
4 Histology 
All aged transgenic animals showed amyloid plaques in their neocortex and 
hippocampus (Figure 9.2B-D; Figure 9.12A-C). In contrast, none of the animals in the 
other 3 groups had plaques. Again, the pathological change in aged tg2576 mice was not 
uniform across subjects. Some animals showed large amounts of plaques (mouse 4) 
whereas some others had relatively few (mouse 1) (Figure 9.12A-C). Additionally, aged 
transgenics had elevated levels of soluble and total Aβ (Table 9.2).  
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Figure 9.11  Distal cue rotation experiment. (A) Place cells from a subset of subjects were 
recorded in a cylinder for three sessions. In the first and third sessions, the distal cues remained 
the same as  before (behavioural training and recording). In the second session, these cues were 
rotated 180 degree. Place cells recroded from all subjects followed the distal cues consistently 
during these sessions, indicating normal visual abilities of these animals. Two sample place fields 
from one mouse of each group were shown in (B) - (E).
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Figure 9.12   Percentage of hippocampal area occupied by amyloid plaques inversely correlated 
with place cell quality and behavioural performance. (A-C) Photomicrographs of 7-µm coronal 
sections through the dorsal hippocampus of three aged Tg2576 mice showing highest (A), mean 
(B) and lowest (C) hippocampal levels of congophilic plaques deposition. (D) Place cell spatial 
information was negatively correlated with the percentage area of the hippocampus covered by 
congophilic plaques of aged Tg2576 mice (r = -0.70, p = 0.036). (E) Place field size was posi-
tively correlated with hippocampal amyloid plaques deposition (r = 0.72, p = 0.029). T-maze 
alternation rate was negatively correlated with the percentage area covered by congophilic 
plaques of the hippocampus (r = -0.86, p = 0.003) (F) and the overlying neocortex (r = -0.83, p = 
0.006) (G).  Scale bar in (A-C) = 100 µm.
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5 Correlation 
Since we had three measurements for each subject (behaviour, place cell physiology, 
and brain pathology), three sets of correlational analysis have been performed.  
5.1 Behaviour and place cell physiology 
Performance on the T-maze alternation task is highly dependent on the hippocampus 
(Deacon et al, 2002): does it correspond to the amount of spatial information carried by the 
place cell population? The variability of both place cell firing quality (Figure 9.3) and 
behavioural performance (Figure 9.1) across the aged transgenic population allowed us to 
test this hypothesis. With place field size and spatial information content as indexes of the 
quality of place cell signalling in the aged (tg2576 and control) animals, there was a good 
correlation with behaviour averaged across all delays (Figure 9.13). This pattern of 
correlations did not change if the performance of three aged tg2576 animals performing at 
less than 50% correct is set to 50% (place field size: r = 0.76, p = 0.001; spatial information 
content: r = 0.76, p = 0.002).   
5.2 Pathological correlates 
Next, in order to identify the potential amyloid species responsible for the behavioural 
and physiological alterations observed in the tg2576 mice, dense core amyloid plaques in 
the hippocampus and overlying neocortex were stained with Congo red, and the 
concentration of soluble and total amyloid in the brain were assessed using a standard 
sandwich ELISA assay. There was a good correlation between congophilic (compact) 
amyloid plaque burden in the hippocampus (Figures 9.10A, B and C) and the spatial 
information content of hippocampal place cells (Figure 9.12D) and their place field size 
(Figure 9.10E). The plaque burden in the overlying neocortex did not correlate with 
hippocampal spatial representation quality (spatial information content, r = -0.61, p = 
0.084; place field size: r = 0.62, p = 0.076; Figure 9.14) nor did the amount of soluble and 
total amyloid in the entire brain  (Table 9.3). In addition, there was a strong correlation 
between each animal’s overall performance on the spatial memory task and the burden of 
Table 9.2  Soluble and total Aβ amount of four groups (nM; mean ± S.E.) 
 
 Soluble Aβ1-40 Soluble Aβ1-42 Total Aβ1-40 Total Aβ1-42 
Young control 0.64 ± 0.10 0.37 ± 0.20 2.14 ± 0.21 2.83 ± 0.87 
Young tg2576 0.69 ± 0.23 0.75 ± 0.69 3.42 ± 0.06 1.93 ± 0.95 
Aged control 0.61 ± 0.16 0.23 ± 0.08 1.59 ± 0.14 2.04 ± 0.09 
Aged tg2576 292.33 ± 67.66 50.22 ± 14.95 982.20 ± 126.86 300.05 ± 78.23 
 
Figure 9.13
Figure 9.13  Correlations between T- maze performance and place cell quality in aged mice. (A) 
Mean spatial information content was positively correlated with alternation rate in aged tg 
animals (red squares) and aged control animals (blue diamonds) (r = 0.83, p < 0.001). (B) Mean 
place field size was inversely correlated with alternation rate (r = 0.83, p < 0.001). Alternation 
rates were means of three delays tested (15-secs, 2 min and 6 min).  
A
B
Figure 9.14
Figure 9.14  Percentage of cortical area occupied by amyloid plaques did not correlate with 
spatial information carried by place cells (r = -0.61, p = 0.084) (A) or mean place field size (r = 
0.62, p = 0.076) (B).
A
B
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
0.000 0.100 0.200 0.300 0.400
Cortical Plaques (%)
S
p
a
ti
a
l 
In
fo
rm
a
ti
o
n
 (
B
it
s
/S
p
k
)
30.00
35.00
40.00
45.00
50.00
0.000 0.100 0.200 0.300 0.400
Cortical Plaques (%)
F
ie
ld
 S
iz
e
 (
%
 E
n
v
)
 132
Table 9.3 Correlations of brain Aβ load with place cells’ properties and behaviour 
 
 Soluble Aβ1-40 Soluble Aβ1-42 Total Aβ1-40 Total Aβ1-42 
Spatial info r=-0.47, p=0.20 r=-0.37, p=0.33 r=-0.43, p=0.25 r=-0.42, p=0.26 
Field size r=0.48, p=0.19 r=0.39, p=0.30 r=0.40, p=0.28 r=0.38, p=0.31 
% Correct r=-0.68, p=0.04* r=-0.70, p=0.03* r=-0.36, p=0.34 r=-0.70, p=0.04* 
 
* p value significant at the 0.05 level. 
plaques in hippocampus (Figure 9.12F) and in the neocortex (Figure 9.12G). Behavioural 
performance also correlated well with both soluble and total levels of Aβ−42 (Table 9.3).  
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Discussion 
 
Chapter 10   Discussion 
 
 
This chapter discusses possible explanations for the findings reported in the previous 
chapter, limitations of the present study, and potential future work.  
 
1 Summary of main findings 
1.1 Behaviour 
The present study has confirmed previous findings that tg2576 mice showed an age-
dependent impairment in spatial learning and memory.  
1.2 Place cell physiology 
Similar to spatial cognition, tg2576 mice showed degraded place cell representation of 
the environment in an age-dependent manner. Place cells in aged transgenic animals had 
reduced spatial information content and increased average field size, but their stability in a 
familiar environment and basic properties such as mean firing rate and spike measures 
were similar to controls.  
At the network level, transgenic mice responded to environmental manipulation in a 
different way compared with control animals. Whereas place cells from all cognitively 
normal control animals followed the box after maze rotation, fewer cells from transgenic 
animals did in this way. Instead, many of them followed the environment or remapped. 
This difference could be present even at a young age when cognitive impairment was 
absent. However a clear conclusion could not be drawn because of the small number of 
subjects available.  
1.3 Pathology 
As described in previous studies, aged (>15 months) tg2576 mice but not young 
transgenics or control animals showed elevated levels of soluble and total Aβ and 
developed amyloid plaques.  
1.4 Correlation 
In aged transgenic animals, there was quite large inter-subject variability regarding 
both the performance in the T-maze alternation task and place cell quality. These two 
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measurements were strongly correlated with each other, and were associated with 
hippocampal plaque burden.  
 
2 Cognitive impairment in tg2576 mice 
2.1 The T-maze alternation task 
The forced T-maze alternation task is frequently used to assess spatial working 
memory in animals. This is based on the fact that rodent species show a tendency to 
alternate their entries to left and right arm of a symmetrical T-maze. The rate of alternation 
depends on mouse strain, maze type, age of subjects, and the integrity of the septo-
hippocampal system (Brito and Thomas, 1981).  
An important issue is how the animal actually solves the task. These are at least four 
strategies available for the subject:  
(1) The extramaze strategy (sometimes called place, spatial, or allocentric strategy in 
the literature): the subject uses spatial relationships between extramaze landmarks to 
identify its location within the environment in the sample trial, and avoids it in the free trial 
(“I was in the east arm in the sample trial, so should go to the west arm in the test trial.”) 
This strategy depends on the hippocampus (O’Keefe and Nadel, 1978);  
(2) The intramaze map strategy: the subject uses the structure of the T-maze as the 
guidance cue to solve the task (“I went to the right arm in the sample trial, so I should go to 
the left one in the test trial.”). The hippocampus is also responsible for this strategy.  
(3) The intramaze body-turn strategy (sometimes named the response strategy): the 
subject tracks his self-motion in the T-maze during the sample trial, and makes the 
alternative turn in the free trial (“I turned right in the sample trial, so should turn left in the 
test trial.”). It is not clear which brain regions primarily mediate this strategy, but the 
hippocampus (McNaughton et al, 1996) and the striatum (Packard et al, 1996; Chang and 
Gold, 2003) may be involved. 
(4) The intramaze local cue strategy: the animal may use some uncontrolled local 
cues (for example, a small mark in one of the two maze arms, or olfactory cues in the maze) 
to identify his choice in the sample trial and turns in the other direction in the test trial. In 
this way this task becomes a recognition task that depends on peri- or post-rhinal cortex 
(Bussey et al, 1999). However, in the present study, this possibility has been eliminated, 
since the T-maze is always replaced with another identical one between sample and test 
trials.  
There are several factors that influence the subject’s choice of strategies in the T-maze. 
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Indeed, animals may use a combination of these strategies in performing the task 
(Dudchenko, 2001). In general, animals trained in enriched environments are more likely to 
use the extramaze strategy than those trained in blank environments (Dudchenko, 2001). 
Additionally, animals tend to use the extramaze strategy in the early phase of training, but 
the intramaze strategy when they are over-trained (Packard et al, 1996; Chang and Gold, 
2003).  
Whichever strategy used, the animal must form a cognitive map that represents the 
environment, and retain information from a specific sample trial until the test trial, to 
successfully solve this task. Both procedures are sensitive to hippocampal damages 
(O’Keefe and Nadel, 1976; Aggleton et al, 1986; Deacon et al, 2002). However, there are 
some differences between these two situations. If the deficit results from an impairment of 
encoding spatial information, introduction of delays between sample and free trials will not 
influence the performance. In contrast, if the animal is unable to hold the trial-specific 
information, the impairment is only apparent when longer delays are introduced (Barnes et 
al, 2004). In this way, introduction of delays between sample and test trials can easily 
differentiate these two mechanisms.  
2.2 Cognitive dysfunction of tg2576 mice 
A number of studies have examined cognitive function of tg2576 mice, some of them 
using the forced T-maze alternation task. Despite some differences regarding the training 
procedure (trial numbers, learning criterion, introduction of delays and so on), these studies 
have reached very similar conclusions: aged (>10 months), but not young (3-5 months) 
transgenic mice show an impairment in acquiring this task. In a recent study, Barnes et al 
(2004) attributed this deficit to impaired spatial processing and encoding abilities in the 
aged transgenics, instead of an increased forgetting rate or interference. Additional support 
comes from two studies from the same group, showing that aged tg2576 mice are able to 
detect object novelty as well as control mice but show impaired conjunctive memory for 
specific object-location associations (Hale and Good, 2005; Good and Hale, 2007).  
The current study has clearly confirmed these results. Performance of aged tg2576 
animals was inferior to both young transgenic animals and aged control animals. Although 
the poor performance even at the shortest delay prevented an adequate assessment of the 
effects of retention interval and the conclusions from Barnes et al, 2004, we have directly 
examined the spatial encoding abilities of aged transgenics, by recording place cell 
activities in these animals.  
Another finding from the present study is the performance impairment in young 
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tg2576 mice. These animals performed worse than controls when the training began. 
However, their performance became indistinguishable from controls in the end. Such an 
age-independent learning deficit has been reported in the same model in the conventional 
water maze task and could result from APP overexpression (Westerman et al, 2001).  
 
3 Place cell physiology in AD: 7euronal properties 
3.1 Place cell properties of tg2576 mice 
The present study is the first attempt to examine place cell properties in a model of AD. 
It is interesting to compare current findings with those from studies on normal aging, given 
these two conditions, though different in nature, share some similarities both behaviourally 
and physiologically (chapters 1-3).  
Although some early studies reported larger firing fields in aged rats (Barnes et al, 
1983), later studies failed to replicate such a result. Individual place cells in aged rats seem 
to hold similar spatial information to young rats (Mizumori et al, 1996; Tanila et al, 1997). 
Only one study has examined place cell physiology in aged mice, which yielded very 
different results from rat studies. Yan et al (2003) reported lower spatial specificity and 
selectivity in of place cells in aged mice, which mainly resulted from higher firing rates 
outside the place field. The stability of place fields after a 24-h interval was also lower in 
old mice than in young mice. 
Data from the present study were consistent with rat studies, and showed that place 
cells in aged transgenic animals show lower spatial content than those of their age-matched 
controls. This difference is unlikely to result from changes in the basic properties of 
hippocampal neurons in aged transgenic animals, since their wave amplitude, wave width 
and global mean firing rate are not different from other groups. In contrast, place cells in 
these animals show significant deficits in all spatial measures, including spatial information, 
field size and peak firing rate. Although place field stability in aged transgenic group was 
comparable with other groups, it must be noted that place fields in this group are 
significantly bigger and fuzzier than others, making it difficult to detect deficient stability 
with the bin-to-bin correlational analysis. Another intriguing finding was that aged 
transgenic animals with poor quality place cells also had fewer cells than those with high 
quality cells. Given that there is no neuronal death in the tg2576 model, this difference 
must result from cell dysfunction. That is, sensory or contextual information that drives 
place cell firing in normal animals can no longer do so in some aged tg2576 mice.  
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In this way, the ability of hippocampal place cells to code for locations in an 
environment is impaired in aged tg2576 animals. The demonstration of a deficit at the level 
of place cell representations complements previous findings of a deficit in hippocampal 
LTP and/or basic synaptic transmission in these animals (Chapman et al, 1999; Fitzjohn et 
al, 2001). According to the cognitive map theory (chapter 6), populations of place cells 
form a cognitive map that provides the necessary spatial information of the environment 
and enables successful navigation. In theory, a larger field size and/or a lower spatial 
information content decreases the cell’s ability to encode and process locational 
information, whereas few place cells provide less locational information for the subject as a 
whole. However, the exact field size or amount of spatial information that support 
successful spatial navigation remains unclear. But consistent with this theory, breakdown 
of such a physiological system in aged tg2576 mice, indicated by the significantly lower 
spatial information and larger field size of their place cells, is accompanied by severe 
spatial cognitive deficits, as in some other transgenic lines (e.g. McHugh et al, 1996; 
Nakazawa et al, 2002; chapter 5). The present data have also directly confirmed 
conclusions from Barnes et al (2004), that impaired spatial processing and encoding 
abilities in aged tg2576 mice underlie their behavioural deficits in the T-maze, because 
these two measurements are correlated with each other (Figure 9.13).  
3.2 Possible sources of place cell dysfunction 
Given that tg2576 mice do not show neuronal loss despite immense pathology, it is 
rational to attribute the changes of place cell properties to the dysfunction of the 
hippocampal network, rather than a simple structural breakdown of it (neuronal death). 
Functionally, there are several possible sources of the place cell dysfunction.  
The hippocampus 
The most straightforward explanation is that mechanisms within the hippocampus 
attribute to this dysfunction. Anatomically, the hippocampus receives highly processed 
multimodal information from widespread cortical areas (chapter 4). Functionally, it is well 
accepted that the hippocampus is crucial for spatial cognition. Rodent hippocampal 
neurons encode the spatial location of the subject in an environment (chapter 5). The fact 
that place cell firing quality correlates better with hippocampal pathology, with only a non-
significant trend towards correlation with neocortical plaques suggests that mechanisms 
within the hippocampus are the primary contributing factor to place cell dysfunction in the 
tg2576 model. 
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AD selectively implicates the hippocampus and related structures (chapter 2). The 
hippocampus of aged tg2576 mice are characterized by massive amyloid plaques and 
elevated levels of Aβ, both of which are neurotoxic and may induce neuronal dysfunction 
(chapters 2 and 3). The perforant path that projects from the entorhinal cortex to the dentate 
gyrus is among the most vulnerable pathways in the cortex with respect to both aging and 
AD pathology (Scheff et al, 1996). There are also reports of decreased spine density in the 
outer molecular layer of the dentate gyrus in tg2576 mice (Jacobsen et al, 2006; Dong et al, 
2007). Anatomically, the entorhinal cortex provides most of the cortical input to the 
hippocampus. Damages to the perforant pathway and the dentate gyrus deprive the 
hippocampus of these inputs and result in an isolation of the hippocampus from the rest of 
the brain, which could explain the significantly smaller number of place cells in some aged 
tg2576 mice. Within the hippocampus, substantial synaptic loss and impaired synaptic 
plasticity have been repeatedly demonstrated in aged tg2576 mice (Chapman et al, 1999; 
Fitzjohn et al, 2001; Jacobsen et al, 2006; chapter 3). All these changes impact the 
hippocampus’ ability to receive, integrate and process spatial information, and may result 
in disrupted place cell representations of the environment, as seen in the present study.  
The entorhinal cortex 
Similar to the hippocampus, the entorhinal cortex is early involved in AD (chapter 2). 
In AD patients, the entorhinal cortex shows even earlier pathological changes than the 
hippocampus (Thal et al, 2000; chapter 2). Yet no studies have examined this issue in 
tg2576 mice.  
In recent years, especially with the discovery of grid cells (Hafting et al, 2005), the 
involvement of the entorhinal cortex in spatial cognition receives more and more attention. 
The hippocampus and entorhinal cortex are related structures located in the medial aspect 
of the temporal lobe. Anatomically, the entorhinal cortex provides most of cortical input to 
the hippocampus, and all three subregions of the hippocampus are directly innervated by 
the entorhinal cortex (chapter 4). Grid cells in this structure show strong spatial modulation 
(Hafting et al, 2005; Sargolini et al, 2006; chapter 5). According to some computational 
models (Burgess et al, 2007), the entorhinal cortex is the primary region of path integration 
and the firing of place cells is driven by a number of entorhinal grid cells (chapter 5). If this 
hypothesis were correct, functional changes of the entorhinal cortex would definitely 
induce hippocampal dysfunction, and one possible source of disrupted place cells in aged 
tg2576 mice could be disrupted grid cells in the same subjects. However, whether this is 
correct remains unclear until grid cell activities are recorded in these animals.  
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Association cortex 
In addition to the hippocampus, neocortex, especially association cortex, also shows 
severe amyloid pathology in aged tg2576 mice (chapters 6 and 9). These areas received 
information from primary cortex and then relay it to the hippocampal formation. Damages 
to these regions deprived the hippocampus of sensory information about the environment, 
which is crucial for spatial cognition. However, the exact working mechanisms of 
association cortex remain poorly understood, making it difficult to judge their role in the 
place cell dysfunction seen in the present study. 
The cholinergic system 
Another possible source of place cell dysfunction is the basal forebrain cholinergic 
system, which is involved in the neural processing of learning and memory as well as 
attention (Geula, 1998). The cortical cholinergic system originates from a large population 
of neurons in the basal forebrain and innervates the entire cortical mantle. Among all brain 
areas, the hippocampus shows the highest density of cholinergic axons (chapter 2). Lesions 
or other manipulations of the cholinergic cells of the basal forebrain interfere with the 
cholinergic innervation of the cortex and impair learning, memory and attention in a 
number of animal species (for a review, see Geula, 1998). The cholinergic basis of this 
deficit was demonstrated through the reversibility of memory loss by cholinergic agonists. 
The basal forebrain cholinergic system also appears to be vulnerable to the pathology 
of AD (Geula, 1998). The loss of cholinergic axons is not uniform, in that the areas with 
the greatest loss of cholinergic innervation are all in the temporal lobe, including the 
entorhinal cortex and the hippocampus (Geula and Mesulam, 1996). The frontal and 
parietal association areas, as well as the insula and temporal pole, show an intermediate 
magnitude of loss. Consistent with the loss of cortical cholinergic axons, the cholinergic 
neurons of the basal forebrain from which these axons emanate also display a major loss in 
AD (Lehericy et al, 1993). Deficits to this system have also been reported in the tg2576 
model (Apelt et al, 2002; Luth et al, 2003; Klingner et al, 2003).  
The head-direction system 
This system provides head direction information to the hippocampus, which is 
important for spatial orientation of the subject in an environment, and its disruption 
severely influences place cell activities (chapter 5). In the present study, one interesting 
phenomenon that happened occasionally in some aged transgenic animals was that all place 
fields rotated 90
o
 coherently across two standard trials (data not shown). This indicates that 
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aged transgenic animals may have an unstable head-direction system. However, physiology 
of head-direction cells in AD or aging remains unexamined. 
The noradrenaline and olfactory system 
The locus coeruleus (LC) is the main source of cortical noradrenaline (NA), and the 
LC/NA system is functionally involved in selective attention, arousal, learning, and 
adaptative behavioural responses (Berridge and Waterhouse, 2003). A dysfunction of the 
noradrenergic system has thus been proposed to be involved in the progression of dementia 
in AD (Marien et al, 2004). In rodents, LC/NA neurons provide strong projections to the 
olfactory bulb (McLean et al, 1989), and it is well known that rodents depend heavily on 
olfaction in their social behaviours. Consistent with this idea, neurodegeneration of the LC 
and olfactory deficiency have been recognized in AD patients (German et al, 1992; 
Murphy, 1999; Marien et al, 2004), as well as the tg2576 model (Guerin et al, 2007). The 
locus coeruleus degeneration in tg2576 mice happened between the age of 6.5 and 8 
months, and was associated with olfactory memory impairments (Guerin et al, 2007). In 
the present study, local olfactory cues were removed by maze replacement during 
behavioural testing and by constant cleaning during recording, but an NA-system-induced 
place cell dysfunction cannot be ruled out.  
The visual system 
Finally, the explanation that all physiological deficits detected could simply result from 
disrupted basic sensory functions in aged transgenic animals, i.e., the animal could not see 
the distal cues as clearly as controls, is not plausible. It is well accepted that basic sensory 
(except olfactory) and motor functions of AD patients remain largely intact even at late 
stages of the disease (chapter 1). Additionally, the tg2576 model is one of the earliest and 
best characterized AD models and no studies have ever reported visual dysfunction of these 
animals (chapter 3). For example, these mice acquire an intramaze brightness 
discrimination task, a simple room discrimination task, and a contextual biconditional left-
right discrimination task as well as control animals (Barnes et al, 2004). The distal cue 
rotation experiment in the present study also excludes such a possibility. However, it needs 
to be noted that deficits in the cholinergic system may affect visual attention, which is a 
potential mechanism for place cell activity changes (Wilson et al, 2004).  
 
4 Place cell physiology in AD: 7etwork properties 
In the present study, the network properties of the animals have been examined by a 
simple maze rotation. Before discussing these data, I will restate results from studies 
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described in the “angular cue dissociation” part of chapter 5. Briefly, many of these studies 
report dissociations of place cells in response to environmental manipulations, in that some 
cells follow distal cues whereas others follow proximal cues. The maze rotation in the 
present study is similar to but also different from manipulations used in these studies. 
Similar, because in both cases there is a conflict between distal and proximal cues and 
hippocampal responses to such a conflict are examined. Different, because in the present 
study the animals are performing a spatial memory task whereas in those studies the 
animals are just performing free navigation.   
Regardless of genotype and age, three different cell responses have been seen in the 
present study: following the box, following the environment, and remapping. Where does 
such a difference come from? It has been suggested that multiple input sets cooperate (or 
compete) to determine the activity of place cells (O’Keefe and Nadel, 1978; chapter 5). 
These functional input sets include external landmarks (including both proximal and distal 
cues) and internal or interceptive information derived from idiothetic or path integration 
system. Individual place cells have multiple firing correlates elicited by different sensory 
inputs or behavioural patterns (chapter 5). The various cell responses to maze rotation by 
different subjects seen in the present study suggest that varied sets of external or internal 
information dominate in each of them.  
In control animals, young and aged, most cells followed the box, suggesting the 
dominance of proximal cues in these animals. Supposedly, these are “normal” animals but 
such a response seems to be inconsistent with angular cue dissociation studies (chapter 5; 
above). However, a careful examination of the training and recording protocol will 
reconcile this conflict. By the time these mice received rotation trials, they have been 
trained for long periods and are highly familiar with the environment and the task. Under 
such conditions, animals are more likely to use intramaze strategies to solve the task 
(Packard et al, 1996; Chang and Gold, 2003), which is consistent with the behavioural 
results in the present study (chapter 9). In this way, it is not surprising that place cells in 
these animals “ignore” the curtained environment and the idiothetic information, but only 
concentrate on proximal cues (the start box). Indeed a careful examination of Figure 9.10B 
indicates that the performance of both control groups and the young tg2576 group in probe 
trials seems better, though not significantly, than aged tg2576 group, whose cells mostly 
stick to distal cues.  
In aged transgenic animals, most cells followed the distal cues. This result is 
comparable with Tanila et al (1997b)’s work on aged rats and it seems that the encoding 
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strategy of these animals relies on the most consistently available distal cues. There are 
several sources of the weakened control of proximal cues on place cells in these animals. 
First, these animals may have problems detecting changes in the local enclosure. For 
example, they have olfactory deficits. Aged (>6.5 months) tg2576 mice show locus 
coeruleus degeneration and olfactory memory impairments (Guerin et al, 2007), supporting 
this explanation. Second, these animals may selectively encode the most stable spatial cues 
(the distal cues), and ignore the rest. This could result from the specific pathological 
changes in the hippocampus of AD. The subregions that show the most severe damages in 
AD are the dentate gyrus and CA1, but not CA3 (chapter 1). Damages to the dentate gyrus 
reduce sensory input to the hippocampus about the environment, whereas intact CA3 can 
still perform pattern completion (chapter 5). In this way, these animals still hold a 
representation of the environment, but in a rigid manner that new changes cannot be 
incorporated. Reduced
 
cholinergic innervation of the hippocampus in these animals may 
also contribute to this mechanism (Apelt et al, 2002; Luth et al, 2003; Klingner et al, 2003). 
There were also many cells that followed neither distal nor local cues. These cells could 
use idiothetic cues for their firing.  
The situation in young tg2576 mice is difficult to discuss due to the small number of 
subjects in this group. Although the majority of cells from this group followed the box, the 
proportion was significantly less than the young control group. Most of the remaining cells 
remapped. Given that distal and proximal cues were in conflict, idiothetic cues could have 
overridden landmarks in these cells and remapping happens.  
 
5 Molecular correlates of place cell dysfunction 
Pathologically, AD brains are characterized by amyloid plaques and NFTs, plus 
neuronal and synaptic degeneration, inflammation and so on. All these changes are 
potentially neurotoxic and may induce physiological dysfunction. But in the tg2576 model, 
tau pathology and neuronal loss are not apparent, making it plausible to attribute these 
changes to amyloid pathology. However, Aβ deposits in the brains of AD patients and in 
animal models have a variety of morphologies, ranging from soluble Aβ oligomeric entities 
to insoluble fibrillar plaques, and their implication in AD has been heavily debated. The 
present study addressed this issue. The quality of place cell firing on the T-maze task was 
strongly correlated with the levels of congophilic plaque burden, but not soluble forms of 
Aβ. In particular, while behavioural impairments correlated with both cortical and 
hippocampal plaque levels, place cell firing quality correlated better with hippocampal 
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pathology, with only a non-significant trend towards correlation with neocortical plaques. 
This suggests that amyloid deposition in the hippocampus is crucial for hippocampal 
network dysfunction in the tg2576 model.  
Although two previous studies on AD animal models reported correlations between 
amyloid plaque burden and cognitive decline (Chen et al, 2000; Gordon et al, 2001), most 
studies have failed to detect such a relationship (e.g. Terry et al, 1991; Arriagada et al, 
1992; Braak et al, 1998). The number of fibrillar β-amyloid (Aβ) deposits in many areas of 
the cortex does not necessarily correlate with either the onset or the severity of cognitive 
decline (Arriagada et al, 1992; Terry et al, 1996). Additionally, functional deficits and 
synaptic loss have been observed even prior to fibrillar Aβ deposition (Hardy and Selkoe, 
2002). This is frequently interpreted as evidence that amyloid plaques represent end-stage 
remains or by-products of the pathological processes in AD, and that more soluble forms of 
Aβ, instead of plaques, are the primary molecules responsible for the cognitive 
impairments (Hardy and Selkoe, 2002, Westerman et al, 2002). However, the present study, 
together with other recent studies (see below), suggests that compact amyloid plaques may 
be more actively involved in the physiological alterations in AD, which, in turn, result in 
the spatial cognitive deficits observed in tg2576 mice.  
Plaque-related mechanisms 
Aβ neurotoxicity has been demonstrated in cell culture where the extent of toxicity is 
clearly influenced by the aggregation state of Aβ, with fibrillar Aβ being far more toxic 
(chapter 2). There are several ways that plaques can cause physiological dysfunction.  
Firstly, deposition of plaques results in synaptic loss. Abnormal neuronal morphology 
has been observed in several strains of transgenic mice
 
that develop amyloid pathology, 
with the most pronounced changes
 
near dense-cored amyloid plaques.
 
Indeed, amyloid 
plaques are selectively associated with dystrophic neurites in these mice (Noda-Saita et al., 
2004), and such deposits have been associated with local structural disruption of synapses 
and breakage of neuronal branches (Tsai et al, 2004). Specifically, in tg2576 mice synapse 
density is lower in areas surrounding compact plaques, providing evidence of a spatial 
relationship between synapse loss and β-amyloid plaques (Lanz et al, 2003; Tsai et al, 2004; 
Spires et al, 2005). Dong et al (2007), using electron microscopy, observed overall 
decreases of dendritic synapse density in the proximity of amyloid plaques in the dentate 
gyrus and the entorhinal cortex at 15-18 months of age in tg2576 mice. There was a 
correlation between lower synapse density and greater proximity to β-amyloid plaques. 
However, this study failed to detect overall changes in synapse density in the CA1 subfield, 
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where place cell activity was recorded in the present study. Another study, using intravital 
multiphoton microscopy, produced similar results. Spires et al (2005) revealed dramatic
 
changes of dendritic trajectory and morphology near plaques, with a linear decrement in 
dendritic spine density in the immediate vicinity (~20 µm) of
 
plaques. In a later study from 
the same group (Spires-Jones et al, 2007), the structural plasticity of dendritic spines was 
examined. Tg2576 mice had normal spine density and plasticity before plaques appeared, 
but after amyloid pathology is established, spine elimination increased, specifically in the 
immediate vicinity
 
of plaques. Spine formation was unchanged, resulting in spine
 
loss. 
These data show a small population of rapidly changing
 
spines in adult and even elderly 
mouse cortex; further, in the
 
vicinity of amyloid plaques, spine stability is markedly 
impaired
 
leading to loss of synaptic structural integrity. The
 
change of synaptic structures 
in a pattern that centers on plaques implies a dramatic synaptotoxic effect of dense-cored
 
plaques. Decreased spine density will likely contribute to altered
 
neural system function 
and behavioural impairments observed in
 
tg2576 mice.   
The accumulation of fibrillar amyloid causes not only local structural disruption of 
synapses, but also neurite breakage, which might interfere with the integration and 
propagation of electric signals at the cellular level. Stern et al (2004) compared 
intracellular recordings from neocortical pyramidal neurons in tg2576 mice and showed 
that substantial accumulation of β-amyloid plaques was associated with defects in cortical 
synaptic integration. Spontaneous membrane potential dynamics were similar, suggesting 
that overall levels of synaptic innervation were intact and the deficits resulted from reduced 
synchrony of converging synaptic inputs. Jacobsen et al (2006) recently detected a 
relationship between decreased spine density in the outer molecular layer of the dentate 
gyrus and the declines in LTP and contextual fear conditioning.  
Finally, dense-cored plaques may be selectively neurotoxic. Urbanc et al (2002), using 
triple immunostaining confocal microscopy, compared Aβ deposition, Aβ morphology, and 
neuronal architecture and found that the vast majority of Aβ deposits do not alter the 
neuronal landscape whereas dramatic, focal neuronal toxicity and loss were associated only 
with thioflavin S-positive fibrillar Aβ deposits. This may explain why neuronal loss is not 
apparent in mouse models of AD. ThioS cores occupy only 1~2% of the cortical surface 
and are distributed widely throughout cortical areas. Even if all neurons within ThioS cores 
were lost, this difference in total neuron numbers would be difficult to detect. 
However, it remains difficult to determine whether these neuronal and synaptic changes 
in proximity to β-amyloid plaques are due to some type of plaque-related tissue disruption 
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or to increased concentrations of Aβ oligomers in the local area (next section). Plaques 
could be a source of specifically toxic species of oligomeric Aβ (Walsh et al, 2002), toxic 
plaque-associated free
 
radicals (McLellan et al, 2003), or
 
cytokines and other bioactive 
substances generated by the activated
 
astrocytes and microglia associated with plaques 
(Nagele et al, 2004). It also has been hypothesized that Aβ may be toxic through an 
excitotoxic cascade (i.e. deregulation of calcium homeostasis inducing oxidative stress and 
abnormal increases in glutamate release), which is facilitated by the proximity of plaques 
(Mattson, 1997; McLellan et al, 2003).  
Possible involvement of soluble Aβ and other molecules 
Although structural changes are most pronounced near plaques, indicating focal 
toxicity, these dense plaques only occupy a small proportion of all the brain tissue, whereas 
the synaptotoxic effect and place cell dysfunction extend beyond the immediate vicinity of 
plaques. Additionally, loss of dendritic spines in the dentate gyrus of tg2576 mice could be 
detected in areas with little or no fibrillar Aβ deposition, or before plaque deposition 
(Holcomb et al, 1998; Jacobsen et al, 2006; Dong et al, 2007). In the present study, 
potential hippocampal dysfunction has also been detected at an age when no plaques are 
present. All this evidence implies the involvement of other molecules or a toxic 
environment in the pathogenesis of AD.  
The identity
 
of these synaptotoxic mediators beyond plaques remains uncertain.
 
Recent 
studies have shown that soluble, low-molecular-weight (8-24 kDa) Aβ oligomers target 
synapses
 
in cultured neurons (Lacor et al, 2004) and disrupt cognition when injected into
 
the brain in vivo (Lambert et al, 1998; Walsh et al, 2002; Mattson, 2004; Cleary et al, 
2005). These molecules are present at elevated levels of soluble Aβ species in the vicinity 
of plaques, disrupt synaptic function and impair hippocampal LTP (Larson et al, 1999; 
Moechars et al, 1999; Walsh et al, 2002; Cleary et al, 2005). Involvement of Aβ in 
synaptotoxic processes is further supported by a study showing that clearing Aβ using 
passive or active immunotherapy prevents synapse loss in transgenic mice (Buttini et al, 
2005). Recently, Lesne et al (2006) have identified a 56-kDa soluble amyloid-β assembly 
(Aβ*56), which is responsible for cognitive deficits in middle-aged tg2576 mice when 
plaque formation is not very obvious. This molecule disrupts memory when administered 
to young rats.  
The present results cannot rule out the possibility that place cell degradation and 
behavioural deficits in the tg2576 mice are caused by elevated soluble β-amyloid, and are 
just indirectly related to plaque deposition. Plaques could be a source of these toxic 
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oligomeric species of Aβ (Walsh et al, 2002). The hypothesis that soluble Aβ species are 
contributing to the behavioural impairments observed in the tg2576 mice is supported by 
the observation that soluble levels of Aβ-42 (as well as total Aβ-42) were correlated with 
aged tg2576 animals’ performance on the T-maze task. Additionally, these molecules could 
be responsible for the hippocampal network dysfunction seen in young tg2576 animals. 
One way to test this hypothesis is to examine place cell physiology in middle-aged animals 
with the aid of Aβ antibodies.  
APP transgene 
The final possible source of physiological changes is the APP transgene expressed by 
the transgenic mice. APP itself, in addition to its product Aβ, is able to modulate neural 
activity (Arendt, 2004). The possible involvement of APP overexpression must be carefully 
considered in analysing physiological and behavioural changes of these mice, especially at 
the young age (<6months) when the level of Aβ is low. One way to solve this issue is to 
use transgenic mice overexpressing normal, instead of mutated form of, APP as a control 
group (Westerman et al, 2002).   
 
6 Correlation between physiological and behavioural changes 
The relationship between place cell activity and spatial behaviour of the subject has 
been a hot topic in hippocampal physiology. Whereas some studies have shown a strong 
correlation (O’Keefe and Speakman, 1987; Lenck-Santini et al, 2001), others do not 
(Jeffery et al, 2003) (see also chapter 5). Most of this work was done in normal animals and 
examined the relationship between place cell firing patterns and spatial choices in a 
multiple-choice task. Some groups have produced transgenic animals targeting molecules 
important for spatial learning, and reported disrupted place fields and impaired spatial 
cognition in behavioural tasks (e.g. Tsien et al, 1996; Nakazawa et al, 2002). One 
intriguing finding from the present study is that place cell dysfunction under pathological 
conditions is accompanied by impaired spatial cognition, supporting the view that place 
cells are part of a navigational system. This conclusion is strengthened by the strong 
correlation between the quality of place cell firing and performance levels in the T-maze 
alternation task. These findings have also directly confirmed the conclusion from Barnes et 
al (2004) that the behavioural deficit of aged tg2576 mice results primarily from the 
impairment of the hippocampus to generate an adequate representation of the environment 
within which the task is set.  
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7 Clinical significance 
There is little doubt that the rodent hippocampus plays a vital role in spatial cognition. 
Similarly, it is widely accepted that this brain region is essential for episodic memory in 
humans. According to the cognitive map theory, the rodent hippocampus represents the 
environments and their contents, providing the neural basis for spatial memory and flexible 
navigation. When it comes to humans, this brain region has a broader function, based at 
least in part on lateralization of function. The right hippocampus still encodes spatial 
relationships, whereas the left has the altered function of storing relationships between 
linguistic entities and is more involved in episodic memory (O’Keefe and Nadel, 1978; 
Burgess et al, 2001).  
An episodic memory deficit characterizes early AD and is possibly the most 
devastating symptom in this disorder. Although it is still controversial whether non-human 
species have episodic memory, several groups have identified episodic-like memory in 
rodents and shown that this type of memory is impaired in animals with hippocampal 
pathology (Chen et al, 2000; Dere et al, 2005; Good et al, 2007). Additionally, how place 
cell activities in rodents fit into such an episodic-like memory system has been proposed in 
several models (Ferbinteanu and Shapiro, 2003; Leutgeb et al, 2005; Knierim et al, 2006; 
Smith and Mizumori, 2006). Thirdly, place cell-like cell activities that signal spatial 
information have been detected in the human hippocampus (Ekstrom et al, 2003). And 
finally brain imaging studies have clearly demonstrated hippocampal hypometabolism and 
hypoperfusion in AD patients (chapter 1). All this evidence suggests that hippocampal 
network dysfunction seen in tg2576 mice may also be the neural substrate for cognitive 
impairments in AD patients and research on these animals helps clarify hippocampal 
dynamics in this disorder and possibly, evaluate potential treatment.  
 
8 Limitations of the present study and future prospects 
Despite the significance of these results, the present study bears undeniable limitations, 
which also direct future work.  
Firstly, a general limitation of all animal studies on AD is that none of these models 
fully replicate the pathology and physiology of the human disease. The tg2576 model does 
not show neuronal loss and NTFs, which undoubtedly influence neuronal and synaptic 
function and contribute to behavioural impairment in humans. So results from the present 
study cannot reveal the full picture of the hippocampal network dysfunction in AD. In 
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recent years several double or triple transgenic models have been developed (chapter 3), 
whose pathology is much more similar to AD patients than the tg2576 model. Research on 
these models will better clarify the pathogenesis of AD at the hippocampal network level.  
Secondly, correlation does not mean causation. The actual molecules responsible for 
physiological and behavioural changes remain unknown. Aβ has a variety of morphologies, 
ranging from soluble forms with little β-pleated sheet to dense core compact deposits. Only 
compact plaques and soluble Aβ have been measured in the present study. One way to 
prove the causative relationship is to ameliorate or postpone the development of 
pathological changes in this model and examine the resulting place cell physiology and 
behaviour. Strategies include active and passive vaccination, which has been shown to 
effectively reduce amyloid pathology and improve cognitive abilities (chapters 1-3), or 
other drugs under investigation.  
Thirdly, the recording apparatus (the start box of the T-maze) in the present study is a 
highly familiar environment for the subjects. According to previous studies, effects of 
normal aging on place cell physiology are much more obvious in novel environments or 
after environmental manipulations. Similar procedures can be performed in Alzheimer 
mice to study changes of hippocampal network dynamics in this disorder. In the present 
study, a simple maze rotation has yielded some surprising results, which may be indicative 
of the pathogenesis of very early stages of AD.  
Fourthly, only CA1 place cells have been examined. Within the hippocampus, CA1 and 
CA3 cells show different properties under some conditions, suggesting functional 
distinctions between these cells (chapter 5). Pathologically, different hippocampal 
subregions are not equally affected in AD (chapter 2). Simultaneous recording in multiple 
sites will help clarify such a pattern at the functional level. Additional interesting recording 
sites include the dentate gyrus and the entorhinal cortex.  
Finally, only young (3-5 months) and very aged (14-18 months) animals have been 
included in the present study. Data from previous studies reveal that behavioural, 
physiological and pathological changes of these animals may start as early as 6 months 
(possibly even earlier with data from the present study). Work on these middle-aged 
animals may yield more significant information about hippocampal physiology in AD. 
Indeed some recording has been performed in such animals, though intriguing, these data 
are not enough to draw any clear conclusions.  
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9 Conclusions 
In conclusion, the present study has revealed that tg2576 mice show an age-dependent 
deficit in their neuronal representations of the environment. The level of place cell 
degradation correlates the animal’s poorer spatial memory and with hippocampal but not 
neocortical amyloid plaque burden.  
AD is characterized by severe cognitive impairments at the behavioural level (chapter 
1). Research in the past decades has suggested that AD represents an Aβ-induced synaptic 
failure at the molecular and cellular levels (chapter 2 and 3). The present study has 
complemented these findings and suggests that AD mice have degraded spatial 
representations at the hippocampal network level. The study of place cells in rodent models 
of AD may provide
 
a powerful tool for identifying the pathogenesis and the respective 
contributions of hippocampal and neocortical
 
pathology to the overall cognitive memory 
dysfunction in AD. Place cell recording may also serve as
 
a powerful testing platform for 
therapeutic interventions. 
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Appendix 
 
List of Abbreviations 
 
Aβ 
AD 
ADN 
AMPA 
ANOVA 
APLP 
apoE 
APP 
CA 
CamKII 
ChEI 
CRE 
CREB 
CTF 
DG 
DNA 
DPX 
EC 
EDTA 
EEG 
ELISA 
EPSP 
FAD 
FTDP-17 
GABA 
HDC 
IEG 
iNOS 
KO 
LC 
LDN 
β-amyloid 
Alzheimer’s disease 
anterodorsal thalamic nuclei 
α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
analysis of variance 
amyloid precursor-like protein 
apolipoprotein E 
amyloid β-protein precursor 
cornu ammonis 
Ca
2+
/calmodulin-dependent protein kinase II 
cholinesterase inhibitor 
cAMP-responsive element 
cAMP-responsive element-binding protein 
carboxy-terminal fragment 
dentate gyrus 
deoxyribonucleic acid 
deoxyribonucleic acid 
entorhinal cortex 
entorhinal cortex 
electroencephalograph 
enzyme-linked immunosorbent assay 
excitatory postsynaptic potential 
familial AD 
frontotemporal dementia with Parkinsonism linked to chromosome-17 
gamma-aminobutyric acid 
head-direction cell 
immediate-early gene 
inducible nitric oxide synthase 
knock-out 
locus coeruleus 
latero-dorsal thalamic nuclei 
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LEA 
LED 
LIA 
LTD 
LTP 
MAP 
MCI 
MEA 
MRI 
mRNA 
MS/DBB 
NA 
NFT 
NMDA 
NO 
NT 
PET 
PHF 
PKC 
PS 
PTP 
RNA 
SD 
SE 
SIA 
SPECT 
STP 
lateral entorhinal area 
light-emitting diode 
large irregular activity 
long-term depression 
long-term potentiation 
microtubule-associated protein 
mild cognitive impairment 
medial entorhinal area 
magnetic resonance imaging 
messenger ribonucleic acid 
medial septum/diagonal band of Broca complex 
noradrenaline 
neurofibrillary tangle 
N-methyl-D-aspartic acid 
nitric oxide 
neuropil thread 
positron emission tomography 
paired helical filament 
protein kinase C 
presenilin 
post-tetanic potentiation 
ribonucleic acid 
standard deviation 
standard error 
small irregular activity 
single photon emission computed tomography 
short-term potentiation 
 
 
